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SUMMARY 
Introduction 
Over time and concurrent development of methods to identify and characterise bacteria, the 
lactic acid bacteria (LAB) have undergone multiple taxonomic revisions. As a result of the 
revisionary nature of LAB taxonomy, the historical characterisation of Lactobacillus 
acidophilus has struggled with misidentification and misrepresentation. Now however, due to 
its global use in food products for both flavour and probiotic effect, L. acidophilus is now one 
of the most well physiologically characterised Lactobacillus species. Bifidobacterium bifidum 
and Bifidobacterium animalis subsp. lactis are also LAB that are considered to have probiotic 
effects. Here modern high-throughput next generation comparative genomic techniques are 
used alongside conventional biochemical and molecular typing methods to analyse the sub-
species level diversity of these three probiotic species. 
 
Results 
Randomly Amplified Polymorphic DNA (RAPD) profile similarity analysis showed limited 
strain-level diversity of L. acidophilus. A species specific marker test was developed for L. 
acidophilus and used to search for L. acidophilus in wild rodent and human faeces. No L. 
acidophilus was detected in wild rodent faeces and its carriage in human faeces was highly 
variable. High-throughput next generation sequencing was used to resequence the genomes of 
28 L. acidophilus isolates. Comparing these sequences indicated a high level of genomic 
conservation in L. acidophilus, which was reflected by limited phenotypic diversity. 
Comparative genomics in Bifidobacterium animalis subsp. lactis supported the hypothesis that 
it is a clonally monophyletic species, whereas B. bifidum strains were genomically diverse. 
 
Conclusions 
Methods for phenotypically characterising and typing LAB have generally been superseded in 
accuracy by DNA sequence based methods. Probiotic bacteria display a range of subspecies 
level population structures. Commercial and culture collection L. acidophilus isolates did not 
significantly differ phenotypically, but were distinct when their genome sequences are 
compared. B. bifidum was genotypically diverse at the subspecies level, while B. animalis 
subsp. lactis appeared to be clonally monophyletic. Comparative genomics and genome 
(re)sequencing of probiotic bacteria will become a “gold standard” method for characterisation 
and typing of isolates. 
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1. INTRODUCTION 
1.1. PROBIOTIC BACTERIA – A GENERAL INTRODUCTION 
The indigenous microbiota of the human gut is a heterogeneous community, considered to 
harbour more than 500 bacterial species (Blaut et al., 2002). One of the primary functions 
of this population, at least from the point of view of the host, is to prevent the colonisation 
of the host gut by pathogenic microorganisms. This is achieved in the most part by out-
competing any potential invasive pathogens for metabolic substrates that are abundant in 
the colon (Tuohy et al., 2003). This system for prevention of gut colonisation by pathogens 
is not infallible however, and may be overcome by infection with specific gut pathogens, 
such as Salmonella species. The gut also may be at risk of colonisation by potential 
pathogens in compromised individuals, such as those suffering from bowel cancer or 
Inflammatory Bowel Disease (IBD), and individuals that have gut microbiota 
compromised by antibiotics. The recognition of these factors led to the development of 
foods and supplements that are specifically designed to reinforce the host gut microbiota in 
the face of perturbations by pathogens. These foods and supplements often contain 
microorganisms termed probiotics. 
 
Probiotics are defined as live microorganisms that, when administered in adequate 
amounts, confer a beneficial effect on the health of the host (FAO/WHO, 2001). 
Furthermore, this definition is expanded upon to state that probiotic organisms used in food 
must be capable of surviving passage through the gut. They must therefore be tolerant to 
gastric juices and exposure to bile. In addition, they must be safe and effective, and 
maintain their effectiveness and potency for the duration of the shelf-life of the product 
(FAO/WHO, 2002).  
 
1.1.1. DELIVERY OF PROBIOTICS 
The variety in manufacturing processes enables the delivery of probiotics to the consumer 
in numerous ways, including dairy foods such as fermented milks and cheeses and non-
dairy foods like cereals, to freeze-dried powders, with each delivery matrix contributing 
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differently to the use and probiotic effect of the product. Delivery matrices may influence 
probiotic functionality in numerous ways; including induction of changes in the cell 
composition and physiology of the probiotic, provision of bioactive compounds, delivery 
of fermentation end products such as organic acids and secondary metabolites like 
bateriocins. The palatability of the delivery matrix can also alter the frequency at which 
probiotic products are consumed and incorporated into the diet (Sanders and Marco, 2010). 
Reasonably, all of the above factors could affect product shelf-life and stability, and 
probiotic cell fitness, directly impacting on the quantity of active probiotic delivered to the 
consumer, which forms a vital part of the manufacturers label claim (Sanders, 2008). 
  
1.1.2. HISTORY OF PROBIOTICS AND PROBIOTIC FOOD PRODUCTS 
The earliest observation of the positive role played by some bacteria was made in 1907 
(Metchnikoff, 1907). Metchnikoff hypothesized that the long and healthy lives of 
Bulgarian peasants were due to their consumption of large quantities of fermented milk 
products containing bacteria. The term “probiotic” was initially proposed as an alternative 
to the term “antibiotic”, to describe substances secreted from microorganisms that 
promoted the growth of another rather than retarded it (Lilly and Stillwell, 1965). The term 
probiotic was subsequently redefined to “organisms and substances which contribute to 
intestinal microbial balance”, more closely analogous its meaning today (Parker, 1974). 
Changes to the definition were made again in 1989 (Fuller), 1992 (Havenaar and Huis in’t 
Veld) and 1996 (Schaafsma). These definitions were generally made and refined by 
individuals, rather than the most recent FAO/WHO definition, which was agreed upon at 
committee (FAO/WHO, 2002). 
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1.1.3. COMMON PROBIOTICS AND THEIR SELECTION CRITERIA 
The choice of organisms to administer as probiotic supplements is largely historical and 
does not necessarily take into account the mode of therapeutic or prophylactic action of the 
organism. The historical definition of an organism as probiotic is largely based on years of 
administration to humans with no harmful side effects. Kopp-Hoolihan (2001) sets out a 
range of criteria that should be met by probiotic organisms: 
 
1. The ability to exert a beneficial effect on the host 
2. The ability to survive transit through the gastrointestinal tract 
3. The ability to adhere to the intestinal epithelial cell lining 
4. The ability to produce antimicrobial substances towards pathogens 
5. The ability to stabilise the intestinal microbiota 
 
Probiotics added to food generally meet at least one of these criteria. There is also a 
practical concern for companies that market probiotics, formulations must have a 
reasonable shelf-life and maintain a consistent number of viable organisms during on-shelf 
storage i.e. in between quality control checks and consumption. Table 1.1 lists organisms 
that are commonly added to commercial probiotic formulations intended for human 
consumption, and describes studies of their efficacy in vivo. The most widely used 
probiotic organisms belong to the Lactic Acid Bacteria (LAB) (section 1.2). The genera 
Lactobacillus and Bifidobacterium are the most extensively studied of the LAB. 
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Table 1.1 Bacterial species commonly used in commercial probiotic formulations.  
Genus Species Comments Reference 
Lactobacillus acidophilus Strain LA-5 reduced antibiotic  Associated diarrhoea 
(Ouwehand et al., 2002) 
 casei Strain Shirota shortened rotavirus diarrhoea  
 fermentum  
 johnsonii Strain LA-1 reduced colonisation by Helicobacter pylori 
 paracasei  
 plantarum Strain 299v relieved symptoms of irritable bowel syndrome 
 rhamnosus Strain GG shortened rotavirus diarrhoea 
 salivarius Strain UCC118 relieved symptoms of irritable bowel syndrome 
Bifidobacterium breve Strain 299v relieved symptoms of irritable bowel syndrome (Brigidi et al., 2001) 
 longum   
 bifidum Strain Bb12 shortened rotavirus diarrhoea (Saavedra et al., 1994) 
Enterococcus faecium   
Saccharomyces boulardii Maintenance treatment of Crohn’s disease (Guslandi et al., 2000) 
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1.1.4. MODE OF ACTION AND CLINICAL IMPLICATIONS OF PROBIOTICS 
There are many products available that contain probiotic bacteria, although little in vivo 
evidence exists to document the means by which probiotics confer a beneficial effect on 
the host. Therapeutically, probiotics have been used to modulate immunity, lower 
cholesterol, treat rheumatoid arthritis, prevent cancer, improve lactose intolerance, and 
prevent or reduce the effects of atopic dermatitis, Crohn's disease, diarrhoea, and 
constipation as well as candidiasis and urinary tract infections (UTI) (Reid, 1999). 
 
The adherence of probiotic organisms to intestinal muscosal cells is observed in vitro 
(Greene and Klaenhammer, 1994) and again, is considered to be a vital property of 
probiotic organisms. Little however, is known about persistence times and processes 
associated with probiotics in vitro, and this is set to remain the case until a gut model that 
is suitably analogous to that of a human is developed. Adherence to intestinal cells may not 
occur in vivo at efficiencies suggested by in vitro experimentation, as probiotic feeding 
studies have shown short persistence times of Lactobacillus acidophilus administered 
within a probiotic capsule (Mahenthiralingam et al., 2009), and their application is 
certainly not followed by a high level of intestinal colonisation. Other health promoting 
aspects of probiotics include: the suggested sequestration of low-density lipoproteins 
(Taylor and Williams, 1998) implicated in increased risk of heart disease, improved lactose 
digestion in lactose intolerant individuals (Sanders, 1993) and immune enhancement in 
infants (Schiffrin et al., 1995). 
 
The production of antimicrobial compounds is thought to be an important factor that 
allows specifically Lactobacillus spp. to competitively exclude harmful or pathogenic 
organisms from the human gut. The antimicrobial compounds produced by Lactobacillus 
species in oxygen depleted environments, such as the human gut, include lactic acid, 
diacetyl and β-hydroxypropionaldehyde. Also produced in vitro are bacteriocidal and 
bacteriostatic peptides that have the ability to influence the growth of numerous organisms, 
including members of the genus Lactobacillus (Sanders and Klaenhammer, 2001) and 
other, less closely related foodbourne, disease-causing organisms (Gilliland and Speck, 
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1977). The in vivo production of bacteriocins and bacteriostatic compounds and their 
subsequent role in the gut is much more poorly documented. 
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1.2. THE LACTIC ACID BACTERIA 
LAB constitutes a diverse group of Gram positive, non-sporulating, catalase-negative 
organisms that are found in a number of habitats (Carr et al., 2002). LAB are comprised of 
multiple genera within the order Lactobacilliales that are acid tolerant, of which 
Enterococcus, Streptococcus and Lactobacillus species are among the most well 
characterised.  They are known constituents of the human gut (Arumugam et al., 2011) and 
also occur widely in dairy, meat, plants and fermented products of commercial value (Carr 
et al., 2002). As a result of their ability to rapidly ferment carbohydrates to lactic acid, they 
have become industrially important bacteria and are used in a myriad of food and 
agricultural fermentations worldwide. Their growth causes acidification of food material, 
preserving the product and imparting unique textures and flavours (Kleerebezem and 
Hugenholtz, 2003). Healthy humans and animals are known to carry a number of LAB 
species within their lower digestive tract, and several LAB are now used as probiotics 
(Shah, 2007). The LAB are mostly associated with environments that are rich in nutrients, 
such as the human gut or various food products.  
 
1.2.1. USES OF LAB 
LAB have been used to create fermented food products for thousands of years, in particular 
they are used in the production of fermented milk products including kefir, yoghurt, 
cheeses and butter.  The addition of LAB to create fermented dairy products centres on 
their ability to reduce the pH of the surrounding food matrix, combined with the 
production of bacteriocins and ethanol which inhibit the growth of other spoilage 
organisms and extends the shelf life of the product (Leroy and De Vuyst, 2004). Lactic 
acid production in milk-based products involves the fermentation of lactose to lactic acid. 
The presence of lactic acid in milk products causes alterations in the structure of the 
proteins present, in effect curdling the product. Other products of heterofermentative 
conversion of lactose to lactic acid, such as acetaldehyde and diacetyl, impart unique 
flavours to the products that contain them (Sanders et al., 1996). LAB also predominate in 
other non-dairy fermented food products such as sauerkraut, fermented sausages, 
fermented fish, pickles, sourdough and rice wine (Leroy and De Vuyst, 2004). 
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1.2.2. HISTORY AND TAXONOMY OF THE LACTOBACILLI  
Lactobacillus is a highly heterogeneous genus, encompassing bacteria with a wide range of 
biochemical and physiological properties (Felis and Dellaglio, 2007, Salvetti et al., 2012). 
The genus Lactobacillus is the largest of  those that belong to the LAB, with 185 species 
validly described at the time of writing, and increasing substantially from 145 in 2008  as a 
result of the reclassification of multiple species (Claesson et al., 2008, Euzéby, 1997). 
 
From the initial description of the species Lactobacillus acidophilus in 1920 (Holland) 
until around 1970, many Lactobacillus isolates from human mucosal surfaces were 
collectively identified as L. acidophilus (Figure 1.1). The identification of isolates using 
traditional phenotypic characteristics such as the fermentation of carbohydrates and 
cellular morphology, combined with the lack of a robust taxonomical framework, had 
historically led to such Lactobacillus isolates being incorrectly designated at the genus 
level. The development of polyphasic taxonomic approaches and use of 
molecular/genomic systematics has greatly improved the classification of Lactobacillus 
species, and are a prerequisite characterisation step for probiotic lactobacilli marketed 
commercially (Vankerckhoven et al., 2008). 
 
Traditionally, the identification of lactobacilli has been mostly undertaken phenotypically, 
based in the most part on the fermentation of carbohydrates, cellular morphology and 
Gram staining (Tynkkynen et al., 1999). Key phenotypic characteristics of lactobacilli 
include cells shaped as rods or coccobacilli, metabolism of carbohydrates by fermentation 
and microaerophilic oxygen requirements. They are chemoorganotrophic, requiring rich 
media for growth (Felis and Dellaglio, 2007). Phenotypic methods of identification are still 
in use, but in more recent years the taxonomy of the Lactobacillus genus has changed, 
based on the advent of genomic structure analysis and the further elucidation of 
phylogenetic relationships between Lactobacillus species (Holzapfel et al., 2001). It is now 
considered that the identification of some Lactobacillus species by biochemical methods 
alone is not reliable (Schleifer et al., 1995). 
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The identification and typing of lactobacilli to the strain level is vitally important in both 
an industrial context and for understanding of the diversity of the Lactobacillus genus. 
Many food products and dietary supplements that claim to contain a specific species or 
strain of Lactobacillus may not, in fact, contain that particular organism (Table 1.2) 
(Holzapfel et al., 2001, Yeung et al., 2002, Mahenthiralingam et al., 2009). 
 
In 1980, six DNA-DNA homology groups were identified, facilitating the definition of L. 
acidophilus, Lactobacillus crispatus and Lactobacillus johnsonii as type species for three 
of these groups (Johnson et al., 1980). Above the species level, three groups were initially 
proposed, consisting of the Lactobacillus delbrueckii group, the Lactobacillus 
casei/Pediococcus group and the Leuconostoc group, which also contained lactobacilli 
(Collins et al., 1991). In 1995, the L. delbrueckii group was reassigned to the L. 
acidophilus group (Schleifer et al., 1995), to better represent its group members, despite L. 
delbrueckii existing as the type species. This study had a polyphasic approach, combining 
both fermentation characteristics and 16S rRNA gene sequence analysis to define five 
phylogenetic sub-groups. Since 1995, the genus Lactobacillus has undergone numerous 
taxonomic reconstructions, and at the last review of the taxonomy, the genus Lactobacillus 
(Felis and Dellaglio, 2007) consisted of 14 phylogenetic sub-groups (Table 1.3). 
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Figure 1.1: History of L. acidophilus in the context of the evolving taxonomy of the Lactobacillus genus 
Major milestones in the development of Lactobacillus taxonomy, and the resulting effects on the taxonomic placement of L. acidophilus. 
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Table 1.2: Lactobacillus strains used in probiotic yoghurts or yoghurt-like products.  
 
Adapted from (Holzapfel et al., 2001) 
 
Probiotic strain Type of product  Identification on the basis of DNA-homology analysis  
L. acidophilus LA-1 Yoghurt L. johnsonii 
L. acidophilus LA-7 Yoghurt L. acidophilus 
L. acidophilus L1  Yoghurt drink L. crispatus  
L. acidophilus LA-H3  Dietetic yoghurt L. acidophilus  
L. acidophilus  Yoghurt L. crispatus  
L. acidophilus  Yoghurt L. acidophilus  
L. casei Actimel  Yoghurt drink L. paracasei  
L. casei Shirota  Probiotic drink L. paracasei  
L. casei GG  Yoghurt drink L. rhamnosus  
L. casei LC-H2  Dietetic yoghurt L. casei  
L. casei  Yoghurt L. paracasei  
L. casei  Yoghurt L. paracasei  
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Table 1.3: Phylogenetic grouping of the genus Lactobacillus 
 
Groups are arranged by descending size. Adapted from (Felis and Dellaglio, 2007). 
L. delbrueckii group (delb)  L. acetotolerans, L. acidophilus, L. amylolyticus, L. amylophilus, L. 
amylotrophicus, L. amylovorus, L. crispatus, L. delbrueckii, L. 
fornicalis, L. gallinarum, L. gasseri, L. hamsteri, L. helveticus, L. iners, 
L. intestinalis, L. jensenii, L. johnsonii, L. kalixensis, L. 
kefiranofaciens, L. kitasatonis, L. psittaci, L. sobrius, L. ultunensis  
L. salivarius group (sal)  L. acidipiscis, L. agilis, L. algidus, L. animalis, L. apodemi, L. aviarius, 
L. equi, L. mali, L. murinus, L. nageli, L. ruminis, L. saerimneri, L. 
salivarius, L. satsumensis, L. vini  
L. reuteri group (reu)  L. antri, L. coleohominis, L. fermentum, L. frumenti, L. gastricus, L. 
ingluviei, L. mucosae, L. oris, L. panis, L. pontis, L. reuteri, L. 
secaliphilus, L. vaginalis  
L. buchneri group (buch)  L. buchneri, L. diolivorans, L. farraginis, L. hilgardii, L. kefiri, L. 
parabuchneri, L. parafarraginis, L. parakefiri associated with L. 
acidifarinae, L. namurensis, L. spicheri, and L. zymae (which form a 
robust group)  
L. alimentarius-L. farciminis 
group (al-far)  
L. alimentarius, L. farciminis, L. kimchii, L. mindensis, L. nantensis, L. 
paralimentarius, L. tucceti, L. versmoldensis  
L. casei group (cas)  L. casei, L. paracasei, L. rhamnosus, L. zeae  
L. sakei group (sakei)  L. curvatus, L. fuchuensis, L. graminis, L. sakei  
L. fructivorans group (fru)  L. fructivorans, L. homohiochii, L. lindneri, L. sanfranciscensis  
L. coryniformis group (cor)  L. bifermentans, L. coryniformis, L. rennini, not robustly associated 
with L. composti  
L. plantarum group (plan)  L. plantarum, L. paraplantarum, L. pentosus  
L. perolens group (per)  L. perolens, L. harbinensis, L. paracollinoides 
L. brevis group (bre)  L. brevis, L. hammesii, L. parabrevis  
Pediococcus dextrinicus group 
(Pdex)  
P. dextrinicus, L. concavus, L. oligofermentans (the latter sometimes 
poorly supported)  
Pediococcus  2 clusters, not associated: the first comprises P. cellicola, P. damnosus 
P. parvulus, P. inopinatus, while the second includes P. acidilactici, P. 
claussenii, P. pentosaceus and P. stilesii   
Couples (couple)  (1) L. rossiae-L. siliginis  
(2) L. vaccinostercus-L. suebicus  
(3) L. manihotivorans-L. collinoides  
Single species (ss)  L. kunkeei, L. malefermentans, L. pantheris, L. sharpeae, 
Paralactobacillus selangorensis  
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The L. acidophilus group is one of the most well-defined and deep-branching 
Lactobacillus phylogenetic sub-group (Figure 1.2). Although its definition is partially 
based on DNA-DNA homology, the genomic GC content of constituent species ranges 
from 32-50% (Felis and Dellaglio, 2007), which is much larger than normally accepted for 
well-defined bacterial genera (Schleifer and Ludwig, 1995). The dawning of the post-
genomic era has now added more tools to the taxonomist’s toolkit, providing clarification 
and as well as further insight into how the taxonomy of the most challenging and complex 
bacterial groups can be resolved. Recent research into the relatedness of species in the L. 
acidophilus group has used polyphasic taxonomy, combining traditional phenotypic 
characteristics such as sugar fermentation patterns (Yeung et al., 2004), sequence analyses 
of genes such as 16S rRNA, rpoA, pheS (Naser et al., 2007), groEL (Claesson et al., 2008), 
tuf (Ventura et al., 2003) and DNA fingerprinting methods such as rep-PCR (Gevers et al., 
2001) and Pulsed-Field Gel Electrophoresis (PFGE) (Yeung et al., 2004). Despite highly 
variable GC content, analyses have shown remarkable congruence with genome 
microarrays and genomic sequence comparisons, indicating that the L. acidophilus 
phylogenetic sub-group is a natural bacterial group. Genome sequencing now offers a 
definitive means to identify Lactobacillus species and strains (Claesson et al., 2007, 
Claesson et al., 2008, Salvetti et al., 2012, Bull et al., 2012). 
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Figure 1.2: Phylogenetic placement of the L. acidophilus phylogenetic subgroup within the 
Lactobacillus genus 
A phylogenetic tree of aligned 16S rRNA gene sequences from type strains of the L. acidophilus 
phylogenetic sub group (indicated with a brace) and representative type strains from the other Lactobacillus 
phylogenetic sub groups. The tree was rooted with the 16S rRNA gene from Bacillus subtilis DSM10. The 
genetic distance scale, bootstrap values and GenBank nucleotide accession numbers are indicated.
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1.3. LACTOBACILLUS ACIDOPHILUS 
Lactobacillus acidophilus is a LAB species, widely recognised to have probiotic effects 
and is the most commonly suggested organism for dietary use (Shah, 2007).  It is 
commonly added to yoghurt and fermented milk products, with approximately 80% of the 
yoghurts produced in the United States in 2006 containing L. acidophilus (Sanders, 2003). 
L. acidophilus isolates also form part of the natural human microbiota and have been 
cultured from oral, digestive and vaginal tracts. By virtue of its widespread use in industry, 
its probiotic effects and human association, L. acidophilus has become one of the most 
well-studied LAB species. L. acidophilus was also the main focus of this PhD study as a 
bacterial species used by the commercial sponsor of this work (see section 1.6).  Key 
research on L. acidophilus, spanning its original isolation from the human gut, through to 
its genomic and molecular characterization (Figure 1.1) and its major genomic, 
biosynthetic and probiotic characteristics (Figure 1.3) is summarised below. 
 
1.3.1. L. ACIDOPHILUS STRAINS AND THEIR HISTORY 
Within the L. acidophilus group, there are some 20 species additional to L. acidophilus 
sensu stricto (Table 1.3). It is vital at this point to distinguish between the strain- and 
species-level classifications of constituent isolates within this group. Much of the early 
research into the L. acidophilus group blurs the lines between bacterial “strains” of the L. 
acidophilus phylogenetic sub-group, which would now be considered as Lactobacillus 
species that belong to the L. acidophilus group, and the present definition of a bacterial 
strain, which is deemed to be a sub-species level taxonomic unit (Klein et al., 1998, Kullen 
et al., 2000). Considerable research effort has contributed to the revisionary nature of 
Lactobacillus taxonomy, which is important for correctly identifying phylogenetic 
relationships between species, ensuring species are correctly represented by their type 
strains, and grouping strains and species in a congruent manner. A lack of rigor and 
historical understanding of the literature surrounding L. acidophilus taxonomy may have 
also contributed to confusion in identifying the species and strains being studied. The 
reassignment, for example, of a strain once belonging to L. acidophilus (Tuomola and 
Salminen, 1998) to Lactobacillus johnsonii, as an entirely separate species (Pridmore et al., 
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2004), had sound systematic support, although some later studies have failed to adopt the 
correct taxonomic nomenclature (Pimentel et al., 2012). 
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Figure 1.3: Major genomic, biosynthetic and probiotic characteristics of L. acidophilus 
Historically, L. acidophilus has been known for its probiotic effects in humans. Through further 
characterisation of this effect, and the determination of the genome sequence of L. acidophilus NCFM, many 
biosynthetic capabilities of L. acidophilus have been described. 
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The variety of names that may be attributed to a single strain (Table 1.4), from both culture 
collections and commercial trademarks, has potentially led to multiple groups 
unknowingly working with the same strain referred to by a different name (Yeung et al., 
2002) and even researchers working on an organism that is not L. acidophilus (Bull et al., 
2012). The commercial success of L. acidophilus may have also contributed to the 
widespread industrial use of what appear to be identical strains because of their proprietary 
protection and use within multiple functional foods or probiotic supplements. With this and 
the taxonomic revisions within the Lactobacillus genus in mind, only data/publications 
related to L. acidophilus sensu stricto and strains thereof are collated below. 
 
L. acidophilus was first isolated by in 1900 (Moro) from infant faeces and at the time was 
described as Bacillus acidophilus. As noted above, multiple strain names have been 
attributed to L. acidophilus (Table 1.4). The variety of strain names that have been be 
given single isolate deposited in multiple locations further complicates establishing the 
provenance of a particular strain. The StrainInfo database  allows users to visually trace the 
history of a particular strain, and can be used to resolve confusion in many cases (Dawyndt 
et al., 2005). Fortunately, much of the body of work on L. acidophilus, particularly 
concerning its probiotic effects, has been undertaken on one particular strain: L. 
acidophilus NCFM. Although the depth of information available on NCFM has ensured 
that it is very well characterised as a true strain of L. acidophilus, derived from the neotype 
strain ATCC 4356 (Sanders and Klaenhammer, 2001), it still has not escaped the confusion 
of being known by multiple strain names and may exist in the literature as NCFM, N2, 
NCK56, NCK45 and RL8K (Table 1.4). The large body of information concerning L. 
acidophilus NCFM has contributed to it being deemed Generally Regarded As Safe 
(GRAS) by the US Food and Drug Administration, as an approved  ingredient in dairy 
products, functional beverages, nutritional powders and more (Bernardeau et al., 2006). 
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Table 1.4: L. acidophilus isolates and their pseudonyms 
 
 
a American Type Culture Collection, USA 
b Deutsche Sammlung von Mikroorganismen und Zellkulturen, Germany 
c
 Belgian Co-ordinated Collections of Micro-organisms, Belgium 
d
 National Collection of Industrial, Food and Marine Bacteria, UK 
ATCCa DSMZb BCCM/LMGc NCIMBd Other Key Names Notes 
ATCC 314   LMG 11467      
ATCC 832   LMG 11428 NCIMB 1723    
ATCC 4355   LMG 11469      
ATCC 4356 T  
  
DSM 20079 T  
  
LMG 13550 T  
LMG 7943 T  
LMG 8150 T  
LMG 9433 T  
NCIMB 701748 T  
NCIMB 8690 T  
  
NCFB 1748 T  
NCTC 12980 T  
  
Neotype strain (Hansen & Mocquot, 1970) 
ATCC 4357 DSM 20242 LMG 11430 NCIMB 8607   
    LMG 13003      
ATCC 4796  LMG 11470   Draft genome sequence (Human Microbiome Project) (Turnbaugh, 
et al., 2007) 
ATCC 9224 
  
  LMG 11429 
LMG 11472 
LMG 19170 
NCIMB 8116 
  
   
ATCC 13651 DSM 9126 LMG 11466 NCIMB 701360    
ATCC 700396 
  
  
  
  
  
  
  
NCFM, N2, NCK56, 
NCK45, RL8K 
  
Derived from ATCC 4356 T (Sanders & Klaenhammer, 2001) 
Genome sequence (Altermann, et al., 2005) 
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1.3.2. BASIC FEATURES OF L. ACIDOPHILUS 
 
 L. acidophilus is a short (2–10 µm) Gram-positive rod that grows optimally from 37°C to 
42°C (Altermann et al., 2005) and is able to grow at temperatures as high as 45°C. The 
species achieves its highest growth rates in slightly acidic media of pH 5.5-6.0, and growth 
ceases below pH 4.0 (Shah, 2007). It is an obligate homofermenter producing lactic acid 
from fermentation of carbohydrates and is among the least oxygen tolerant lactobacilli 
(Archibald and Fridovich, 1981, Claesson et al., 2007). 
 
From examination of the biosynthetic pathways encoded within its genome, L. acidophilus 
is auxotrophic for 14 amino acids and seems unable to synthesise multiple cofactors and 
vitamins including riboflavin, vitamin B6, nicotinate, nicotinamide, biotin, and folate 
(Altermann et al., 2005). These deficits in anabolic capacity are exemplified by the need to 
use nutrient rich media such as deMan, Rogosa and Sharpe (MRS) agar (de Man et al., 
1960, Morishita et al., 1981) for its routine culture. L. acidophilus forms at least two 
colony morphotypes when grown under standard culture conditions on MRS agar, referred 
to as rough and smooth colonies (Figure 1.4). The proportion of rough to smooth colony 
morphotypes exhibited by L. acidophilus is influenced by the exposure to antibiotics such 
as Penicillin G (Khaleghi et al., 2011) or bile (Khaleghi et al., 2010), which causes a dose-
dependent proportional shift towards the smooth morphotype.  
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Figure 1.4: Colony morphotypes of L. acidophilus 
Panel A shows the “rough” colony morphotype, panel B the smooth colony morphotype at 25x magnification 
on MRS agar after 24h incubation at 37°C 
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Although L. acidophilus has been isolated from multiple human-associated sources (Ahrné 
et al., 1998, Kulp and Rettger, 1924, Rogosa and Sharpe, 1960) recent phylogenomic 
characterization by Claesson et al (2008) established that the most likely environmental 
niche of L. acidophilus was the GI tract, with other lactobacilli broadly inhabiting plants 
and meat. The neotype L. acidophilus strain ATCC 4356 was described as isolated from 
the human microbiota, although the records do not give the precise bodily location from 
where it was isolated.  
 
Metagenomic studies indicate that lactobacilli may compose just 0.2-1% of the total 
microbiota in the human colon and faeces and also show that their prevalence is highly 
variable between individuals (Kleerebezem and Vaughan, 2009, Walter, 2008). This 
suggests that L. acidophilus may be just a small and variable fraction of this small carriage 
of the genus. Culture-independent studies from other hosts also show wide variations in the 
prevalence of this LAB species. For example L. acidophilus was present as the most 
abundant member of the lactobacilli in broiler chickens (Lu et al., 2003), while in contrast, 
a total absence of L. acidophilus was found in pigs (Leser et al., 2002). Culture-dependent 
techniques suggest that the lactobacilli in pigs are largely comprised of the L. acidophilus 
group, although no L. acidophilus species were isolated (Korhonen et al., 2007). Overall, 
gut carriage of L. acidophilus appears highly variable.  
 
1.3.2.1. Colony-based strain typing and tracking of L. acidophilus in 
the human gut 
Human gut passage of L. acidophilus has been modelled in a probiotic capsule feeding 
study (Mahenthiralingam et al., 2009). Participants were pre-screened for faecal presence 
of L. acidophilus using culture-based methods in tandem with DNA fingerprinting to 
identify the Lactobacillus strain being administered. Three of the 12 participants were 
found to be culture positive for L. acidophilus prior to probiotic feeding, indicating faecal 
carriage of L. acidophilus in humans is not universal (Mahenthiralingam et al., 2009). 
After feeding (5.6 x 109 viable bacteria per capsule, taken daily), the administered L. 
acidophilus strain was detected in 10 out of the 12 subjects, reaching cultivatable levels as 
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high as 1 x 107 colony forming units per gram of faeces in 3 of the volunteers 
(Mahenthiralingam et al., 2009). Longterm carriage of L. acidophilus for 28 days post-
feeding was detected in 3 subjects, who notably did not culture L. acidophilus before 
feeding. Overall, these results suggest that dietary intake is a major influence on the human 
carriage of L. acidophilus.  
 
1.3.3. GENOMICS OF L. ACIDOPHILUS 
 
The genome sequence of L. acidophilus NCFM was the third of the Lactobacillus genomes 
to be published, behind Lactobacillus plantarum WCFS1 (Kleerebezem et al., 2003) and L. 
johnsonii NCC 533 (Pridmore et al., 2004); it was the first genome sequence from an L. 
acidophilus phylogenetic sub-group species (Table 1.5). In silico analyses of the L. 
acidophilus NCFM shows it is able to synthesise only a limited number of amino acids 
(cysteine, serine, and aspartate) and to compensate its genome is enriched in genes coding 
for amino acid transport and fermentative functions (Altermann et al., 2005).  
 
Prophages and horizontally transferred elements are common features of LAB genomes 
(Foschino et al., 2001). In silico analysis of the L. acidophilus NCFM genome did not 
uncover any complete prophages, but three regions constructed from remnants of prophage 
were discovered due to their constituent ORFs showing homology to phage genes. These 
three regions were designated as Potential Autonomous Units (PAU) 1-3. All are present 
within the first 500 ORF of the genome and consist of a core of seven ORF. Further 
analysis in silico predicted a core consisting of an integrase, IntG, a replication protein, 
RepA, and a DNA segregation ATPase, FtsK, involved in DNA partitioning.  The study 
suggests that PAU3 either evolved in a different organism and was acquired later or was 
the most ancient integration event into the chromosome. The study also suggested that due 
to the high degree of similarity between RepA, FtsK, and the two hypothetical proteins 
flanking FtsK between PAU1 and PAU2 suggested a more recent duplication of PAU1, 
resulting in PAU2. 
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Table 1.5: Completed and published genome sequences from the L. acidophilus group 
 
Organism Strain Origin / Use 
GC 
(mol%)  
Genome 
Size (Mb) 
Gene 
Count  
CRISPR 
Count  
Coding Base 
Count %  Plasmids Publication 
Lactobacillus acidophilus  NCFM Probiotic 35 1.99 1970 1 89.64 0 (Altermann, et al., 2005) 
Lactobacillus amylovorus GRL 1118 Pig intestine 38 1.98 1994 3 86.86 2 (Kant, et al., 2011) 
Lactobacillus amylovorus  GRL 1112 Pig intestine 38 2.13 2193 0 86.99 2 (Kant, et al., 2011) 
Lactobacillus crispatus  ST1 Chicken 37 2.04 2100 3 89.37 0 (Ojala, et al., 2010) 
Lactobacillus delbrueckii 
subsp. bulgaricus ATCC 11842 Yoghurt 50 1.86 2234 1 76.01 0 (van de Guchte, et al., 2006) 
Lactobacillus delbrueckii 
subsp. bulgaricus ATCC BAA-365 
Cheese, 
yoghurt 50 1.86 1865 1 79.63 0 (Makarova, et al., 2006) 
Lactobacillus delbrueckii 
subsp. bulgaricus 2038 
Milk, 
Probiotic 50 1.87 1907 1 84.52 0 (Hao, et al., 2011) 
Lactobacillus delbrueckii 
subsp. bulgaricus ND02 
Milk, 
Probiotic 50 2.13 2139 2 84.82 1 (Sun, et al., 2011) 
Lactobacillus gasseri  ATCC 33323 Human, probiotic 35 1.89 1874 0 90.11 0 (Makarova, et al., 2006) 
Lactobacillus helveticus  DPC 4571 Cheese 37 2.08 1830 1 74.8 0 (Callanan, et al., 2008) 
Lactobacillus helveticus  R0052 Probiotic 37 2.13 2084 0 80.22 1 (Tompkins, et al., 2012) 
Lactobacillus helveticus  H10 Fermented 
milk 37 2.17 2052 2 81.32 1 (Zhao, et al., 2011) 
Lactobacillus johnsonii  DPC 6026 Human 35 1.97 1840 2 88.6 0 (Guinane, et al., 2011) 
Lactobacillus johnsonii  FI9785 Human 34 1.79 1804 0 89.64 2 (Wegmann, et al., 2009) 
Lactobacillus johnsonii  NCC 533 Probiotic 35 1.99 1941 0 91.09 0 (Pridmore, et al., 2004) 
Lactobacillus 
kefiranofaciens  ZW3 
Kefir, 
Probiotic 37 2.35 2222 3 80.76 2 (Wang, et al., 2011) 
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The amino acid biosynthetic capability of L. acidophilus NCFM is limited, with only 
cysteine, serine and aspartate capable of being synthesised de novo. Subsequently seven 
derivatives may be synthesised from these three. There were no predicted biosynthesis 
pathways (de novo or by conversion) for the remaining amino acids. This restricted 
biosynthesis capability is mirrored by the inability of L. acidophilus NCFM to synthesise 
most vitamins and cofactors. This degree of auxotrophy is likely influenced by the nutrient 
rich environments in which L. acidophilus inhabits (e.g. the human gut) and is reflected by 
its demanding nutrient requirements when grown on synthetic media (Morishita et al., 
1981). 
 
The comparatively small (1,993,564 bp) genome of L. acidophilus has a low (35%) 
average GC content, compared to other members of the L. acidophilus phylogenetic sub-
group (mean GC content = 40%), which have an upper range of 50% GC (L. delbrueckii 
subsp. bulgaricus). The GC content of the L. acidophilus genome rises to 50% in the four 
regions containing rRNA genes as expected (Altermann et al., 2005). Other than GC 
content, basic genomic attributes such as size and gene content do not vary significantly 
from other member of the L. acidophilus group. Plasmids are also common features of 
members of the L. acidophilus group, present in seven of the 16 strains detailed in Table 
1.5. Their distribution is heterogeneous, with multiple strains of some species with the 
same number of plasmids (L. amylovorus), some species showing strains with and without 
plasmids (L. johnsonii and L. helveticus) and others showing no evidence of plasmids at all 
(L. acidophilus and L. gasseri). Despite the lack of L. acidophilus NCFM and L. johnsonii 
NCC533 plasmids, a recent study examining phylogenetic trees of 401 proteins identified 
Horizontal Gene Transfer (HGT) of up to 40% of the core genome genes between the two 
species, causing an unprecedented level of phylogenetic incongruence (Nicolas et al., 
2007).  
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1.3.4. FOOD AND INDUSTRIAL USE OF L. ACIDOPHILUS 
 
L. acidophilus is a major commercial LAB species, present in products including milk, 
yoghurt and toddler formula, as well as in dietary supplements with reported probiotic 
effects (Altermann et al., 2005, Sanders and Klaenhammer, 2001). It is part of many 
undefined starter cultures for milk fermentation, a preservation process that was developed 
in the Early Neolithic era and has been used in the production of traditional fermented 
foods for more than 10,000 years (Tamime, 2002). Its slow growth in milk (Azcarate-Peril 
et al., 2009) means that most of the fermentation in fermented milk products is achieved 
with a yoghurt starter culture (e.g. Lactobacillus delbrueckii subsp. bulgaricus and 
Streptococcus thermophilus) and then L. acidophilus is subsequently added for  additional 
probiotic value (Shah, 2000) in functional milk products.  
 
1.3.5. PROBIOTIC STRAINS OF L. ACIDOPHILUS 
 
Probiotic bacterial strains are commonly mislabelled or unlabelled in products, often due to 
the difficulties in discerning both species and strains of Lactobacillus (Yeung et al., 2002). 
The primary commercial probiotic strains of L. acidophilus are described by Shah (2007) 
and include L. acidophilus LA-1 and LA-5 (Chr. Hansen, Denmark), NCFM (Dansico, 
Madison, US), DDS-1 (Nebraska Cultures, Nebraska, US) and SBT-2026 (Snow Brand 
Milk Products, Tokyo, Japan). L. acidophilus NCFM was developed as a major 
commercial strain, has identical fermentation and growth characteristics to the type strain 
ATCC 4356T and is also closely related in PFGE profile (Sanders and Klaenhammer, 
2001). Although similar information regarding the derivation of L. acidophilus LA-5 is 
limited, L. acidophilus isolated from products claimed to contain L. acidophilus LA-5 
produced DNA fingerprints with a high degree of similarity (91.9%) to the type strain L. 
acidophilus ATCC 4356 by Randomly Amplified Polymorphic DNA (RAPD) fingerprint 
analysis (Schillinger et al., 2003). L. acidophilus LA-1 is no longer available as a product 
from Chr. Hansen . A wealth of research dedicated to “L. acidophilus La1” a commercial 
strain marketed by Nestlé may also be found in the published literature (Link-Amster et al., 
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1994). However, this strain has subsequently been taxonomically reassigned to L. johnsonii 
and has a genome sequence available as L. johnsonii NCC 533 (Pridmore et al., 2004). 
Comparative information on the differences in probiotic effect between each commercial 
strain is not available, however, it is recognised, that different Lactobacillus species may 
display similar probiotic effects in vitro, yet have markedly divergent properties when 
assessed in vivo (Ibnou-Zekri et al., 2003). 
 
1.3.6. PROBIOTIC CHARACTERISTICS AND PHYSIOLOGY 
 
The probiotic effects of L. acidophilus NCFM are well characterised, aided recently by the 
availability of its genome sequence and the necessity of in-depth characterisation for 
application for GRAS status. Although a genome sequence is not available, L. acidophilus 
LA-5 is similarly characterised for patent claim information. The characterisation of 
probiotic strains may be broadly divided into two categories. The first is desirable probiotic 
physiology demonstrable in vitro such as stability in products (Shah, 2000), resistance to 
bile (Khaleghi et al., 2010, Pfeiler et al., 2007, Pfeiler and Klaenhammer, 2009) and 
tolerance to low pH (Azcarate-Peril et al., 2004, Azcarate-Peril et al., 2005), adherence to 
human enterocytes in cell culture (Buck et al., 2005), antimicrobial production (Sanders 
and Klaenhammer, 2001, Tabasco et al., 2009) and lactase activity (Sanders et al., 1996). 
The second category encompasses the gross probiotic effect observable in the context of 
feeding studies such as mediation of host immune response (Bron et al., 2012), lowering 
host serum cholesterol (Shah, 2007), improving host lactose metabolism (Gilliland, 1989) 
and preventing or treating infection (Wang et al., 2004). Several recent feeding trails have 
also shown that consumption of probiotic products containing L. acidophilus NCFM in 
combination with Bifidobacterium species can produce health benefits in the hose, the 
“gold-standard” for a probiotic label claim. For example, they reduce bloating in adults 
with functional bowel disorders (Ringel-Kulka et al., 2011) and suppress cold and 
influenza-like symptoms in children (Leyer et al., 2009).  
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Analysis of the L. acidophilus NCFM genome sequence has directly facilitated the 
functional characterisation of its ability to tolerate exposure to both low pH and bile, 
important factors for a probiotic organism that must pass through the gastrointestinal tract. 
Functional microarray experiments with L. acidophilus NCFM showed upregulation of 
transcripts from three transporter genes (two major facilitator [MFC] superfamily and the 
permease component of an ABC transporter) in the presence of bile (Pfeiler et al., 2007). 
Similar transporters had previously been shown in other species to be involved in bile 
efflux from the cell (Solheim et al., 2007).  Furthermore, a study that generated deletion 
mutants lacking these three transporter genes showed a significant decrease in their ability 
to survive in bile (Pfeiler and Klaenhammer, 2009). L. acidophilus NCFM is also able to 
survive exposure to pH 3.0 for 5 hours with no loss of viability (Azcarate-Peril et al., 
2004), with a two component regulatory system, similar to the lisRK system in Listeria 
monocytogenes, implicated in its ability to sense and react to changes in extracellular pH.  
 
L. acidophilus is able to utilise a variety of carbon sources for growth (Sanders and 
Klaenhammer, 2001, Yeung et al., 2004), but a comprehensive understanding of the 
mechanisms behind the uptake and metabolism of carbon sources has not yet been 
achieved. A study describing several genetic loci responsible for carbohydrate metabolism 
again demonstrated the utility of the L. acidophilus complete genome sequence (Barrangou 
et al., 2006). Several classes of transporter (ATP-binding cassette, phosphoenol-pyruvate 
phosphotransferase system and galatoside pentose hexuronide permease) were found to be 
induced in the presence of their respective substrates but repressed in the presence glucose, 
suggesting that carbohydrate metabolism in L. acidophilus is strongly regulated by 
catabolite repression. The strong link between carbohydrate source and regulation of sugar 
uptake and metabolism genes likely contributes to the competitive ability of L. acidophilus 
in the human gastrointestinal tract. The metabolism of these complex carbohydrates also 
provides a function that is not present in humans and other microbiota, potentially 
enriching the growth of L. acidophilus and other probiotic LAB in the human 
gastrointestinal tract (Zhu et al., 2009).  
 
CHAPTER ONE - INTRODUCTION 
29 
 
Studies have demonstrated the ability of L. acidophilus to adhere to human Caco-2 
enterocytes in vitro. An analysis of the adhesion factors involved in L. acidophilus NCFM-
Caco-2 epithelial cell interaction found significant involvement of S-layer proteins, linked 
to the gene slpA, fibronectin binding protein (FbpA) and mucin binding protein (Mub) 
(Buck et al., 2005). Alhtough these in vitro results suggest that L. acidophilus can colonise 
the gastrointestinal tract, the low dominance seen in metagenomic studies (Kleerebezem 
and Vaughan, 2009, Walter, 2008), and the lack of persistence seen in probiotic feeding 
studies (Mahenthiralingam et al., 2009), indicates that L. acidophilus may not have 
primarily evolved as a human gastrointestinal tract organism.  
 
One genomic feature that does vary considerably across Lactobacillus genomes are 
clustered regularly spaced short palindromic repeat (CRISPR) regions.  CRISPRs were 
first described in LAB (Bolotin et al., 2004), are commonly identified in Lactobacillus 
genomes from the L. acidophilus phylogenetic subgroup (Table 1.5) and beyond, with 
approximately half (26/53) of the sequenced Lactobacillus genomes possessing CRISPR 
regions, as identified by BlastP (Koonin and Makarova, 2009). The L. acidophilus NCFM 
CRISPR region has features characteristic of these regions, being approximately 1.5 kb in 
size and composed of 32  near-perfect 29 base repeats, interspersed with unique 32 base 
spacer DNAs (Altermann et al., 2005). No physiological function was attributed to 
CRISPR regions at the time of the NCFM genome publication (Altermann et al., 2005), 
however subsequent observations that the unique CRISPR spacer sequences were  almost 
identical to fragments of virus and plasmid genes led to the hypothesis that CRISPR 
regions may be involved in defence against selfish DNA elements (Makarova et al., 2011). 
This has been validated by the demonstration that a short phage-like sequence inserted into 
the CRISPR locus of Streptococcus thermophilus conferred resistance against its cognate 
phage (Barrangou et al., 2007). 
 
Prophages and phage interactions are commonly encountered in both the study of LAB 
genomics and the large scale manufacture of fermented products by LAB (Mahony et al., 
2012), where as a result of the economic implications of a large-scale phage contamination 
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in dairy fermentations, many LAB phages have been well characterised (Brüssow, 2001). 
The genome sequence of L. acidophilus NCFM revealed evidence of three isolated phage 
remnants, or Potential Autonomous Units (PAUs) designated PauLA-I-III. Each PAU is 
composed of seven core ORFs, with synteny and ORF size highly conserved between 
PauLA-I and PauLA-II, with PauLA-III lacking a single ORF of hypothetical function. The 
high degree of similarity between PauLA-I and PauLA-II suggests that these may have 
been formed following a duplication event, and PauLA-III was evolved in a different 
organism and was integrated at a different time to the progenitor or PauLA-I and PauLA-II 
(Altermann et al., 2005). Interestingly, there is an absence of literature on functional 
bacteriophages capable of infecting strains of L. acidophilus sensu stricto compared to 
other members of L. acidophilus phylogenetic sub-group. 
 
1.3.7. L. ACIDOPHILUS: SUMMARY AND PERSPECTIVE 
 
L. acidophilus is an important commercial bacterium with a long history that plays a 
pivotal role in the characterisation of the genus Lactobacillus. However, given the highly 
progressive nature of Lactobacillus taxonomy, L. acidophilus as a species has struggled 
with being misidentified and misrepresented in its past characterisation. Given the 
increased regulatory criteria being placed on the definition and sale of microbial species as 
probiotics, L. acidophilus strain NCFM has emerged as one of the most well characterized 
probiotics within this species. However, for other areas of study such as the investigation 
of environmental niches or microbial composition of fermented foods, care should be taken 
to clearly identify if L. acidophilus sensu stricto strains are present, and going forward it 
will be important to clarify data provided for both (i) the species level Lactobacillus 
identification, by ensuring new publications are not made with references to old taxonomic 
names, and (ii) the strain level identification of L. acidophilus, by conducting comparisons 
to well characterised control strains.  Ensuring that these parameters are clearly defined for 
L. acidophilus will overcome problems with the multiple strain names used for the same 
original “isolate” greatly improve our understanding of this biotechnologically important 
Lactobacillus species. 
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1.4. THE GENUS BIFIDOBACTERIUM 
 
All members of the genus Bifidobacterium are non-motile, non-sporulating, non-gas-
producing and catalase-negative (except Bifidobacterium indicum and Bifidobacterium 
asteroids) members of the Actinomycetales branch of the high–G+C Gram-positive 
bacteria. Generally, Bifidobacteria are anaerobic, although some species can tolerate 
oxygen (Ventura et al., 2004). All species described so far are grouped in six different 
ecological niches: the human intestine, oral cavity, the animal gastrointestinal tract (GIT), 
the insect intestine and sewage, although a faecal contamination event may have caused the 
rare latter case (De Dea Lindner et al., 2007). 
 
1.4.1. TAXONOMY AND IDENTIFICATION 
 
Bifidobacteria were first isolated from faeces of a breast-fed infant in 1899 (Tissier, 1900), 
were named Bacillus bifidus. Their morphological and physiological features however, 
which are similar to those of lactobacilli, meant that they were classified as members of the 
genus Lactobacillus for a large part of the 20th century have only been recognized as a 
different genus relatively recently. The majority of today’s species were originally isolated 
from mammalian GITs (Schell et al., 2002). There are now 38 validly described species 
belonging to the Bifidobacterium genus, with four taxa (Bifidobacterium animalis, 
Bifidobacterium longum, Bifidobacterium pseudolongum and Bifidobacterium 
thermacidophilum) further divided into subspecies, all of which display greater than 93% 
identity of their 16S rRNA gene sequences (Miyake et al., 1998) (Figure 1.5).  
Traditional identification and typing of bifidobacteria was similar to lactobacilli, with the 
methods relying on examining phenotypic characteristics to differentiate species. 
Enzymatic and carbohydrate acidification profiles were instrumental in characterising new 
isolates and redefining clusters of species (Bahaka et al., 1993). These carbohydrate 
fermentation patterns have been shown to be more related to strains than species however 
(Roy and Ward, 1990, Roy et al., 1996), and more appropriate methods have since been 
applied.
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Figure 1.5: Phylogenetic relationships within the Bifidobacterium genus 
A phylogenetic tree of aligned 16S rRNA gene sequences from available type strains of the Bifidobacterium 
genus. The tree was rooted with the 16S rRNA gene from Micrococcus luteus CSM 20030. The genetic 
distance, scale, bootstrap values and GenBank nucleotide accession numbers are indicated. 
 
 
 
CHAPTER ONE - INTRODUCTION 
33 
 
16S rRNA gene sequence homology analysis has proved a powerful method for analysing 
phylogenetic relationships between other bacteria (Stackebrandt and Goebel, 1994). 
Bifidobacterium 16S rRNA gene sequences showed only 7% difference across the whole 
genus (Zhu et al., 2003), with four groups of species showing just 1% sequence divergence 
across multiple species (Miyake et al., 1998), too similar to differentiate between these 
species. DNA-DNA hybridisation was subsequently evaluated as a superior method for 
speciating closely related bifidobacterial species. Other conserved macromolecules such as 
the tuf gene encoding the Tu elongation factor, recA encoding recombinase A and groEL 
gene have all been proposed as alternative molecular chronometers for bifidobacteria 
(Ventura et al., 2004). 
 
Molecular fingerprinting methods such as RAPD (Vincent et al., 1998, Simpson et al., 
2003) and PFGE using XbaI (McCartney et al., 1996, Simpson et al., 2003) have been used 
successfully to describe both intra- and inter-species diversity of bifidobacteria. In the 
current era of relatively inexpensive and highly accurate genome resequencing however, 
the next “gold-standard” of isolate identification and elucidation of taxonomic and 
phylogenetic relationships is the complete genome sequence of an isolate. 
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1.4.2. BIFIDOBACTERIUM GENOMICS 
Currently, the genus Bifidobacterium is represented by 38 species, of which 10 have at 
least one isolate with its genome completely sequenced and publically available (Table 
1.6). This is in direct contrast to the Lactobacillus genus whose widespread use as active 
ingredients in functional foods, and their extreme phylogenetic, phenotypic and ecological 
diversity has ensured many more representative genomes have been decoded (Ventura et 
al., 2009a). The generation and analysis of bifidobacterial genome sequences has forged 
the discovery and analysis of genetic and metabolic characteristics of these important 
probiotic bacteria, alongside enhancing knowledge of their evolutionary relationships. 
 
1.4.2.1.  Comparative genomics 
The chromosomes of bifidobacteria range in size from 1.9 to 2.8 Mb, with a GC content of 
between 59 and 63% (Table 1.6). This is again in direct contrast to the genomes of 
lactobacilli, which have much greater diversity of both size (Ventura et al., 2012) and GC 
content (Table 1.5). It should be pointed out however, that bifidobacteria with reduced 
genomes are extensively used in functional foods, and therefore may have been propagated 
for a considerable length of evolutionary time in synthetic media. It has been demonstrated 
that such treatment of bifidobacteria may cause genome decay (Lee et al., 2008), with 
isolates losing apparently dispensable regions of their chromosomes in an environment 
different from their original ecological niche. 
 
Extrachromosomal elements in the form of plasmids are common amongst all bacteria. B. 
longum strains show some diversity in the number of plasmids harboured (Table 1.6), with 
B. longum subsp. longum DJO10A harbouring two plasmids, pDOJH10L (10 kb) and 
pDOJH10S (3.6 kb) (Bottacini et al., 2010), while B. longum subsp. longum NCC2705 
possesses a single plasmid, pBLO1 (3.6 kb) (Schell et al., 2002). All other sequenced 
genomes appear to lack plasmids. There are no obvious unusual species-specific features 
with regard to the coding density.  
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A comparison of genomes across the whole Bifidobacterium genus showed that the 
bifidobacterial pan-genome was likely to consist of more than 5000 genes (Bottacini et al., 
2010), more than double the coding capacity of a single bifidobacterial genome. The core 
genome shared by all bifidobacterial isolates was 967 genes, with mostly housekeeping 
function (replication, transcription, translation, cell envelope biosynthesis and signal 
transduction) (Bottacini et al., 2010). Genes unique to each genome ranged from 21 to 230 
across the nine genomes studied, with many of unknown function (Bottacini et al., 2010), 
although given the propensity of bifidobacteria to dispense of genomic regions not useful 
to their present lifestyle and niche, they are likely to have a specialized role within that 
particular niche (Turroni et al., 2011). 
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Table 1.6: Completed Bifidobacterium genome sequences  
N/D: No Data
Genome Name / Sample Name Strain Origin / Use GC % 
Genome 
Size (Mb) 
Gene 
Count 
Coding Base 
Count (%) Plasmids Publication 
Bifidobacterium adolescentis   ATCC 15703 Human, probiotic 59 2.1 1709 87.83 0 NCBI RefSeq 
Bifidobacterium animalis subsp. animalis ATCC 25527 Rat 60 1.9 1597 85.88 0 (Loquasto et al., 2011) 
Bifidobacterium animalis subsp. lactis Bl-04 Human, probiotic 60 1.9 1631 87.15 0 (Barrangou et al., 2009) 
Bifidobacterium animalis subsp. lactis AD011 Human, probiotic 60 1.9 1587 85.13 0 (Kim et al., 2009) 
Bifidobacterium animalis subsp. lactis DSM 10140 Human, yoghurt, probiotic 60 1.9 1629 86.94 0 (Barrangou et al., 2009) 
Bifidobacterium animalis subsp. lactis BB-12 Probiotic 60 1.9 1706 90.39 0 (Garrigues et al., 2010) 
Bifidobacterium animalis subsp. lactis CNCM I-2494 Human, probiotc 60 1.9 1724 90.86 0 (Chervaux et al., 2011) 
Bifidobacterium animalis subsp. lactis B420 Probiotic 60 1.9 1625 86.03 0 (Stahl and Barrangou, 2012) 
Bifidobacterium animalis subsp. lactis V9 Human, probiotic 60 1.9 1636 87.20 0 (Sun et al., 2010) 
Bifidobacterium animalis subsp. lactis BLC1 N/D 60 1.9 1622 87.54 0 (Bottacini et al., 2011) 
Bifidobacterium animalis subsp. lactis Bi-07 Probiotic 60 1.9 1625 86.03 0 (Stahl and Barrangou, 2012) 
Bifidobacterium asteroides   PRL2011 Honey bee GIT 60 2.2 1731 87.44 0 (Bottacini et al., 2012) 
Bifidobacterium bifidum   BGN4 Human, probiotic 63 2.2 1903 86.12 0 (Yu et al., 2012) 
Bifidobacterium bifidum   S17 Human, probiotic 63 2.2 1845 86.04 0 (Zhurina et al., 2011) 
Bifidobacterium bifidum   PRL2010 Human, probiotic 63 2.2 1767 84.40 0 (Turroni et al., 2010) 
Bifidobacterium breve   UCC2003 Human, probiotic 59 2.4 1914 84.63 0 (O'Connell Motherway et al., 2011) 
Bifidobacterium breve   ACS-071-V-Sch8b Human, vaginal 59 2.3 1890 83.77 0 Human Microbiome Project 
CHAPTER ONE - INTRODUCTION 
37 
 
 
 Table 1.6: Completed Bifidobacterium genome sequences (cont.) 
Genome Name / Sample Name Strain Origin / Use 
GC 
(mol%) 
Genome 
Size (Mb) 
Gene 
Count 
Coding Base 
Count (%) Plasmids Publication 
Bifidobacterium dentium   Bd1 Human, dental, probiotic 59 2.6 2197 86.95 0 
(Ventura et al., 
2009b) 
Bifidobacterium longum   DJO10A Human, probiotic 60 2.4 2074 87.14 2 (Lee et al., 2008) 
Bifidobacterium longum   NCC2705 Human, probiotic 60 2.3 1805 86.32 1 (Schell et al., 2002) 
Bifidobacterium longum subsp. 
infantis 157F Human, commensal 60 2.4 2070 86.73 2 (Fukuda et al., 2011) 
Bifidobacterium longum subsp. 
infantis ATCC 15697 Human, probiotic 60 2.8 2577 85.88 0 (Sela et al., 2008) 
Bifidobacterium longum subsp. 
infantis JCM 1222 Human, commensal 60 2.8 2641 86.17 0 (Fukuda et al., 2011) 
Bifidobacterium longum subsp. 
longum KACC 91563 Biotechnological 60 2.4 2050 86.56 2 (Ham et al., 2011) 
Bifidobacterium longum subsp. 
longum JDM301 Human 60 2.5 2022 85.60 0 (Wei et al., 2010) 
Bifidobacterium longum subsp. 
longum BBMN68 Human 60 2.3 1870 85.43 0 (Hao et al., 2011b) 
Bifidobacterium longum subsp. 
longum JCM 1217 Human, commensal 60 2.4 2009 87.03 0 (Fukuda et al., 2011) 
Bifidobacterium longum subsp. 
longum F8 Human, commensal 60 2.4 1744 72.09 0 MetaHIT 
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1.4.3. PHYSIOLOGICAL AND PROBIOTIC CHARACTERISTICS 
 
1.4.3.1. Carbohydrate metabolism  
Carbohydrate metabolism is particularly instrumental in the life of Bifidobacteria in the 
mammalian GIT, with the availability of many complex polysaccharides (e.g. xylose and 
arabinose containing compounds) that are beyond the hydrolysing capability of host 
enzymes, which are mostly restricted to disaccharides (e.g. lactose and sucrose) and 
specific polysaccharides such as starch (Ventura et al., 2007b). These more complex 
polysaccharides would be unavailable to the host if the diverse mixture of anaerobic 
bacteria (including bifidobacteria) were not present in the gut. This is a mutually beneficial 
relationship, were the host gains carbon and energy through short-chain fatty acid 
absorption, and the bacterial community have access to a wide variety of glycans in a 
protected anoxic environment (Ventura et al., 2007b). For context, bacteria such as 
Lactobacillus tend to be more numerous in the upper GIT (Vaughan et al., 2005) where 
they ferment relatively simple mono- and di-saccharides, and bifidobacteria more common 
in the lower GIT where their success is likely due to their capacity to metabolise the 
complex carbohydrates that are more common in the large intestine. 
 
Bifidobacterial genomes contain genes that reflect their adaptation to the GIT niche, 
exemplified by the large number of genes encoding carbohydrate-modifying enzymes, 
such as glycosyl hydrolases, sugar ABC transporters, and PEP-PTS (PEP—
phosphoenolpyruvate; PTS—phosphotransferase system) components, all of which are 
needed for the metabolism of  carbohydrates (Barrangou et al., 2009, Kim et al., 2009, 
Schell et al., 2002). Additionally a large number of genes are predicted to be involved in 
sugar metabolism, with almost half of these are devoted to carbohydrate uptake, by means 
of ABC transporters, permeases and proton symporters, rather than through PEP-PTS 
transport (Ventura et al., 2012). 
 
Hexose sugars are metabolised through a metabolic pathway unique to bifidobacteria, 
referred to as the “bifid-shunt”, which is built around the fructose-6-phosphoketolase 
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enzyme (F6PPK.) (de Vries and Stouthamer, 1967). This enzyme is considered to be a 
taxonomic marker for the family of Bifidobacteriaceae (Felis and Dellaglio, 2007). When 
operated in tandem with enzymes for transporting carbohydrates, encoded in the rest of the 
bifidobacterial genome, the bifid-shunt confers a competitive advantage on Bifidobacteria 
by producing more ATP from the same quantity of carbohydrate than fermentative 
pathways, like those operating in homofermentative LAB for example (Pokusaeva et al., 
2011). 
  
1.4.3.2. Temperature and oxygen requirements 
Bifidobacteria display niche specific growth temperature requirements, with isolates from 
humans GIT able to grow at temperatures ranging between 36°C and 38°C. In contrast, 
Bifidobacterium species isolated from animals GITs show growth at higher temperatures 
(41°C to 43°C), with B. thermacidophilum exhibiting a maximal growth temperature of 
49.5 °C (Ventura et al., 2004), showing general adaptations to temperature conditions in 
their respective niches.  
 
Bifidobacteria are described as strict anaerobes although some species (B. lactis, B. 
aerophilum and B. psychroaerophilum) can tolerate oxygen (Ventura et al., 2004). The 
biochemistry of oxygen requirements is different for each bifidobacterial species, with 
weak catalase activity or the presence of NADH oxidase able to confer oxygen tolerance, 
by removing or avoiding the synthesis of hydrogen peroxide (de Vries and Stouthamer, 
1968). In species that are highly sensitive to oxygen, accumulation of hydrogen peroxide is 
the principal reason for reduced metabolism since its presence inactivates F6PPK, a key 
enzyme of the “Bifid-shunt” (Ventura et al., 2004). 
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1.4.3.3. Probiotic effect and host interactions 
There is economical interest in the probiotic effect of bifidobacterial isolates, and 
numerous strains are added in high numbers (commonly greater than 109 cfu per dose) to 
products to create functional foods (Stanton et al., 2005). When applied to the human GIT, 
probiotic microorganisms have a potentially symbiotic relationship with their host, 
contributing to host nutrition by impacting on intestinal cell proliferation and 
differentiation, modulating the host immune system, competitively excluding pathogenic 
microorganisms and supressing intestinal inflammation (Saxelin et al., 2005). In the 
bifidobacterial context, probiotic effect is built on the foundation of carbohydrate 
metabolism combined with the highly efficient bifid-shunt pathway. The complex 
carbohydrates that are not able to be digested by the endogenous, host enzymatic suite 
(including fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), gluco-
oligosaccharides, xylo-oligosaccharides, inulin, starch, arabinoxylan and arabinogalactan, 
lactulose and raffinose (Guarner and Malagelada, 2003, Turroni et al., 2011)) constitute 
fermentable substrates for intestinal bacteria such as Bifidobacterium.  
 
In neonates, human milk is often the only source of nutrition. It contains Human Milk 
Oligosaccharides (HMO), complex oligosaccharides that are central carbohydrate 
constituents of this nutrient-rich food (Asakuma et al., 2008). These complex 
oligosaccharides are built from N-acetylglucosamine, D-glucose, D-galactose, L-fucose 
and N-acetylneuraminic acid residues in a large variety of carbohydrate configurations 
(Sela and Mills, 2010). Bifidobacteria and other early colonisers of the human gut are 
capable of degrading HMOs and isolates of B. bifidum and B. longum from infants are 
typically do so, although isolates recovered from adults are usually not able to utilise 
HMOs (Sela and Mills, 2010), potentially due to genome reduction of non-essential genes. 
 
Bifidobacterial genome sequences all appear encode extracellular polysaccharide (EPS), 
which may be implicated in adherence to host cells in the GIT and potentially confers 
increased levels of resilience to stomach acids and bile salts (Perez et al., 1998, Ventura et 
al., 2007a), which is important in a probiotic context and especially so if the probiotic is 
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fed in a “live culture” that must traverse the entirety of the GIT. Additionally, the genomes 
of both lower-GIT (Klijn et al., 2005) and oral (Ventura et al., 2009b) originating 
bifidobacteria are predicted to encode glycoprotein fimbriae-like structures, which are 
implicated in microbial adhesion and colonization of host epithelial cell surfaces in other, 
well-studied, probiotic bacteria (Kankainen et al., 2009). 
 
1.4.4. BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS 
 
1.4.4.1. Characteristics and physiology 
Bifidobacterium animalis subsp. lactis is commonly found in the GIT of healthy humans 
and the infant gut microbiota, primarily in faecal (Turroni et al., 2009) and ileal (Wall et 
al., 2007) samples. It is also the most common Bifidobacterium species used as a probiotic 
in commercial dairy products in both North America and Europe (Gueimonde et al., 2004, 
Masco et al., 2005). By virtue of its wide use and commercial probiotic importance, many 
studies have been undertaken using strains of B. animalis subsp. lactis to elucidate their 
potentially probiotic effects. Potential probiotic effects include survival in the GIT (Wall et 
al., 2007), modification of host fecal flora (Bartosch et al., 2005), modulation of the host 
immune response (Paineau et al., 2008), adherance to human epithelial cells in vitro (Gopal 
et al., 2001) and prevention of microbial gastroenteritis and colitis (Philippe et al., 2011). 
In addition to the above specific probiotic properties, B. animalis subsp. lactis retains the 
ability of the rest of the genus to metabolise oligosaccharides that are not digestible by the 
host, contributing to its ability to compete in the human gut (Barrangou et al., 2009). The 
described benefits linked with certain strains of B. animalis subsp. lactis have resulted in 
their inclusion in a large array of dietary supplements and foods (see Table 1.1), including 
dairy products such as yoghurt.  
 
Despite the commercial and probiotic significance of B. animalis subsp. lactis however, 
methods for differentiating B. animalis subsp. lactis at the strain-level has proved 
challenging, due to the genetic identity of the species as determined by PFGE (Briczinski 
and Roberts, 2006) and other nucleic acid-based techniques such as ERIC-PCR (Ventura 
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and Zink, 2002a). Currently, eight B. animalis subsp. lactis genome sequences are 
complete and publically available (Table 1.6), providing both reference sequences for 
ongoing metagenomic analyses of the human environment, and a detailed insight into the 
strain-level diversity of B. animalis subsp. lactis. 
 
1.4.4.2. Strain-level diversity 
A recent study by Milani et al (2013) used comparative genome sequence analysis to 
establish the strain-level diversity of B. animalis subsp. lactis at the genomic level. Very 
high genome sequence similarity was observed between strains of B. animalis subsp. 
lactis, corroborated by a high degree of conservation in terms of genome size, 
organization, and sequence (Milani et al., 2013).  It was postulated that the isogenic nature 
of all B. animalis subsp. lactis strains, combined with the overall absence of polymorphism 
was symptomatic of a genetically monomorphic subspecies. A pan-genome analysis of the 
B. animalis subsp. lactis taxon indicated a closed pan-genome, suggesting no new genetic 
coding ability will be discovered by additional genomic resequencing attempts (Milani et 
al., 2013). This signifies that B. animalis subsp. lactis is a highly clonal, potentially 
recently evolved, taxon from the B. animalis species, although alternatively, the 
resequenced strains may all be members of the same clade and the genetic diversity of B. 
animalis subsp. lactis may not be adequately represented within these strains. The only 
validated difference between strains of B. animalis subsp. lactis was found in the non-
coding CRISPR region (Section 1.3.3), where three homology groups were observed with 
19, 20 and 23 CRISPR repeats respectively (Milani et al., 2013). 
 
1.4.4.3. Strain typing 
Briczinski et al (2009) proposed a method for differentiating between strains of B. animalis 
subsp. lactis using Single Nucleotide Polymorphisms (SNPs), insertions and deletions. 24 
strains of B. animalis subsp. lactis were indistinguishable by both PFGE and RAPD using 
seven arbitrary primer sets (Briczinski et al., 2009). Strain-specific differences in sugar 
fermentation patterns were observed, although differences depended on the original culture 
medium for each isolate, with the exception of glucose uptake, whose rate correlated with a 
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SNP in the glucose transporter glcU (Briczinski et al., 2009). In the 50 variable genetic loci 
(SNPs), transporters and CRISPR elements were highly represented, perhaps indicating 
selective pressure on hypervariable loci (CRISPR) and genes involved in adaptation to an 
environmental niche (transcriptional regulators, carbohydrate uptake and metabolism) 
(Briczinski et al., 2009). The type strain, B. animalis subsp. lactis DSMZ 10140, was the 
most genetically distinct from the rest of the species, with other isolates falling into distinct 
families of strains, broadly correlating with the single SNP in glcU and therefore rate of 
glucose metabolism (Briczinski et al., 2009).  
 
1.4.5. BIFIDOBACTERIUM BIFIDUM  
 
1.4.5.1. Probiotic Characteristics 
Bifidobacterium bifidum is one of the four major bifidobacterial species commonly 
detected in adult and infant faeces (Matsuki et al., 2003). Healthy infants were found to 
have proportionally high levels of faecal B. bifidum compared to infants that displayed 
raised immunoglobulin E (IgE) responses to common environmental antigens, indicating 
that they were allergic (He et al., 2001). When fed in combination with antibiotics, B. 
bifidum OFR9 and prevented an overall decrease in the numbers of bifidobacteria in the 
gut, and restored the gut microbiota to normal more rapidly than just antibiotic (Chung et 
al., 1997).  Other potential probiotic characteristics of strains of B. bifidum include 
modulation of the host immune response (Ko et al., 1999, Park et al., 2002), production of 
bifidocin B, a bacteriocin (Yildirim et al., 1999). B. bifidum PRL2010 is also able utilise 
host-derived glycans such as mucin (Turroni et al., 2010). 
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1.5. EXAMINING STRAIN-LEVEL DIVERSITY 
Strain typing of bacteria is based on the assumption that the clonal descendants of a single 
ancestor will share characteristics that will differ from those of unrelated strains. These 
characteristics should be diverse within the species yet both stable and easily measurable. 
Many common bacterial typing methods have been adapted to encompass the typing of 
lactobacilli. The typing methods detailed below require the prior cultivation of isolates to 
be typed, in order to obtain either separate colonies or pure cultures (Dykes and von Holy, 
1994). 
 
1.5.1. DNA FINGERPRINTING METHODS 
 
1.5.1.1. Pulsed Field Gel Electrophoresis (PFGE) 
PFGE allows the high-resolution separation of DNA fragments of a larger size than 
permitted in traditional gel electrophoresis with the use of a continually reorienting (or 
pulsed) electric field. In PFGE, the complete bacterial genome is digested with a sparsely-
cutting restriction enzyme (such as NotI or SfiI for lactobacilli (Tynkkynen et al., 1999)) 
and then subjected to pulsed-field gel electrophoresis in order to separate the fragments of 
DNA. Tynkkynen et al. (1999) suggest that PFGE is the most discriminatory method for 
typing isolates of Lactobacillus rhamnosus and Lactobacillus casei.  
 
1.5.1.2. RAPD Fingerprinting 
RAPD fingerprinting uses short (usually ~10 bp) oligonucleotides with a random sequence 
as a primer in a low stringency PCR. The primers anneal to complementary or partially 
complementary regions on the target DNA. When the primers anneal on opposite strands 
within approximately 1 kb of one another, a PCR amplicon is generated. The PCR product 
is then subjected to separation by size by electrophoresis, and a RAPD fingerprint is 
created. This method generally allows differentiation between species and to some extent, 
strains within a species (Satokari et al., 2003). RAPD fingerprinting has been widely 
applied to the LAB (Du Plessis and Dicks, 1995). RAPD fingerprinting is generally 
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considered to be simple and rapid, although care needs to be taken to ensure the 
reproducibility of results generated by this PCR-based method.  
 
1.5.1.3. Repetitive Element PCR Fingerprinting  
Rep-PCR genomic fingerprinting makes use of DNA primers complementary to naturally 
occurring, highly conserved, repetitive DNA sequences, present in multiple copies in the 
genomes of several Gram-positive bacteria, including lactobacilli (Stephenson et al., 
2009). There are three families of repetitive sequences; the 35-40 bp repetitive extragenic 
palindromic (REP) sequence, the 124-127 bp enterobacterial repetitive intergenic 
consensus (ERIC) sequence (de Bruijn, 1992), and the 154 bp BOX element (Gevers et al., 
2001). These sequences are well distributed in intergenic positions around the genome. 
PCR primers have been designed to allow DNA synthesis outward from the inverted 
repeats in REP and ERIC, and from the boxA subunit of BOX. This PCR leads to the 
amplification of distinct genomic regions located between REP, ERIC or BOX elements. 
The corresponding procedures are referred to as REP-PCR, ERIC-PCR and BOX-PCR 
genomic fingerprinting respectively. The PCR amplicons may then be resolved using 
agarose gel electrophoresis, yielding a rep-PCR genomic fingerprint. REP-PCR and ERIC-
PCR have been applied to lactobacilli, and have shown excellent discriminatory ability at 
the subspecies level (Gevers et al., 2001, Ventura and Zink, 2002b). 
 
1.5.2. DNA SEQUENCE-BASED METHODS 
 
1.5.2.1. Multi Locus Sequence Typing (MLST) 
MLST was developed by Maiden et al (1998) for typing Neiserria meningitidis and has 
been effectively applied to strain typing of bacterial pathogens such as Escherichia coli 
(Lacher et al., 2007) and the Burkholderia cepacia complex (Baldwin et al., 2005). MLST 
schemes for species of LAB, including Lactobacillus plantarum (de las Rivas et al., 2006) 
and L. casei (Cai et al., 2007) have also been developed. MLST relies on partially 
sequencing six or seven ‘housekeeping’ genes, allowing the characterisation of alleles at 
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relatively conserved genomic loci, and as such, may differentiate between bacterial strains 
with much greater resolution than rRNA gene sequence analysis, which relies on 
polymorphism at a single locus. Each unique sequence type at each locus is designated a 
number, and hence strains may be defined by their seven-number sequence type. The 
MLST scheme for L. casei targets the genes encoding the following proteins: protein 
elongation factor EF-2 (fusA), isoleucyl-tRNA synthetase (ileS), GTP-binding protein 
LepA (lepA), leucyl-tRNA synthetase (leuS), CTP synthetase (pyrG), recombinase A 
(recA) and ATP-dependent DNA helicase (recG). The L. plantarum MLST scheme targets 
the genes encoding the following proteins: phosphoglucomutase (pgm), D-alanine-D-
alanine ligase (ddl), B subunit of DNA gyrase (gyrB), ATPase subunit of 
phosphoribosylaminoimidazole carboxylase (purK1), glutamate dehydrogenase (gdh), 
DNA mismatch repair protein (mutS) and transketolase (tkt4). 
 
1.5.3. SPECIES SPECIFIC PROBES BASED ON RIBOSOMAL RNA SEQUENCES 
Numerous specific oligonucleotide probes, specifically targeting rRNA genes, have been 
designed for different species of human intestine occurring lactobacilli (Satokari et al., 
2003). These are designed by analysing the sequence of rRNA genes to discover variable 
regions that contain information suggestive of phylogenetic groupings of different levels. 
Probes may therefore be designed to detect and differentiate organisms at the group, genus, 
species or strain level, providing there is sufficient sequence diversity at each level. 
Lactobacilli present a challenge when designing probes that differentiate at the genus level 
or below because of their phylogenetic heterogeneity. 
 
The development of species specific probes allows the detection of specific DNA 
sequences by PCR. This, in turn, allows quantification of these sequences in the 
environment, providing information concerning the quantity of the organism to which the 
sequence is specific. Number of sequences present and numbers of viable organisms are 
not directly equivalent however, as most species possess more than one copy of the rRNA 
gene sequence in question, and the presence of a specific sequence does not indicate a 
viable organism. 
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1.5.4. THE POST-GENOMIC ERA 
 
1.5.4.1. Comparative genomics 
The advent of relatively cheap and  highly accurate next-generation sequencing 
technologies has made the reseqeuncing of bacterial strains a viable laboratory method for 
strain typing, which also provides a vast amount of information supplementary to strain 
type. The decoding of an isolate’s genome sequence is the ultimate genotyping method (Li 
et al., 2009). The progressive gathering of genotyping information from DNA 
fingerprinting methods to whole genome sequencing has driven improvements in 
taxonomical accuracy across all bacterial species; pathogens, industrial organisms and 
probiotics. Relevant examples of the use of comparative genomics in the wider context of 
this study are provided for the lactobacilli (Section 1.2.2) and B. animalis subsp. lactis 
(Section 1.4.4.2). Recently, the development of ribosomal MLST (rMLST) provides 
resolution from the sub-species level to the whole bacterial domain, by indexing variation 
of sequences that encode ribosomal proteins (rps genes) (Jolley et al., 2012), and is 
discussed in more detail in Chapters 4 and 6. 
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1.6. PROJECT AIMS 
Probiotic bacteria are a diverse and heterogeneous group of organisms that have been 
utilised since the turn of the century for their health benefits and for thousands of years in 
fermented dairy and other products. Comparatively little is known about their population 
biology and evolution, specific mode of action, and their effects on both the metabolites 
and indigenous microbiota of the human gut.  
 
This PhD, a Collaborative Awards in Science and Engineering (CASE) studentship was 
funded by the Biotechnology and Biological Sciences Research Council (BBSRC) in 
collaborative partnerhip with Cultech Ltd., an internationally recognised innovator and 
premium quality manufacturer within the nutritional supplement industry, based in Port 
Talbot, Wales, UK. The questions and aims investigated in this study reflect their 
commercial interests, characterising and examining the diversity of probiotic bacteria at 
the molecular level, with specific focus on isolates used by Cultech Ltd. To bring a genetic 
context to the phenotypic information available on the bacteria used by Cultech Ltd., state-
of-the-art next-generation sequencing combined with genome-scale analysis techniques 
was used to build upon classical strain typing methods.  
 
Cultech Ltd. produce four different nutritional supplements, three for the UK and one for 
the North American markets, all of which contain the Lab4® probiotic mixture. Lab4® 
consists of two strains of L. acidophilus, CUL 21 and CUL 60 and two bifidobacterial 
strains B. bifidum CUL 20 and B. animalis subsp. lactis CUL 34. Clinical trials conducted 
with the Lab4® probiotic mixture have been shown prevent atopic sensitization and atopic 
eczema when administered to pregnant women and infants aged 0-6 months (Allen et al., 
2012), significantly reduce total symptoms and improve quality of life in diagnosed IBS 
sufferers (Williams et al., 2009) and reduce the incidence of Clostridium difficile-
associated diarrhoea in hospitalised patients (Plummer et al., 2004). 
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The specific objectives of this PhD study were to characterise a selection of these bacteria 
as follows:  
 
Strain typing Lactobacillus acidophilus 
o The  major focus of the PhD study was L. acidophilus and evaluation of genetic 
typing methods for this species were investigated in order to: 
 Establish the sub-species level diversity of L. acidophilus using Randomly 
Amplified Polymorphic DNA (RAPD) fingerprint analysis 
 Develop robust molecular markers for  detecting L. acidophilus at the species 
level 
 Test molecular markers in culture independent approach using a diverse 
range of samples to investigate L. acidophilus distribution 
 
Minimum taxonomic criteria for bacterial genome sequence depositions 
o During the course of the PhD, an announcement of the genome sequence of L. 
acidophilus strain 30SC was made (reference). When the 30SC genome was 
compared to the L. acidophilus senso stricto genomes as part of ongoing work, it 
became clear that the 30SC isolate was not a member of this species. The 
following analyses were performed to establish the correct species-identity of 
strain 30SC: 
 Analyse the phylogenetic placement of L. acidophilus 30SC using its recently 
published genome sequence 
 Construct Lactobacillus phylogenies using simple analyses based on the 16S 
rRNA gene sequence  
 Construct Lactobacillus phylogenies using simple analyses based on the 
sequence of other phylogenetic marker genes such as gyrase B  
 Set out a simple standard bioinformatic process that can be applied to newly 
generated genome sequences to ensure that they are accurately assigned to 
the genus or species level before deposition to a database and subsequent 
announcement 
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Lactobacillus acidophilus genomics and population structure 
o To enhance the strain level diversity analysis performed using RAPD, next-
generation sequencing and cutting edge genomic comparative techniques were 
used to: 
 Obtain whole genome sequences for three isolates of L. acidophius; two 
commercial isolates (CUL21 and CUL60) and an isolate with an early 
deposition date (LMG 11428) 
 Use comparative genomics to establish the diversity of commercial isolates 
 Expand genomic information on L. acidophilus strains by resequencing the 
genomes of 28 L. acidophilus isolates 
 Apply Methyl Methane Sulphonate (MMS) to L. acidophilus to alkylate 
DNA and potentially induce mutations that could later be detected by DNA 
resequencing 
 Establish evolutionary history of L. acidophilus isolates 
 Investigate potential basis for limited isolate genetic diversity 
 
 
 
Phenotypic diversity of Lactobacillus 
o To complement the genetic analysis of L. acidophilus, phenotyping analysis was 
carried out to: 
 Examine species-level differences in Lactobacillus in the metabolism of 
carbohydrates using API 50CHL and evaluate as a method for identifying L. 
acidophilus 
 Evaluate the use of Matrix Assisted Laser Desorption/Ionisation – Time Of 
Flight (MALDI-TOF) mass spectrometry as a tool to examine the gross 
proteome of Lactobacillus isolates 
 Assess the use of MALDI-TOF MS as an identification tool for Lactobacillus 
isolates on both the species and strain levels 
 Establish the strain-level diversity of the gross proteome of L. acidophilus 
 Measure growth kinetics of L. acidophilus strains 
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Genomic diversity of bifidobacteria 
o As a final component of this PhD study, preliminary genomic analysis of two 
Bifidobacterium isolates used by Cultech Ltd was carried out in order to:  
 Obtain whole genome sequences for two commercial bifidobacterial isolates, 
Bifidobacterium bifidum CUL20 and Bifidobacterium animalis subsp. lactis 
CU34 
 Use comparative genomics to establish the evolutionary history of 
commercial isolates 
 Develop robust molecular markers for  detecting Bifidobacterium bifidum 
and Bifidobacterium animalis subsp. lactis at the species level 
 Test molecular markers in culture independent approach to establish efficacy 
and to investigate distribution of bifidobacteria. 
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2. ANALYSIS OF THE SUB-SPECIES LEVEL DIVERSITY OF 
LACTOBACILLUS STRAINS AND DEVELOPMENT OF NOVEL TOOLS 
FOR DETECTION OF L. ACIDOPHILUS 
 
2.1. INTRODUCTION 
Development and subsequent use of accurate tools for identifying lactobacilli at the species 
and sub-species level is vitally important, particularly of organisms that are used in 
commercial environments and food products such as starter-cultures for fermentation and 
probiotics. Sub-species level identification to identify strains of lactobacilli is important in 
the biotechnology industry, which requires tools to monitor, for example; the use of 
proprietary or patented strains, for quality control of batches of these organisms, or to 
distinguish between probiotic strains and those occurring naturally in the host 
gastrointestinal tract. It is also crucial to be able to compare clinical isolates and 
biotechnological strains and to be able to ascertain and monitor the genetic stability of 
commercial strains (Klein et al., 1998). 
Molecular genotyping approaches are usually undertaken when studying the epidemiology 
of infectious disease pathogens; however, this study has used molecular genotyping to 
assess the intra-species diversity of a single probiotic bacterium, L. acidophilus, in the 
context of other closely-related species, belonging to the remarkably large and diverse 
Lactobacillus genus. Given that probiotic effect is often specific to a particular strain 
(Ouwehand et al., 2002, Luyer et al., 2005), accurate identification of cultures presumed to 
have probiotic properties is essential. It is accepted that probiotics should be classified and 
identified using internationally recognised methods such as Pulsed-Field Gel 
Electrophoresis, DNA-DNA hybridisation and 16S RNA gene sequencing (Pineiro and 
Stanton, 2007). Bacterial 16S rRNA gene sequencing is commonly used as a rapid and 
effective means of determining a genus- or species-level taxonomic identification although 
it provides little to no strain information (Naser et al., 2007). In biotechnological and 
industrial applications, identification is traditionally limited to these techniques and 
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conventional phenotypic identification using physiological parameters, rather than more 
modern methods practised in a research setting. 
 
Traditionally, the identification of lactobacilli has been based mainly on fermentation of 
carbohydrates, morphology, and Gram staining, and these methods are still used. However, 
in recent years, the taxonomy has changed considerably with the increasing knowledge of 
the genomic structure and phylogenetic relationships between Lactobacillus species (Klein 
et al., 1998, Stiles and Holzapfel, 1997). Modern methods of strain typing are typically 
based on PCR, for example, random amplified polymorphic DNA (RAPD); or DNA 
fingerprinting method based on the restriction enzyme digestion of DNA, such as PFGE 
and ribotyping (Tynkkynen et al., 1999). In RAPD analysis, short DNA oligos of arbitrary 
sequence are used as PCR primers that produce amplification product patterns that are 
specific to each individual strain. PFGE relies on rare-cutting enzymes to digest genomic 
DNA into large fragments which are subsequently separated by electrophoresis, generating 
a fingerprint unique to each strain, while ribotyping uses rRNA genes or their spacer 
regions as probes that hybridize to genomic restriction fragments. Mainly due to 
methodological differences, discrepancies are often seen in the results of these techniques, 
and as such, any subspecies taxonomic assignation should be achieved as part of a 
polyphasic taxonomic approach (Vandamme et al., 1996). 
 
Previous work has shown that when RAPD analysis was applied to a small collection of 
six reference isolates, L. acidophilus appeared to have very limited strain-level diversity 
(Mahenthiralingam et al., 2009). To increase the scope and depth of analysis beyond that 
of the previous study (Mahenthiralingam et al., 2009), this chapter presents a strain-level 
diversity analysis of a disparate group of LAB isolates, with particular focus on L. 
acidophilus reference and commercial isolates using RAPD analysis. An L. acidophilus 
specific PCR test was also developed in order to screen disparate niches for L. acidophilus, 
to expand and develop the range of isolates studied beyond those used in industrial 
CHAPTER TWO – STRAIN DIVERSITY OF LACTOBACILLUS AND DEVELOPMENT OF DETECTION 
TOOLS 
54 
 
processes or collected as reference strains, and overall, to ensure that the range of isolates 
tested fully represent the strain level diversity of L. acidophilus as a LAB species. 
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2.1.1. SPECIFIC AIMS 
 
The aims of this chapter were as follows: 
 
• Investigate the sub-species level diversity of L. acidophilus using Randomly 
Amplified Polymorphic DNA (RAPD) fingerprint analysis. 
 
 
• Develop robust molecular markers for detecting L. acidophilus at the species level. 
 
 
• Develop molecular markers for each commercial L. acidophilus isolate using 
genome sequence information to investigate targets. 
 
 
• Test molecular markers in culture independent approach using a diverse range of 
samples to investigate L. acidophilus distribution. 
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2.2. METHODS 
2.2.1. STORAGE OF BACTERIAL ISOLATES 
Stocks of bacterial isolates were prepared by resuspending fresh colonial growth from a 
pure culture plate into broth MRS (Oxoid, Basingstoke, UK) (de Man et al., 1960) 
containing 8% (v/v) DMSO or 15% (w/v) glycerol.  Stocks were then maintained at            
– 80ºC.  
 
2.2.2. GROWTH CONDITIONS 
Unless otherwise stated, bacterial isolates were revived from frozen stocks and cultured on 
a MRS (de Man et al., 1960) agar at 37ºC. Liquid cultures (24 hours) were prepared by 
inoculating 3 ml of MRS broth media with a single colony from a revival plate, tubes were 
then incubated, statically at 37ºC for 24-48 hours, depending on the growth requirements 
of each isolate. 
 
2.2.3. RAPID DNA EXTRACTION FROM COLONY MATERIAL  
A single bacterial colony from a pure culture plate (with < 72 hours’ growth) was 
aseptically transferred to 50 µl of 5% (w/v) chelex® 100 resin solution (Biorad, 
Hertfordshire, UK, sterilised by autoclaving prior to use). DNA extraction was performed 
by heating the sample to 98°C on a heated block for a 5 minute cycle, then immediately 
placing the sample at 4ºC for 5 minutes. This process was repeated twice. Samples were 
then centrifuged briefly at 800 x g to sediment the resin and cellular debris and the 
supernatant containing the crude DNA removed for subsequent use.  
 
2.2.4. GENERATION OF RAPD FINGERPRINTS 
RAPD analysis was carried out as described by (Mahenthiralingam et al., 1996a). Primer 
272, 5’- TGC GCG CGG G -3’ (MWG Biotech, Covent Garden, London) was used for all 
reactions; reagents were from Qiagen (Qiagen, Crawley, Sussex, UK). Profile analysis was 
performed in 25 µl reaction mixtures containing: 1x PCR buffer, 1 x Q-solution, 3 mM 
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MgCl2, 200 µm dNTPs mixture, 1.6 µM RAPD primer, 1 U of Taq polymerase  and 2 µl of 
DNA template obtained by Chelex protocol. PCR thermal cycles were performed using a 
BioRad C1000 thermal cycler (BioRad, Hemel Hempstead, United Kingdom) as follows: 5 
minutes at 94ºC, 4 cycles of 5 minutes at 36ºC, 5 minutes at 72ºC, 5 minutes at 94ºC, 30 
cycles of 1 minute at 94ºC, 1 minute at 36ºC, 2 minutes at 72ºC followed by a final 
extension time of 10 minutes at 72ºC. 1 µl of the product was run on an Agilent 
Bioanalyser 2100 (Agilent, Santa Clara, US) using a DNA 7500 chip according to the 
manufacturer’s protocol. 
 
2.2.5. ANALYSIS OF RAPD FINGERPRINTS 
Electropherogram data from the BioAnalyzer, in the form of a csv file, was converted to a 
GelCompar II (v6.6.8)-compatible format using a dedicated script provided by Applied 
Maths (Sint-Martens-Latem, Belgium) was applied to each csv-file to convert the profiles 
to a GelCompar-compatible format. Internal marker bands were then removed and band-
searching set to a minimum profiling value of 2.0%. Similarity between fingerprints was 
calculated using the Pearson coefficient. Dendrograms were constructed by the unweighted 
pair group method with arithmetic means (UPGMA). 
 
2.2.6. PCR AMPLIFICATION OF PAU REGIONS SPECIFIC TO L. ACIDOPHILUS 
PAU gene amplification was used to identify the presence of L. acidophilus. PCR primers 
were generated using Primer3 (Rozen and Skaletsky, 2000) and are listed in Table 2.3. A 
25 µl PCR mixture was set up as follows: 1x PCR buffer, 1x Q-solution, 100 µM final 
concentration of dNTPs, 0.4 µM final concentration of each primer, 2 µl of template DNA 
(extracted with Chelex (section 2.2.3), from total faecal DNA (Sections 2.2.10 and 2.2.11) 
or from the first round of PCR), and 1 U of Taq DNA polymerase. The nested PCR was 
carried out in two stages using a BioRad C1000 thermal cycler (BioRad, Hemel 
Hempstead, United Kingdom) the first using the program; 96°C for 1 min, then 30 cycles 
of 60 sec at 96ºC, 60 sec at 56ºC, 60 sec at 72ºC, then a final step at 72ºC for 10 min. The 
product from this PCR was then used as the template DNA for the second round of PCR 
using the program; 95°C for 2 min, then 35 cycles of 30 sec at 94ºC, 30 sec at 52ºC, 90 sec 
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at 72ºC, then a final step at 72ºC for 5 min. The resulting PCR products were visualised by 
agarose gel electrophoresis on a 1.5% (w/v) gel. 
 
2.2.7. DETERMINATION OF THE PURE-CULTURE DETECTION LIMIT OF THE L. 
ACIDOPHILUS SPECIFIC MARKER PCR 
A bacterial suspension of L. acidophilus NCFM was serially diluted in MRS broth. To 
enumerate, triplicate 10 µl drops were aspirated onto the surface of MRS agar plates and 
incubated at 37ºC for 24 hours. Individual colonies were counted and the number of viable 
cells calculated and expressed as colony forming units per ml (CFU/ml). DNA was 
extracted from suspensions at each dilution using the following method: Cells were 
pelleted by centrifugation 1,200 x g for 10 min. The pellet was resuspended in 100 µl of 
TE (10 mM Tris-Cl pH8, 10 mM EDTA, pH 8) and transferred to a 2 ml screw-cap 
microcentrifuge tube containing approximately 0.5 ml of 0.1 mm diameter Zirconium 
beads (Biospec Products, Bartlesville, Oklahoma) and 500 µl lysis buffer (50 mM Tris-Cl 
pH8, 70 mM EDTA pH8, 1% (w/v) SDS) with 0.5 mg/ml Pronase (Roche, Hertfordshire, 
UK). The bacteria were then lysed by a 10 sec pulse on a mini bead-beater device (Biospec 
Products) and incubation at 37˚C for 1 hour to digest proteins. 200 µl of saturated 
ammonium acetate was then added, followed by a 5 sec pulse on the bead-beater device. 
The tubes were then centrifuged for 1 min at 16,100 x g, followed by the addition of 600 µl 
of chloroform. The tubes were pulsed on the bead-beater device for 5 sec and then phases 
were separated by centrifugation for 7 min at 16,100 x g. Genomic DNA was collected 
from the cleared aqueous phase by ethanol precipitation. After the DNA pellet was washed 
with 70% (v/v) ethanol and vacuum dried it was resuspended in 50 – 300 µl low EDTA-TE 
(10 mM Tris-Cl  pH 8, 0.1 mM EDTA) with RNase A at 0.5 µg/ml. The extracted DNA 
was then used as template DNA as described in (Section 2.2.6). 
 
 
2.2.8. ISOLATING LAB FROM THE FAECES OF WILD RODENTS 
Wild rodents were trapped near Llysdinam in Wales, UK using baited live-capture 
Longworth traps that were set overnight. Faeces was collected from the traps aseptically 
and stored in 1.5ml Eppendorf tubes at -20°C. LAB were isolated from mouse faeces by 
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disrupting a thawed faecal pellet in 1.5ml Maximum Recovery Diluent (MRD; Oxoid, 
Basingstoke, UK). Serial dilutions were then plated onto MRS agar supplemented with 120 
units per ml of Polymixin B (Sigma Aldrich, Gillingham, UK), and incubated at 37°C for 
72 hours. Fresh colonies were simultaneously picked into 50 µl of 5% (w/v) Chelex resin 
for RAPD typing and testing with PAU-based specific marker PCR and into MRS broth for 
growth before storage at -80°C (Section 2.2.1).  
 
2.2.9. BACTERIAL 16S RRNA GENE AMPLIFICATION OF LAB ISOLATES CULTIVATED 
FROM WILD RODENTS 
16S rRNA gene amplification and sequencing was used to identify the bacteria isolated 
from wild rodent faeces. Primers 27F (5’- AGA GTT TGA TC(AC) TGG CTC AG -3’) 
and 1492R (5’- GGT TAC CTT GTT ACG ACT T -3’) (Lane, 1991) were used to amplify 
the near full length 16S rRNA gene as follows. A 50 µl PCR mixture was set up as 
follows: 1X PCR buffer, 1 X Q-solution, 100 µM final concentration of dNTPs, 0.4 µM 
final concentration of each primer, 3 µl of Chelex template DNA, and 1 U of Taq DNA 
polymerase. PCR was carried out in BioRad C1000 thermal cycler (BioRad, Hemel 
Hempstead, United Kingdom) as follows: 95°C for 2 min, then 35 cycles of 30 sec at 94ºC, 
30 sec at 52ºC, 90 sec at 72ºC, then a final step at 72ºC for 5 min. The resulting PCR 
product was analysed by agarose gel electrophoresis and sequenced on the forward strand 
using primer 27F and the reverse strand with primer 1492R in order to obtain a full length 
sequence of the 16S rRNA gene. Sequencing reactions were carried out using Applied 
Biosystems Big Dye Terminator ready reaction mix version 3.1, with subsequent analysis 
on an Applied Biosystems ABI-Prism 3100 automated sequencer. Alignments were 
constructed with BioEdit v7.2.1(Ibis Biosciences, Carlsbad, US) and phylogenetic trees 
were constructed using MEGA 4 (Tamura et al., 2007). 
 
2.2.10. EXTRACTION OF TOTAL FAECAL DNA FROM RODENT FAECAL PELLETS 
Total faecal DNA was extracted from the faecal of wild rodents and rodents on the Lab4® 
probiotic feeding trial using a FastDNA Spin Kit for Soil (Qbiogene Inc., Carlsbad, CA) 
and following the manufacturer’s instructions. 
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2.2.11. EXTRACTION OF TOTAL FAECAL DNA FROM HUMAN FAECES 
DNA was extracted from human faecal material using the QIAamp® DNA Stool Mini Kit 
(Qiagen, Crawley, Sussex, UK) following the manufacturer’s instructions, modified to 
include an additional disruption step. 0.5 g of 0.1 mm zirconium beads (Biospec Products, 
Bartlesville, Oklahoma) were added to each sample, which was subsequently disrupted in 
three one-minute bursts using a Fastprep® machine with a 24x2ml adaptor (MP 
Biomedicals, Solon, US).  
 
CHAPTER TWO – STRAIN DIVERSITY OF LACTOBACILLUS AND DEVELOPMENT OF DETECTION 
TOOLS 
61 
 
2.3. RESULTS 
For clarity, the results were divided into three parts, the first (Section 2.3.1) concerns the 
application of RAPD profile similarity analysis to a collection of LAB isolates, with 
particular emphasis on L. acidophilus, which included two L. acidophilus isolates from the 
Cultech Lab4® probiotic supplement (CUL21 and CUL60). The assembled collection of L. 
acidophilus isolates (Table 2.1) were originally isolated from a relatively limited range of 
locations, with the majority from commercial products (dairy, probiotic and other 
fermented products) and Cultech products, and were all associated with human processes. 
The second part (Section 2.3.2) describes the development of a reliable method for 
detecting L. acidophilus from collection both cultured and uncultured samples. The third 
(Section 2.3.2) seeks to expand the scope of the isolate collection by applying the 
developed method to samples from a variety of hosts, also allowing investigation into the 
distribution of L. acidophilus in various hosts.  
 
2.3.1. RAPD FINGERPRINTING OF LAB ISOLATES 
 
2.3.1.1. Validation of RAPD fingerprinting method for LAB isolates 
A broad collection of 72 LAB isolates from a variety of isolation sources (Table 2.1) was 
used to assess the discriminatory ability and reproducibility of the RAPD fingerprinting 
method when applied to a large collection of LAB isolates, with the broad emphasis on 
assessing the genetic diversity of LAB isolates and primary goal of defining overall 
diversity within L. acidophilus. The use of primer 272 (Mahenthiralingam et al., 1996b) for 
RAPD fingerprinting of LAB was validated by generating least five PCR products of 
differing size for each of the isolates. The use of the Bioanalyzer greatly reduced between-
gel profile variation seen between standard 1.5% (w/v) agarose gels, indicated by repeated 
typing of a control strain showing at least 90.6% profile stability (Figure 2.1). The stability 
and reproducibility of the control fingerprint over time shows the value of RAPD as strain 
typing method for analysing isolates over a long time period. 
CHAPTER TWO – STRAIN DIVERSITY OF LACTOBACILLUS AND DEVELOPMENT OF DETECTION 
TOOLS 
62 
 
Table 2.1: LAB isolates, their RAPD profile types and isolation sources 
Species (16S rRNA 
gene sequence) 
Species based on 
RAPD profile Isolate name 
Source or product from which 
the isolate was cultivated 
RAPD 
profile type 
L. acidophilus - BFT2 Commercial probiotic 1 
L. acidophilus - C21 Cultech Ltd. 1 
L. acidophilus - C46 Cultech Ltd 1 
L. acidophilus - C47 Cultech Ltd. 1 
L. acidophilus - C49 Cultech Ltd. 1 
L. acidophilus - C77 Cultech Ltd. 1 
L. acidophilus - C85 Cultech Ltd. 1 
L. acidophilus - CUL21 Cultech Ltd. 1 
L. acidophilus - CUL60 Cultech Ltd. 1 
L. acidophilus - Rm344 Cultech Ltd. 1 
L. acidophilus - Rm345 Cultech Ltd. 1 
L. acidophilus - CulT2 Cultech Ltd. 1 
L. acidophilus - HBAP T1 Commercial probiotic 1 
L. acidophilus - HBCA Commercial probiotic 1 
L. acidophilus - LAB 283 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 444 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 64 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 66 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 67 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 683 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 69 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 76 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 77 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 79 Peter Vandamme (Unpublished) 1 
L. acidophilus - LAB 74 Peter Vandamme (Unpublished) 1 
L. acidophilus - NCFM Reference (Human) 1 
L. acidophilus - LMG 11428 Reference (Rat faeces) 1 
L. acidophilus - LMG 11430 Reference (Human) 1 
L. acidophilus - LMG 11466 Reference 1 
L. acidophilus - LMG 11467 Reference (Human) 1 
L. acidophilus - LMG 11469 Reference (Rat intestine) 1 
L. acidophilus - LMG 11470 Reference  1 
L. acidophilus - LMG 11472 Reference  1 
L. acidophilus - LMG 13550 Reference (Human) 1 
L. acidophilus - LMG 9433 Reference (Human) 1 
L. acidophilus - TT1 Commercial probiotic 1 
L. brevis - LMG 6906 Reference  (Human faeces) 2 
L. casei - P7T1 Commercial 3 
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Table 2.1: LAB isolates, their RAPD profile types and isolation sources (cont.) 
Species (16S rRNA 
gene sequence) 
Species based on 
RAPD profile Isolate name 
Source or product from which 
the isolate was cultivated 
RAPD 
profile type 
L. casei  - C48 Cultech Ltd. 4 
L. casei  - C65 Cultech Ltd. 5 
L. casei  - LMG 6904 Reference  (Cheese) 6 
L. acidophilus L. casei TBCC Commercial probiotic 6 
L. gasseri - C44 Cultech Ltd. 7 
L. gasseri - C63 Cultech Ltd. 7 
L. gasseri - C67 Cultech Ltd. 7 
L. gasseri - C64 Cultech Ltd. 8 
L. gasseri - LMG 9203 Reference (Human) 9 
L. gasseri - SSMB Commercial probiotic 10 
L. jensenii - C66 Cultech Ltd. 11 
L. acidophilus L. jensenii C68 Cultech Ltd. 12 
L. jensenii - C72 Cultech Ltd. 12 
L. johnsonii - LMG 9436 Reference  (Human blood) 13 
L. paracasei subsp. 
paracasei - LMG 7955 Reference  14 
L. plantarum - C13 Cultech Ltd. 15 
L. plantarum - LMG 6907 Reference  (Pickled cabbage) 15 
L. plantarum - HBRAT1 Commercial 16 
L. rhamnosus - FMDT2 Commercial probiotic 17 
L. rhamnosus - GG Commercial probiotic 18 
L. rhamnosus - QAPT1 Commercial probiotic 19 
L. salivarius - CulT1 Cultech Ltd. 20 
L. suntoryeus - C78 Cultech Ltd. 21 
L. suntoryeus - C80 Cultech Ltd. 21 
L. suntoryeus - C81 Cultech Ltd. 21 
L. suntoryeus - C82 Cultech Ltd. 21 
L. suntoryeus - C84 Cultech Ltd. 21 
L. suntoryeus - FMDT1 Commercial probiotic 21 
L. suntoryeus - HS1 Cultech Ltd. 21 
L. suntoryeus - HS3 Cultech Ltd. 21 
unknown L. suntoryeus HT2 Commercial probiotic 21 
L. suntoryeus - HBRAT2 Commercial probiotic 22 
L. suntoryeus - P7T2 Commercial probiotic 22 
L. suntoryeus - QAPT2 Commercial probiotic 22 
Pediococcus 
pentosaceus - HBRAT3 Commercial probiotic 23 
Enterococcus faecalis - C22 Cultech Ltd. 24 
Enterococcus faecium - LMG 14205 Reference  25 
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2.3.1.2. Application of RAPD fingerprint analysis to LAB isolates 
Table 2.1 details the RAPD type assigned to each isolate using RAPD primer 272. RAPD 
profile types were differentiated on the basis of 75% fingerprint similarity. This level of 
similarity was chosen as a cut-off value for strain type designation based on the findings 
from RAPD analysis surveys of Pseudomonas aeruginosa isolates from cystic fibrosis 
patients (Campbell et al., 2000). It was also supported by empirical evidence, with the 
value of 75% correlating to the assessment of profile types that were visually distinct 
(Figure 2.2).  
 
Three RAPD profile types, 1, 6, and 12 (Table 2.1), were initially associated with isolates 
identified by partial 16S rRNA gene sequence analysis as L. acidophilus. The majority of 
L. acidophilus isolates generated a single RAPD profile (type 1) with profile types 6 and 
12, in each case represented by just a single isolate. L. acidophilus TBCC (isolated from a 
commercial probiotic product) generated a RAPD profile type that was subsequently found 
to be shared by L. casei LMG 6904 (Table 2.1). L. acidophilus C68 (isolated by Cultech 
Ltd) shared a profile type with L. jensenii C72. Accordingly, species designations were 
updated for these isolates, and further proof of the correct reclassification of L. acidophilus 
TBCC to L. casei TBCC was also observed after carbohydrate fermentation profiling (see 
Chapter 5; Figure 5.2).  
 
All isolates of L. acidophilus that were unequivocally confirmed as this species type were 
found to have the same RAPD profile type (type 1), including the two commercial strains 
from the Cultech Lab4® probiotic supplement, L. acidophilus CUL21 and L. acidophilus 
CUL60. In comparison, other LAB tested showed a variety of different RAPD profile 
types per species (Table 2.2). L. casei and L. gasseri displayed the greatest within-species 
RAPD profile variability, with the majority of isolates tested generating a distinct RAPD 
profile (Table 2.2). However, L. suntoryeus showed only two RAPD profile types over 12 
isolates tested (Table 2.2).  
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Figure 2.1: Clustered RAPD profiles from multiple re-typing of L. acidophilus LMG 9433T as an 
internal control.  
Re-typed L. acidophilus LMG 9433T isolates cluster together at greater than 90.6%. Clustering analysis was 
performed using GelCompar II (Applied Maths, Belgium). Pearson correlation similarity coefficient with a 
UPGMA dendrogram type was used, and position tolerance optimisation was set to 0.5%.  
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Figure 2.2: Clustered RAPD profiles of Lactobacillus and Enterococcus isolates from a range of 
isolation dates and sources.  
L. acidophilus isolates clustered at greater than 79%. Cluster analysis was performed using GelComparII 
(Applied Maths, Belgium). Pearson correlation similarity coefficient with a UPGMA dendrogram type was 
used, with position tolerance optimisation set to 0.5%. Strain-type profile similarity cut-off (75%; Section 
2.3.1) is indicated. 
 
75% profile 
similarity 
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Table 2.2: RAPD profile type represented by LAB 
Species Isolates RAPD profile types 
L. acidophilus sensu stricto 33 1 
L. brevis 1 1 
L. casei 5 4 
L. gasseri 6 4 
L. jensenii 2 1 
L. johnsonii 1 1 
L. paracasei subsp. paracasei 1 1 
L. plantarum 3 2 
L. rhamnosus 3 3 
L. salivarius 1 1 
L. suntoryeus 12 2 
P. pentosaceus 1 1 
E. faecalis 1 1 
E. faecium 1 1 
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2.3.2. DEVELOPMENT OF A SPECIFIC TEST FOR L. ACIDOPHILUS 
 
2.3.2.1. Development of the Potentially Autonomous Units (PAUs) of L. 
acidophilus as species specific markers 
The three PAU regions of L. acidophilus were selected as prospective targets for 
development as species-specific markers because of their unique nature within the L. 
acidophilus NCFM genome (Figure 2.3). As an initial screening procedure, the DNA 
sequences corresponding to target ORFs within the PAU region (Table 2.3) were searched 
against the non-redundant nucleotide database at the National Centre for Biotechnology 
Information (NCBI) to establish their specificity. Only sequences belonging to L. 
acidophilus were returned as similar (100% coverage, 100% identity, e=0), indicating that 
the only record of the PAU regions in the NCBI’s nucleotide database were from L. 
acidophilus.  
 
The LBA0479 open reading frame within the Pau3 region was selected as a gene target and 
a simple PCR test for PAU DNA was devised using primers FPau3 and RPau3 (Table 2.3). 
Initial testing indicated that these PCR primers would allow detection of approximately 
5000 colony forming units (cfu) in pure culture. In order to decrease the number of L. 
acidophilus cfu able to be detected by this test, a further, nested, PCR primer set was 
designed. The target sequences of these PCR primers are interior to FPau3 and RPau3, and 
coupled with a second thermal cycle, decreased the detection limit of the PAU specific 
marker test to 50 cfu in pure culture (Figure 2.4) . 
 
The specificity of the PAU specific marker system was tested using DNA extracted from 
relevant LAB cultures. The test panel was composed of DNA extracted from a panel of 32 
LAB species and a single isolate of B. cepacia J2315 (Table 2.4). The panel of 32 LAB 
comprised of 25 L. acidophilus isolates from various isolation sources and dates, as well as 
reference isolates of L. casei, L. plantarum, L. paracasei subsp. paracasei, L. gasseri and 
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L. johnsonii (Table 2.1). Also included were two L. acidophilus isolates reclassified by 
RAPD profile similarity analysis; L. casei (L. acidophilus) TBCC and L. jensenii (L. 
acidophilus) C68. For the purpose of testing the sensitivity and specificity of the L. 
acidophilus specific marker system, the 25 isolates that generated a type 1 RAPD profile 
were considered to be L. acidophilus sensu stricto 
 
The PAU-based L. acidophilus specific marker test was 100% specific for identification of 
L. acidophilus isolates when compared with other LAB species. All reference isolates from 
other LAB species failed to generate a positive PCR product, as did B. cepacia. Also, the 
two re-classified isolates; L. casei (L. acidophilus) TBCC and L. jensenii (L. acidophilus) 
C68, did not amplify the specific marker region. The PAU3 PCR was not successful at 
detecting all L. acidophilus isolates of RAPD profile type 1 however, producing a 
sensitivity of 92% within this species, with isolates LMG 11466 and LMG 11469 proving 
negative for amplification of the specific LBA0479 ORF (Table 2.4). After resequencing 
the genomes of these isolates, they were found to lack the PAU3 region (See Section 
4.3.2.2.2). All commercial commercial isolates, including L. acidophilus CUL21 and 
CUL60 from the Lab4® complex probiotic, were found to amplify the specific marker 
region. 
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Figure 2.3: Three PAU regions of the L. acidophilus NCFM genome 
The genome is represented by a black line, and base-pair intervals are shown in bp. Three PAUs were aligned at the 5′ end of the integrase, which is shown as an orange arrow, 
and are drawn to scale. RepA is represented by green arrows and FtsK is represented by red arrows. ORFs with no predicted functions that are assumed to be part of a PAU are 
shown as black arrows. Blue ORFs indicate proteins potentially involved in unit stabilization. Adjacent ORFs are shown as white arrows. tRNAs are drawn as gray boxes on the 
genome line. 
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Table 2.3: PCR primer sequences for L. acidophilus specific PCR, based on PAU regions 
Primer Name ORFa ORF Function 
ORF Size 
(bp) Orientation Tm Sequence 
Product 
size (bp) 
FPau3 
LBA479 hypothetical 702 
Forward 
58.75 TGATAATGACCCAATAACAATCG 
535 
RPau3 Reverse 
60.73 GGTCAAGACTGTGTGTAACAATGG 
FPau3_NESTED 
LBA479 hypothetical 702 
Forward 
53.14 TCCTAGAATGGTAAGAGATTGGCGGGA 
405 
RPau3_NESTED Reverse 
53.82 AGCAAATGCTGTGAAGCATCAGGTGT 
aORF designations extracted from L. acidophilus NCFM genome sequence (GenBank accession: CP000033) 
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Figure 2.4: Detection limits of L. acidophilus specific markers in pure culture.  
Number of input colony forming units (cfu) into DNA extraction before PCR decreases 10-fold moving from 
left-most lane to right-most lane. Lane 1= 5 x 108 cfu, lane 2 = 5 x 107 cfu, lane 3 = 5 x 106 cfu, lane 4 = 5 x 
105 cfu, lane 5 =5 x 104 cfu, lane 6 = 5 x 103 cfu, lane 7 = 500 cfu, lane 8 = 50 cfu. Marker lane is denoted M 
and relevant molecular weight marker sizes are included in bp. 
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Table 2.4: Specificity of PAU-based L. acidophilus specific markers 
Species Isolate PAU3 PCR 
L. acidophilus LMG 9433 + 
L. acidophilus LMG 11428 + 
L. acidophilus LMG 11430 + 
L. acidophilus LMG 11470 + 
L. acidophilus LMG 11472 + 
L. acidophilus LMG 11466 - 
L. acidophilus LMG 11469 - 
L. acidophilus LMG 13550 + 
L. acidophilus CUL60 + 
L. acidophilus CUL21 + 
L. acidophilus C21 + 
L. acidophilus C46 + 
L. acidophilus C47 + 
L. acidophilus C49 + 
L. acidophilus LAB 66 + 
L. acidophilus LAB 69 + 
L. acidophilus LAB 76 + 
L. acidophilus LAB 79 + 
L. acidophilus LAB 444 + 
L. acidophilus LAB 283 + 
L. acidophilus NCFM + 
L. acidophilus Rm344 + 
L. acidophilus Rm345 + 
L. acidophilus CulT2 + 
L. acidophilus HBCA + 
L. casei (L. acidophilus)a TBCC - 
L. casei LMG 6904 - 
L. plantarum LMG 6907 - 
L. paracasei subsp. paracasei LMG 7955 - 
L. jensenii (L. acidophilus)a C68 - 
L. gasseri LMG 9203 - 
L. johnsonii LMG 9436 - 
Burkholderia cepacia J2315 - 
 
a Species names given in brackets were assigned before RAPD profile similarity analysis. 
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2.3.3. PAU-BASED SPECIFIC MARKERS IN CULTURE-DEPENDENT AND CULTURE-
INDEPENDENT APPLICATIONS 
 
2.3.3.1. Isolation of L. acidophilus from mouse faeces  
With the intention of expanding the host diversity of the LAB examined in this study, the 
PAU-based specific markers were applied in a culture-dependent approach to LAB isolated 
from faecal pellets of wild rodents. A total of 45 wild rodents were trapped over a 24 hour 
period consisting of; 25 bank voles (Myodes glareolus), 11 wood mice (Apodemus 
sylvaticus), six yellow-necked mice (Apodemus flavicollis), and three common shrews 
(Sorex araneus). Faecal pellets from traps containing more than one rodent were discarded. 
Faecal pellets were obtained from 37 of the traps. Briefly, the faecal pellets collected from 
wild rodents were homogenised and diluted before spreading onto MRS agar to enrich for 
growth of LAB. Colonies were screened based on their morphology, and any resembling L. 
acidophilus were selected for further analysis. In addition, colonies were also picked at 
random to populate the LAB isolate collection with a diversity of isolates. In total, 70 
colonies were isolated from 37 wild rodent faecal pellets. 
 
Immediately prior to storage of the picked colonies, a rapid DNA extraction using 
Chelex® resin was performed and this DNA was used as input for PCRs amplifying part of 
the 16S rRNA gene and the L. acidophilus specific PAU marker region. Additionally, a 
RAPD-PCR using PCR primer 272 was undertaken on each colony. Total faecal DNA was 
also extracted from any remaining faecal material and was used as input for a nested PCR 
targeting the L. acidophilus specific PAU marker region to detect the presence of L. 
acidophilus using a culture-independent approach. 
 
A phylogeny based on the partial 16S rRNA gene sequences of the isolated LAB showed 
the dominant isolated species to be L. animalis and L. murinus. Isolates belonging to the L. 
acidophilus group were captured, but these belonged to L. intestinalis rather than L. 
acidophilus species (Figure 2.5). No L. acidophilus was isolated, with, no isolates testing 
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positive for the PAU-based L. acidophilus marker region and no RAPD profile matching 
the unique L. acidophilus profile type (type 1, Table 2.1, Figure 2.1). Finally, when applied 
to total faecal DNA extracted from wild rodent faeces in a culture-independent approach, 
the PAU-based L. acidophilus specific marker PCR detected no L. acidophilus at either the 
first round (detects more than approximately 5,000 cfu) or the second round (detects more 
than approximately 50 cfu). 
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Figure 2.5: LAB isolated from wild rodent faeces 
Neighbour-joining tree based on the 16S rRNA gene sequences of LAB isolated from wild rodents. Isolates 
(coded in black text) are compared to relevant reference sequences (red text, GenBank accession nos. 
indicated). Above-species-level groups are indicated with a brace. Alignments over 398 positions, 1000 
replicates generated bootstrap figures, scale is indicated in substitutions-per-site. The tree is rooted with 
Pseudomonas aeruginosa 16S rRNA gene sequence. 
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2.3.3.2. Culture-independent application of L. acidophilus specific PAU-based 
markers 
To further test the ability of the PAU-based marker test to detect L. acidophilus DNA in 
total faecal DNA from a range of host species and systems, total faecal DNA was prepared 
from (i) adults from the Republic of Côte d'Ivoire, (ii) healthy human males enrolled on a 
probiotic (Lab4®) feeding trial, (iii) rats enrolled on a Lab4® probiotic feeding trial, and 
(iv) wild rodent faeces, and used a template DNA for the L. acidophilus specific PAU-
based marker PCR.  
 
No adults from Republic of Côte d'Ivoire tested positive for more than 5,000 cfu of L. 
acidophilus (Figure 2.6, panels (i)A and (i)B). After the second round of PCR, 6/19 
individuals tested positive for PAU DNA indicating that between 50-5,000 cfu of L. 
acidophilus was present in these samples (Figure 2.6, panels (i)B, lanes 9, 12, 13, 15, 18  
and 19). When the same test was applied to sixteen healthy human adults enrolled on a 
Lab4® probiotic feeding trial (pre-feeding samples), four participants tested positive for 
PAU DNA representative of more than 5,000 cfu of L. acidophilus being present (Figure 
2.6, panel (ii)A, lanes 2, 6, 7 and 10). An additional eight tested positive for PAU DNA 
when the second round PCR was carried out to detect between 50-5,000 cfu of L. 
acidophilus (Figure 2.6, panel (ii)B, lanes 5, 8, 9, 11, 13, 14, 15 and 16).  
 
When applied to total faecal DNAs from rats that were being fed the probiotic Lab4® 
mixture, no individuals were found to be carrying PAU DNA representative of greater than 
5,000  cfu of L. acidophilus (Figure 2.7, panel A).  However, the majority of rats (10/11) 
were found to be carrying the PAU marker at a level representing between 50 and 5,000 
cfu of L. acidophilus (Figure 2.7, panel B). When the same test was applied to total faecal 
DNA extracted from wild rodents, no detectable levels of L. acidophilus were seen with 
the specific marker test. 
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Figure 2.6: Examining adult total faecal DNA from (i) Adults from Republic of Côte d'Ivoire and (ii) 
healthy human males enrolled on a probiotic (Lab4®) feeding trial (pre-feeding), for the presence of L. 
acidophilus using PAU-based L. acidophilus specific marker 
Panel (iA) shows PCR products from 19 total faecal DNAs (lanes 1-19), a negative PCR water control (lane 
20) and L. acidophilus NCFM DNA as a positive control (lane 21). Panel (iB) shows the same, with an 
additional L. acidophilus NCFM DNA positive control for the second round of PCR (lane 22) and an 
additional water PCR control for the second round of PCR (lane 23). Panel (iiA) shows 16 total faecal DNAs 
(lanes 1-16), an L. acidophilus NCFM DNA as a positive control (lane 17) and a negative PCR water control 
(lane 18). Panel (iB) shows the same, with an additional L. acidophilus NCFM DNA positive control for the 
second round of PCR (lane 19) and an additional water PCR control for the second round of PCR (lane 20). 
Lane M contains molecular size marker with sizes of relevant bands given in bp. 
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Figure 2.7: Examining total faecal DNA from rats after feeding of the Lab4® probiotic (Lab4®) for the 
presence of L. acidophilus using PAU-based L. acidophilus specific marker 
Panel A shows PCR products from 11 total faecal DNAs (lanes 1-11), a negative PCR water control (lane 12) 
and L. acidophilus NCFM DNA as a positive control (lane 13). Panel B shows the same, with an additional 
L. acidophilus NCFM DNA positive control for the second round of PCR (lane 15) and an additional water 
PCR control for the second round of PCR (lane 14) 
CHAPTER TWO – STRAIN DIVERSITY OF LACTOBACILLUS AND DEVELOPMENT OF DETECTION 
TOOLS 
82 
 
2.4. DISCUSSION 
 
2.4.1. STRAIN TYPING LAB USING RAPD PROFILE SIMILARITY ANALYSIS 
 
2.4.1.1. Typing Lactobacillus isolates 
PCR-electrophoresis-based strain typing methods, particularly RAPD, have previously 
been criticised for their low repeat reproducibility (Maukonen et al., 2003). The 
reproducibility of RAPD profiles for the same isolate, generated at multiple time points 
and on different microfluidics chips, showed that the use of the Bioanalyzer microfluidics 
platform in this study reduced repeat variability to less than 10%, less than half the profile 
variability expected to be seen within a single profile type (Figure 2.1). This allowed 
RAPD to be performed on a large collection of LAB isolates by enabling accurate 
comparisons of RAPD profiles generated on different microfluidics chips. This supported 
previous work that showed the microfluidics system was advantageous over agarose gel 
electrophoresis (Cooper et al., 2008), where comparisons can only be drawn with any 
accuracy from a small dataset on a single agarose gel.  
 
RAPD profile similarity analysis was successfully applied to 75 LAB isolates, belonging to 
14 distinct species. High quality RAPD profiles for all 75 LAB isolates, which were 
originally isolated from a wide range of sources and years, were generated and 
subsequently compared to examine the genetic diversity of LAB isolates, with particular 
emphasis on L. acidophilus isolates. Across the 14 LAB species examined, the study 
identified distinct 25 RAPD profile types, based on 75% profile similarity (Table 2.1). 
Generally, there was high intra-specific RAPD profile variation. L. casei, L. gasseri, L. 
jensenii, L. plantarum, L. suntoryeus and L. rhamnosus all generated at least two distinct 
RAPD profiles per species, although the 12 isolates identified as L. suntoryeus showed 
only two RAPD profile types. The high level of sub-species diversity is consistent with 
levels seen in other studies on L. plantarum (Aznar and Chenoll, 2006), L. rhamnosus 
(Vancanneyt et al., 2006), L. casei (Roy et al., 1999) and L. gasseri (Du Plessis and Dicks, 
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1995). L suntoryeus is somewhat of a special case, as its 16S rRNA gene is 99.3% similar 
to L. helveticus (Cachat and Priest, 2005). Since the proposal of L. suntoryeus as novel 
species, sequence similarity analyses of housekeeping genes (atpA, rpoA, pheS, tuf, slp and 
groEL) have shown high relatedness between it and L. helveticus, leading to designation of 
L. suntoryeus as taxonomic unit with the species L. helveticus (Naser et al., 2006). , The 
two taxonomic groups could be clearly distinguished, however, by Amplified Fragment 
Length Polymorphism (AFLP) (Naser et al., 2006). In the current study two RAPD profile 
type were captured for isolates designated as L. suntoryeus, correlating to the 
reclassification of L. helveticus and identification of at least two taxonimic groups within 
this species (Naser et al., 2006). 
 
2.4.1.2. Typing L. acidophilus 
Despite numerous studies detailing the application of RAPD strain typing to other LAB 
species (section 2.4.1.1) there has been little work to establish the diversity of L. 
acidophilus at the strain level, despite its broad commercial importance. Numerous studies 
have evaluated the interspecific diversity of the L. acidophilus group (Johnson et al., 1980, 
Berger et al., 2007, Schillinger et al., 2003), but this is the first to examine such a number 
of strictly L. acidophilus species isolates in the context of other LAB.  In contrast to the 
relatively high level of intra-specific RAPD profile diversity of the other LAB isolates 
tested, 10 reference, 15 commercial probiotic and 11 other isolates of L. acidophilus were 
assigned the same RAPD type (type 1). The reference isolates were originally deposited 
into culture collections in disparate years (Figure 2.2) and were originally isolated from 
various hosts and systems (Table 2.1), including rat faeces (L. acidophilus LMG 11428), 
humans (L. acidophilus LMG 9433). When expanded to cover isolates from industrial 
applications such as in probiotic products (L. acidophilus CUL21 and L. acidophilus 
CUL60), the current study has arguably one of the widest scopes for capturing strain 
diversity within this species. 
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Although RAPD data should be used only tentatively to describe genetic relatedness 
between isolates of LAB, this study also demonstrated the power of RAPD as a strain 
typing method across multiple LAB. With this fact in mind, since this study demonstrated 
that the numerous isolations of L. acidophilus (disparate both geographically and 
temporally), all had the same RAPD profile type, it suggests that either: (i) L. acidophilus 
may be a monophyletic Lactobacillus taxon, (ii) that the examined isolates belonged to the 
same evolutionary clade, or (iii) the isolates examined do not fully represent the diversity 
of L. acidophilus strains. To examine the latter question of whether full isolate diversity 
had been captured, an accurate cultivation-independent method of identifying L. 
acidophilus using the PAU-region was devised in order to rapidly identify whether it was 
present in other hosts, such as wild rodents. If L. acidophilus DNA was detected in these 
faecal samples, then a cultivation-based approach could be applied to collect these isolates 
and add further diversity to the isolate collections available for RAPD genotyping analysis. 
 
2.4.2. PAU REGIONS AS SPECIFIC MARKER REGIONS FOR L. ACIDOPHILUS 
Previous studies have developed PCR primers or specific oligonucleotide probes for L. 
acidophilus targeting the 23S rRNA gene (Pot et al., 1993), the ribosomal intergenic spacer 
(ITS) region (Song et al., 2000) and the 16S rRNA gene (Walter et al., 2000). The 
sequence identity observed in the 16S rRNA gene of the L. acidophilus group which is 
>99% in between certain species (Sarmiento-Rubiano et al., 2010) makes it a challenging 
target for species-specific probes design. This high level of identity may also account for 
the reduced specificity of probes based on the rDNA region and raises the question of 
developing marker regions from other genomic loci would prove a more accurate means to 
differentiate between Lactobacillus species.  
 
A simple PCR test for the presence of PAU3 was developed with the design of PCR 
primers to amplify a region of an ORF present in PAU3 (Figure 2.3, Table 2.3). As L. 
acidophilus NCFM is the only complete genome sequence available, this study screened 
32 lactobacilli (25 L. acidophilus isolates) to examine the distribution of PAU3 among 
lactobacilli and hence validate the region as one specific to L. acidophilus. All but two 
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isolates (LMG 11466 and LMG 11469) designated as L. acidophilus tested positive for the 
PAU3 specific marker (confirmed by DNA sequence), and no other lactobacilli (including 
members of the L. acidophilus group) cross-reacted with the specific PCR primers. The 
lack of the PAU3 marker region in L. acidophilus LMG 11466 and LMG 11467 was 
attributed to an absence of this DNA after genome re-sequencing (see Chapter 4) PAU 
regions are phage remnants and instability is associated with these mobile elements 
(Altermann et al., 2005, Brüssow, 2001). Further discussion of the genomics of this region 
is provided in Chapter 4. 
 
The PAU region of the L. acidophilus NCFM genome was originally selected as a potential 
L. acidophilus specific target region based on its highly conserved sequence within 
genome sequenced L. acidophilus isolates and because it was unique in sequence to L. 
acidophilus isolates when tested with a nucleotide Blast (BlastN). Recent analyses have 
shown however, that PAU region structural homologues exist in L. johnsonii NCC533, 
Lactococcus lactis subsp. cremoris SK11 and Streptococcus agalacticae NEM316 
(Altermann and Klaenhammer, 2011). The amino acid sequences of these regions are less 
conserved between species than they are within the same genome, that is to say PAU3 is 
more similar to PAU2 and PAU1in L. acidophilus than it is to any PAU analogues in other 
species, although functional classification of the genes in these regions is conserved, 
suggesting that these elements arose from different roots (Altermann and Klaenhammer, 
2011). The wider than anticipated distribution of these elements, which combine 
characteristics of both bacteriophage and plasmid DNA, suggests that they are not peculiar 
to the L. acidophilus genome, but potentially represent a whole class of mobile genetic 
elements that may be sub-divided into distinct families. No function or in vivo activity has 
yet been attributed to these regions (Altermann and Klaenhammer, 2011). Despite the 
presence of the these structural homologues in other LAB species, the LBA479 ORF 
probes developed to detect the L. acidophilus PAU3 remain 100% specific for this region 
as the PCR primers in terms of sequence homology and are mis-matched in these other 
PAU homologous regions.   
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2.4.3. HOST RANGE OF L. ACIDOPHILUS 
 
2.4.3.1. Searching for L. acidophilus in wild rodents 
The detection limit of the specific marker test improved to 50 cfu by developing a nested 
PCR primer set, combined with a two-round PCR thermal cycling program. When applied 
to total DNA extracted from wild rodent faeces, no PAU DNA was detected, indicating an 
absence, or at least undetectable levels of L. acidophilus present. Culture-independent 
studies have shown that lactobacilli represent between 5 and 8% of the total sequence reads 
from the natural rodent gut, however their high species-level diversity would cause the 
abundance of a single species to be relatively low (Brooks et al., 2003, Tomas et al., 2012). 
When applied to rodents that were being fed the Lab4® probiotic, whose proportional 
presence of L. acidophilus was expected to be higher as they had been fed over 109 L. 
acidophilus each day, the PAU-based specific marker system was able to detect L. 
acidophilus in 91% of rat faeces. 
 
Using a culture-based approach, no L. acidophilus was isolated from the faeces of wild 
rodents. Proportionally large numbers of L. animalis and L. murinus were isolated, which 
was to be expected as both naturally reside in the gut of rodents (Fraga et al., 2005, Sarma-
Rupavtarm et al., 2004). RAPD profile similarity analysis also showed no isolates with 
similar profiles to L. acidophilus, ensuring that the PAU-based L. acidophilus specific 
marker did not fail to identify any L. acidophilus that may have been present. Rodents such 
as rats and mice are commonly used to model systems of human disease, and metagenomic 
studies of rodents with perturbations of their normal gut microbiota abound (Turnbaugh et 
al., 2006, Murphy et al., 2010, Turnbaugh et al., 2008). These studies are performed on 
laboratory-bred and raised animals that certainly do not have a “wild type” microbiota.  
 
L. acidophilus is well documented as a human associated organism with a human gut-
specific gene set, functionally different to that of Lactobacillus helveticus, a species found 
in dairy products that shares 98.4% 16S rRNA sequence identity  (O'Sullivan et al., 2009). 
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This study was able to detect L. acidophilus in human faeces in a semi-quantitative culture-
independent manner, with between 32 and 75% of studied individuals appearing to carry L. 
acidophilus at a level over the lower detection limit of the specific marker test. This wide 
range of carriage rates of L. acidophilus in humans is reflected by what we already know 
about the “patchy” distribution of L. acidophilus in healthy adults from culture-based 
(Mahenthiralingam et al., 2009) and culture-independent studies (Kleerebezem and 
Vaughan, 2009, Walter, 2008). It should be noted however, that use of the 16S rRNA gene 
as molecular target for indexing microbial diversity in the GIT may give a broad overview; 
it is not effective at distinguishing some Lactobacillus to the species level because of the 
high 16S rRNA gene similarity. The development of next-generation sequencing 
technologies promising increased sequence read length at no detriment to overall diversity 
indexed will allow improved species-level assignments based solely on the extra 
phylogenetic information afforded by increased read lengths. 
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2.5. CONCLUSIONS 
The main conclusions from this chapter are as follows: 
 
1) RAPD profile similarity analysis is an effective method of both identifying LAB 
and examining their sub-species level genetic diversity. It was highly reproducible 
and could be successfully applied to a large collection of LAB isolates.  
 
 
2) LAB generally show a relatively high amount of sub-species level diversity. The 
exceptions to this rule are L. suntoryeus-L. helveticus and L. acidophilus. L. 
acidophilus isolates were from disparate isolation locations, deposition dates and 
host species. All L. acidophilus sensu stricto isolates generated a single RAPD 
profile type, based on 75% profile similarity, indicating the possibility that L. 
acidophilus isolates were all from a single strain type. 
 
 
3) To ensure that the genetic diversity of L. acidophilus was reflected by the isolates 
tested, wild rodents were surveyed for the presence of L. acidophilus both culture 
dependently and independently. The PAU-based specific marker test proved 
effective at detecting L. acidophilus specifically. No L. acidophilus was found in 
wild rodents and the human carriage rate was variable. 
 
 
4) Further work, at a discriminatory power above that of RAPD, is necessary study to 
examine the genetic structure of L. acidophilus as a species and whether it is 
clonally monophyletic. 
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3. MINIMUM TAXONOMIC CRITERIA FOR BACTERIAL GENOME 
SEQUENCE DEPOSITIONS 
 
The majority of the analyses and discussion within this chapter was published within:  
“BULL, M. J., MARCHESI, J. R., VANDAMME, P., PLUMMER, S. & 
MAHENTHIRALINGAM, E. 2012. Minimum taxonomic criteria for bacterial genome 
sequence depositions and announcements. Journal of Microbiological Methods, 89, 18-21” 
 
3.1. INTRODUCTION 
The genomic revolution has impacted multiple fields of microbiology facilitating the 
application of DNA sequence-based analyses to numerous questions in ecology, infection and 
industry (Medini et al., 2008). Bacterial genome sequence information is highly accessible 
and with minimal training researchers that are not specialists in a given field can use it to 
develop a wealth of molecular tools such as strain or species-specific PCR markers. In doing 
so, however, researchers are heavily reliant on the accurate deposition of data associated with 
genome sequences and the genetic databases. Although the taxonomy of many bacterial 
groups continues to change, the use of correct nomenclature for bacterial species is part of a 
fundamental language that allows microbiologists to communicate with each other and across 
other disciplines. Hence, when the species nomenclature associated with a bacterial genome 
sequence is incorrect it can have broad implications and impact on a multitude of fields.  In 
2008 (Field et al.) recognised the need for minimum descriptive criteria for genomes and 
metagenomes. They provided examples of data deposition records listing multiple criteria that 
included taxonomic status as a leading descriptor (Claesson et al., 2008). However, correctly 
assigning taxonomic status to an organism’s genome is generally left to the research group 
submitting the sequence. With the current level of sequence data being deposited, it is 
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difficult for the DNA databases to further analyse the sequences and ensure that the 
taxonomic status of a genome is correct.  
 
The availability of a complete bacterial genome sequence facilitates the application of several 
bioinformatic analyses to enable the source organism to be assigned to formally classified 
species or phylogenetic groups (Coenye et al., 2005). For all newly determined bacterial 
genomes it should therefore be relatively straightforward to systematically classify the 
bacterium from which the genome originates. However, the deposition of genome sequences 
assigned to the wrong systematic nomenclature may still occur if the sequences are not 
carefully analysed in a taxonomic context.  Oh et al. (2011) recently deposited a genome 
sequence for Lactobacillus acidophilus 30SC, a bacterial isolate recovered from swine gut. 
The taxonomy of the genus Lactobacillus has changed considerably in recent years rendering 
biochemical or phenotypic analysis alone unable to permit accurate species identification for 
several constituent groups. For the existing Lactobacillus species however, DNA sequence-
based methods can facilitate their accurate assignment at the species level (Naser et al., 2007). 
By examination of the L. acidophilus 30SC genome using just two defining characteristics, its 
full length 16S rRNA gene phylogeny and two conserved protein-encoding gene phylogenies, 
we were able to demonstrate that the genome sequence in fact must have originated from a 
strain of Lactobacillus amylovorus. To reduce the potential for such misclassification in 
future, we outline a simple bioinformatic analysis scheme and a minimum set of taxonomic 
criteria that should be applied to bacterial genomes before their formal deposition and 
announcement to the microbiology community. 
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3.1.1. SPECIFIC AIMS 
 
The aims of this chapter were as follows: 
 
1) Analyse the phylogenetic placement of L. acidophilus 30SC using its recently 
published genome sequence. 
 
2) Construct Lactobacillus phylogenies using straightforward analyses based on the 16S 
rRNA gene sequence. 
 
3) Construct Lactobacillus phylogenies using analyses based on the sequence of other 
phylogenetic marker genes such as gyrase B. 
 
4) Set out a standard bioinformatic process that can be applied to newly generated 
genome sequences to ensure that they are accurately assigned to the genus or species 
level before deposition to a database and subsequent announcement. 
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3.2. RESULTS 
The methods used in this chapter are described below, not in the earlier methods chapter, as 
they form an integral part of the bioinformatic workflow that was developed to correctly 
assign taxonomy for a bacterial genome sequence. 
 
3.2.1. METHODS REQUIRED TO IMPLEMENT THE BIOINFORMATIC WORKFLOW 
 
3.2.1.1. L. acidophilus 30SC gene sequences 
Full-length sequences of the 16S rRNA, gyrB and pheS genes were downloaded from the 
30SC genome (GenBank ID: CP002559). 
 
3.2.1.2. 16S rRNA gene systematics  
The 16S rRNA gene sequence of L. acidophilus 30SC was compared to the Ribosomal 
Database Project II (RDP II; http://rdp.cme.msu.edu) databases using the sequence match 
(SeqMatch) tool to facilitate identification (Cole et al., 2009). The SeqMatch tool allowed the 
identification and subsequent acquisition of 16S rRNA gene sequences of 20 type strains that 
were most closely related to the 16S rRNA gene of L. acidophilus 30SC. These were imported 
into MEGA5 (Oh et al., 2011, Tamura et al., 2011), aligned and trimmed. MEGA5 was also 
used to construct a neighbour-joining phylogeny. 
 
3.2.1.3. Protein-coding gene phylogenies 
 The gyrase B subunit gene, gyrB, sequences were acquired using the Functional Gene 
pipeline and repository (FunGene; http://fungene.cme.msu.edu); gyrB sequences from 
Lactobacillus type strains with 16S rRNA genes most closely related to L. acidophilus 30SC 
were specifically selected. Sequences of the phenylalanyl-tRNA synthase alpha subunit gene, 
pheS, were drawn from a study by Naser et al (2007) and downloaded from Genbank. The 
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gyrB and pheS were imported into MEGA5 and analysed in the same way as the 16S rRNA 
gene sequences. 
 
3.2.2. A SIMPLE BIOINFORMATIC WORKFLOW FOR CLASSIFICATION OF BACTERIAL 
GENOMES 
A bioinformatic scheme to facilitate the accurate taxonomic identification of a bacterial 
genome was developed (Figure 3.1).  The workflow facilitated the assignment of genus- or 
species-level nomenclature in the case of known species, while for bacteria belonging to 
novel taxonomic groups it can be used to define a nearest phylogenetic neighbour. Since 
multiple bioinformatic analyses may be used to assign the taxonomy of a bacterial genome 
(Coenye et al., 2005), a simplified workflow dependent on just two phylogenetic criteria was 
selected. The scheme can be easily applied by researchers not necessarily skilled in 
bioinformatic analyses and despite its simplicity was sufficient to provide accurate resolution 
of a genome to a known species or taxonomic group. 
 
The first analytical criterion analysed the 16S rRNA gene sequence of a genome (Figure 3.1) 
as the most fundamental genetic tool available for bacterial taxonomic classification 
(Stackebrandt and Goebel, 1994). Bacterial 16S rRNA gene sequences can be rapidly 
compared at the Ribosomal Database Project II (RDP II; http://rdp.cme.msu.edu) or other 
curated databases and the search criteria limited to only identify closely related sequences 
obtained from well classified type strains. If related species type strains are not available for a 
given genome sequence, the related 16S rRNA gene sequences from the RDP II output may 
be searched for reference strains or well characterized sequences for uncultured 
microorganisms; these organisms can then be identified as the nearest defined phylogenetic 
neighbours of the genome sequence (Figure 3.1). 
 
The second taxonomic criterion applied in the bioinformatic workflow was to analyse the 
sequence of protein coding genes from the genome and compare them to homologs encoded 
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within the related species/phylogenetic groups revealed by the initial 16S rRNA gene analysis 
(Figure 3.1).  Analysis of protein-coding genes such as recA (Eisen, 1995) or gyrB 
(Yamamoto and Harayama, 1996), has been shown to be highly effective in assigning the 
taxonomy of species with particularly conserved 16S rRNA gene sequences. However, since 
protein-coding gene phylogenies may not always be congruent with the 16S rRNA gene for 
many bacterial species due to the lower taxonomic resolution of the latter ribosomal gene and 
the possibility of recombination and lateral gene transfer (Lukjancenko et al., 2011), we 
suggest two or more protein-coding genes should be examined to bring a finer resolution to 
the taxonomic placement of a genome (Figure 3.1). 
 
In addition to using the latter databases to compare the 16S rRNA gene and selected protein-
coding gene, phylogenetic trees of both taxonomic markers should also be constructed using 
the sequences from the most closely related species (Figure 3.1). This step will ensure that an 
accurate evolutionary placement of genome can be made and avoid assigning relatedness 
based on the percentage match of DNA sequences. Examination of the 16S rRNA gene and 
protein-coding gene phylogenies should also be made to ensure they are consistent in their 
assignment of the nearest match to the genome.  On the basis of these combined analyses the 
correct up-to-date bacterial nomenclature can be obtained from the List of Prokaryotic names 
with Standing in Nomenclature (LSPN; http://www.bacterio.cict.fr). If the genome does not 
match a validly named species in terms of its 16S rRNA or protein-coding gene analyses, its 
nearest well characterized phylogenetic neighbour should be provided (Figure 3.1). 
CHAPTER THREE - MINIMUM TAXONOMIC CRITERIA FOR BACTERIAL GENOME SEQUENCE 
DEPOSITIONS 
 
 
96
 
 
 
 
Figure 3.1: Bioinformatic work flow for assignment of taxonomic status to a bacterial genome. 
An analysis scheme based primarily on analysis of the 16S rRNA gene with additional analysis of at least two 
protein coding genes is illustrated. The phylogeny of the latter genes should be compared for a given bacterial 
genome, and then the correct taxonomic nomenclature or nearest phylogenetic neigbor assigned. If the genome is 
representative of a cultured bacterial species, it should also be deposited in a recognised culture collection. The 
bioinformatic tools are available from the databases described in section 3.2.1. 
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Figure 3.2: Whole genome comparison of L. acidophilus 30SC to L. acidophilus NCFM and L. amylovorus 
GRL1118. 
Genome sequences are represented by horizontal lines with L. acidophilus as the central horizontal lines. 
Regions of similar sequence are linked with lines between genomes. Sequence identity is indicated by shade 
intensity. Red indicates similar sequence in the forward direction, blue in the reverse.  
L. acidophilus NCFM 
L. amylovorus GRL1112 
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3.2.3. APPLICATION OF THE BIOINFORMATIC WORKFLOW TO THE L. ACIDOPHILUS 
30SC GENOME 
After deposition of the L. acidophilus 30SC genome, we performed a genome comparison to 
that of L. acidophilus NCFM, a well characterized probiotic strain of this species (Altermann 
et al., 2005), and observed that the two genomes were not closely related when compared 
using the Artemis Comparison Tool  (ACT; Figure 3.2). The L. acidophilus 30SC genome 
sequence clearly showed greater identity with the genome sequence of L. amylovorus 
UCC1118 (indicated by the deeper shade of red) than the genome sequence of L. acidophilus 
NCFM (lighter shade of red). We therefore applied the bioinformatic analysis scheme and 
minimum criteria (Figure 3.1) to L. acidophilus 30SC genome to clarify its taxonomic 
assignment. Use of the SeqMatch tool at the RDP II demonstrated that the L. acidophilus 
30SC 16S rRNA gene was most closely related to L. amylovorus sequences. After 
downloading and phylogenetically analysing the full length 16S rRNA genes for 20 type 
strains of the most closely related Lactobacillus species, the resulting tree also demonstrated 
that L. acidophilus 30SC sequence was most similar to that of L. amylovorus LMG 9496T 
(Figure 3.3, panel A; 99.8% identity).  The 16S rRNA gene for the L. acidophilus-type strain, 
LMG 9433T, placed in a completely distinct phylogenetic cluster (Figure 3.3, panel A; 98.2% 
identity). 
 
Since the taxonomy of genus Lactobacillus has been heavily revised in recent years by the 
description of numerous new species and because the discriminatory power of the 16S rRNA 
gene for differentiation of its constituent taxa is limited for several clusters of species, we 
searched the available literature to identify protein-coding genes which were useful for 
species identification. The gyrB gene had been used as part of a multilocus sequence typing 
(MLST) scheme for Lactobacillus plantarum strains (de las Rivas et al., 2006). We therefore 
used the FunGene database to compare the gyrB from the L. acidophilus 30SC genome to the 
gyrB genes available for  type strains of those Lactobacillus species that were most closely 
related by analysis of the 16S rRNA gene (Figure 3.3, panel A). The gyrB phylogeny 
demonstrated that the L. acidophilus 30SC gyrB sequence was most similar to that of L. 
amylovorus LMG 9496T (Figure 3.3, panel B; 99.8% identity). The gyrB sequence of the L. 
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acidophilus type strain, LMG 9433T, clustered separately from that of strain 30SC (Figure 
3.3, panel A) and was considerably less similar (88.1% identity). 
 
Although the gyrB analysis was consistent with the 16S rRNA gene assignment, in order to 
avoid over reliance on a single-protein gene we searched the literature for an additional 
protein-coding gene useful for Lactobacillus systematics. Naser et al. (Naser et al., 2007) had 
examined the pheS gene and demonstrated that it offered a discriminatory means of species 
identification within the genus Lactobacillus. The pheS gene of the L. acidophilus 30SC 
genome was 99.1% similar to that of L. amylovorus and phylogenetically clustered with this 
species (Figure 3.4); it was not closely related to the L. acidophilus pheS sequence (Figure 
3.4, 88.7% identity). Overall, even though the gyrB (Figure 3.3, panel B) and pheS (Figure 
3.4) phylogenetic trees were not absolutely congruent with 16S rRNA gene phylogeny across 
all the Lactobacillus species examined, the respective L. acidophilus 30SC sequences were 
consistently placed adjacent L. amylovorus as the nearest phylogenetic neighbour and 
indicating this species is the most likely taxonomic group to which the 30SC isolate belonged. 
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Figure 3.3: Phylogenetic trees of lactobacilli related to L. acidophilus 30SC.  
Phylogenetic analysis of aligned 16S rRNA (panel A) and gyrB (panel B) genes from representative 
Lactobacillus reference strains classified as most closely related (similarity scores >0.949) to the L. acidophilus 
30SC (indicated in bold font) genes is shown. The trees for each gene were rooted with the corresponding 
sequence from Pediococcus pentosaceus LMG 11488; the genetic distance scale and bootstrap values are 
indicated. 
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Figure 3.4: Phylogenetic tree of pheS genes of lactobacilli related to L. acidophilus 30SC 
Phylogenetic analysis of aligned pheS genes from representative Lactobacillus reference strains classified as 
most closely related to the L. acidophilus 30SC (indicated in bold font) gene is shown. The tree was rooted with 
the corresponding sequence from Pediococcus pentosaceus LMG 11488; the genetic distance scale and bootstrap 
values are indicated. 
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3.3. DISCUSSION 
With the continued improvement and innovation in technology, particularly the advent of 
next-generation sequencers, researchers have unprecedented access to nucleotide sequence 
data. There is no doubt that the massive expansion of DNA sequence datasets has 
considerably advanced the study of life sciences, however, there is also a feeling that our 
ability to collect sequence data far surpasses our ability and power to analyse it (Brenner, 
2010). In addition, as more sequence analysis tools are developed to enable large scale data 
mining, the outputs from these analyses may have less value if the original sequence data 
inputs are poorly characterised at source. Here we illustrate an example of how such 
oversights are still occurring in genomic microbiology, with the taxonomically incorrect 
deposition and announcement of the L. acidophilus 30SC genome (Oh et al., 2011). Using a 
straightforward analysis based on two minimal criteria, assignment via the 16S rRNA gene 
and protein-coding gene phylogenies; we have clearly demonstrated that the L. acidophilus 
30SC genome most likely derives from a strain of L. amylovorus (Figure 3.3).  
 
Many disciplines rely heavily on taxonomic nomenclature to provide a common language that 
can be understood by both specialist researchers and also extend into wider public 
understanding. Taxonomy is particularly important in microbiology where there is such an 
extensive diversity of organisms, that a microbial commons and systematic guidelines are 
absolutely vital for advancement of the discipline (Moore et al., 2010). Like many 
microorganisms, the lactic acid bacteria, within which L. amylovorus and L. acidophilus 
reside, are of considerable ecological, clinical and commercial interest (Pfeiler and 
Klaenhammer, 2007). The widespread use of these bacteria as probiotics and diary starter 
cultures forms a multi-million dollar industry, with basic researchers, industry and regulatory 
agencies demanding much clearer definitions of Lactobacillus strains. The incorrect 
deposition of the strain 30SC genome as a representative of the species L. acidophilus may 
potentially have had significant future ramifications, especially since genomes for these 
bacteria are now being obtained by non-specialist researchers and commercial groups. 
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In summary, we suggest the need for a systematic review of the way genome sequence data is 
deposited and propose a simple, minimum-standard system for characterisation of new 
bacterial genome sequences prior to their announcement. We have proposed an analytical 
scheme which is straightforward and for the most part can be performed using publicly 
available databases and software, to compare the 16S rRNA gene and at least two protein-
coding genes from a given genome. For researchers skilled in bioinformatic analyses, this 
scheme could easily be expanded to include analyses of multiple protein coding genes such as 
those used in MLST schemes (de las Rivas et al., 2006), the average nucleotide identity of 
shared genes or even whole genome phylogenies (Konstantinidis and Tiedje, 2005). In 
addition, we also suggest that if the genome sequence is for an easily cultured microorganism, 
that the corresponding strain is deposited in a recognised International Depository Authority 
culture collection and hence can be easily analysed by the research community (Figure 3.3); 
this will add considerable future value to a microbial genome sequence. We hope that our 
illustration of genome misclassification and a simple bioinformatic workflow to avoid it will 
increase the consistency of future genome sequence taxonomy. This will ensure that users of 
these incredibly valuable genomic datasets, particularly those who are not specialists in the 
field, can be confident in the identity of a deposited sequence. 
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3.4. CONCLUSIONS 
The conclusions from this chapter are as follows: 
 
1) The developed bioinformatic workflow successfully identified that the L. 
acidophilus 30SC genome was wrongly attributed to L. acidophilus. DNA 
biomarker genes used for this bioinformatics workflow, the 16S rRNA, gyrB and 
pheS genes, all showed greater similarity to L. amylovorus LMG 9496. 
Secondarily, whole genome comparisons of available L. acidophilus and L. 
amylovorus genome sequences also showed that the genome of L. acidophilus 
30SC showed greater synteny with L. amylovorus UCC1118 than L. acidophilus 
NCFM. 
 
2) The reliance of future analyses on the attached metadata of genome sequence 
depositions means that it is imperative that this metadata is correct, particularly the 
species name that is attached to the genome record. The proliferation of genome 
resequencing means that a technology once restricted to the cutting-edge of 
genomics is now available to a wider audience, including non-specialists and 
commercial parties. The development of a simple bioinformatic workflow for 
classifying a genome sequence will ensure that users of a deposited sequence can 
be confident of its identity and nomenclature.  
 
3) Organisms of considerable ecological, clinical and commercial interest, like L. 
acidophilus and L. amylovorus, may have probiotic effects that are strain-specific. 
Therefore, ensuring that a genome sequence for one of these bacteria is assigned 
the correct taxonomic nomenclature is vitally important. In addition, the regulatory 
standards for including bacteria in probiotic and food-related products continue to 
be developed, with accurate descriptions of the organisms present now a 
fundamental criterion. 
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Note added in proof: 
Analysis of glycolysis and pentose phosphate pathways across Lactobacillales to depict 
evolution of this order recently corroborated the phylogenetic placement and 
reclassification of L. acidophilus 30SC. Salvetti et al (2013) used genome sequences from 
42 LAB and inferred phylogeny using the concatenated sequences of 42 ribosomal 
proteins. Subsequently, the distribution and organisation of 42 genes related to glycolysis 
and the pentose phosphate pathway was analysed. L. acidophilus 30SC was identical to L. 
amylovorus GRL1112 at all ribosomal sites and all glycolysis pathway loci. Interestingly, 
L. acidophilus 30SC differed to L. amylovorus GRL1112 at only a single locus of its 
pentose phosphate pathway.  
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4. POPULATION GENOMICS OF L. ACIDOPHILUS 
4.1. INTRODUCTION 
 
4.1.1. GENOMICS IN LAB 
Numerous approaches have been used to explore the relationships and species assignments 
of members of the LAB (see Section 1.3.1). These include DNA-DNA hybridization, 16S 
rRNA gene sequence analysis, phenotypic characteristics and sequence analysis of other 
phylogenetic marker genes. These analyses have ranged in taxonomic breadth from 
examining all LAB (Makarova et al., 2006, O'Sullivan et al., 2009), to all lactobacilli 
(Claesson et al., 2008), to the L. acidophilus group (Berger et al., 2007), to strains of a 
single Lactobacillus species (Hao et al., 2011a). The evolution of techniques for 
identifying and classifying bacteria has impacted on the taxonomy of the LAB, resulting in 
numerous species re-classifications and re-definitions of above-species-level taxonomic 
groups (Salvetti et al., 2012). 
 
The recent availability of whole genome sequences of probiotic bacteria, and the reduction 
in financial investment and expertise required to re-sequence new isolates for species that 
already have a representative genome-sequenced isolate, has made the use of genome 
sequences to characterise bacteria, a viable proposition for a growing number of the 
scientific community. Bacterial genome sequencing is now being carried out by a large 
number of research laboratories and commercial enterprises, to examine environmental 
and health-related issues.  
 
Several post-genomic studies have been undertaken on various taxonomic levels within the 
LAB. These  include the examination of phylogenetic relationships between bacteria on 
the i) genus level from both a phylogenetic (Makarova et al., 2006, Coenye and 
Vandamme, 2003) and functional (Klaenhammer et al., 2005, O'Sullivan et al., 2009) 
perspective, ii) group level (Berger et al., 2007) and iii) the species level in both 
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Lactococcus lactis (Passerini et al., 2010) and L. plantarum (Molenaar et al., 2005). No 
single study however, has fully utilised next-generation sequencing technologies in 
combination with highly efficient genome assembly and analysis methods to carry out 
genomic diversity profiling of a large cohort of isolates of a single LAB species. In this 
section, the genomic diversity of L. acidophilus was explored at multiple taxonomic levels. 
During the study, access to next-generation sequencing (NGS) technologies altered so 
much that two approaches were used. The first used single genome re-sequencing by a 
commercial sequence provider and illustrates how genome sequencing technologies have 
made single genome resequencing economically viable. The second approach used 
massively-parallel genome resequencing and assembly technologies provided by an 
academic genome sequencing centre, together with the analysis on a web-based database 
(Jolley and Maiden, 2010), and illustrates how decoding of tens of bacterial genomes is 
now a viable prospect for LAB researchers 
 
4.1.2. APPLICATION OF NOVEL GENOME SURVEYING STRATEGIES 
 
4.1.2.1. Analysing multiple bacterial genomes 
The advent of massively parallel sequencing technologies has revolutionised phylogenetic 
data collection with massively multiplexed, high-throughput, short-read sequencing 
making it possible to obtain DNA sequence for virtually every locus of a genome in an 
achievable time-frame and at economical cost (Medini et al., 2008). With the decline in 
costs of genome sequencing, it is now more economical to derive an MLST profile 
(normally the partial sequencings of seven house-keeping gene loci) by sequencing the 
entire genome of an isolate and extracting the sequences of the relevant loci, than the 
classical method of amplifying each locus with specific PCR primers and Sanger 
sequencing the resulting product (Sheppard et al., 2012). The derivation of a complete 
genome sequence for isolates of interest undoubtedly provides a wide range of 
opportunities to improve the understanding of epidemiology and functional biology of 
bacterial populations, far beyond a simple MLST scheme. There are various approaches to 
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describe genome sequence variation among bacterial isolates, and these, together with 
other interesting variable loci which can be mined from the data are discussed below. 
4.1.2.2.  Analysis of genomes using a reference genome sequence 
The mapping of sequence data from multiple isolates to a finished reference genome 
sequence allows the identification of polymorphic sites compared to this reference isolate. 
This can be accomplished with relative ease and is computationally, orders of magnitude 
less intensive than a de novo sequence assembly. Analysis of Single Nucleotide 
Polymorphisms (SNPs) generated by read mapping has been used to compare genomes of 
clinically important pathogens (Harris et al., 2010) and probiotic species (Briczinski et al., 
2009). The results should however, be interpreted with some degree of caution. Parallel 
sequencing technologies are relatively more error prone than classical sequencing 
technologies, and read mappings will be highly dependent on the finished reference 
sequence to which variation is mapped. Therefore, the reference sequence used should be 
highly representative of the isolates that are being compared to it, as variation in genes that 
are not present in the reference genome cannot be detected 
 
4.1.2.3.  Analysis of genomes using gene-by-gene comparison to a reference 
sequence  
An alternative to the reference genome sequence assembly approach is a de novo, 
reference-free assembly, followed by gene-by-gene comparisons to a reference sequence 
(Jolley and Maiden, 2010). The unit of comparison and analysis then becomes a more 
functional unit (i.e. the gene[s]), rather than the whole genome. In this case, “the gene” as 
a unit of comparison may be extended to include any identifiable unit of analysis, 
including but not limited to sequences found at a particular genetic locus, given coding 
sequences (CDS) or any other identifiable sequence motif whether it be nucleotide or 
protein (Sheppard et al., 2012). The variation between genomes is then categorised one 
“gene” unit at a time, essentially in the same way the variation between MLST loci is 
described (Maiden, 2006). Although MLST schemes to date are generally composed of 
seven loci there is no reason, other than balancing the economy of research investment 
with information return, that the scheme should not be extended to encompass more loci. 
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As the investment in generating a genome sequence assembly for a single isolate is now 
small enough to be a viable proposition for many researchers, MLST may now be 
extended to incorporate all loci defined within a particular reference genome sequence, as 
such creating a “genome-wide” MLST scheme (Sheppard et al., 2012). 
 
There are several advantages to the gene-by-gene approach when compared to approaches 
that rely on multiple- or pairwise-alignment of whole genome sequences for the 
identification of SNPs (Sheppard et al., 2012). Comparisons are performed using “gene”-
length units that can be compared to establish the total diversity in each one of these 
regions, removing the need for closely related reference sequences for mapping. This 
increases the scope of the approach to handle genomes from diverse sources. Secondarily, 
the gene-by-gene approach is particularly well-suited to analysing the output from de novo 
sequence assemblers, which often produce partial, draft genome sequences comprised of 
multiple contigs. Thirdly, any sequencing errors that are introduced by the parallel 
sequencing technology are screened out by ensuring that sequencing depth is great enough 
to identify them in the assembly process. The main limitation of the gene-by-gene 
approach is similar to that of the whole genome mapping approach, in that variation can 
only be captured in loci already defined in the reference gene set, so information outside of 
these regions will not be analysed, and the reference gene set will be expected to define the 
whole set of loci to be compared. Also, this technique relies heavily on the ability of the de 
novo assembly to construct draft genomes composed of a few, long contigs. The success of 
generating such contigs is linked to the genome sequence features of the isolates studied, 
with small, low complexity, low GC genomes ideal for this analysis. It is also highly 
dependent on the sequencing quality obtained and type of NGS technology applied. 
 
4.1.2.4. CRISPR regions 
A detailed discussion of CRISPR regions in L. acidophilus can be found in Chapter 1. 
CRISPR regions have been found in over half of the genome sequences available for 
lactobacilli, although they vary in sequence considerably across the genus Lactobacillus. 
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In Escherichia coli, CRISPR regions are highly variable, and can be used as strain specific 
markers (Díez-Villaseñor et al., 2010). Given that RAPD profile similarity analysis of L. 
acidophilus isolates shows limited diversity (Chapter 3), the CRISPR regions of this 
species investigated further as loci with the greatest chance of variation between highly 
clonal isolates, as seen in B. animalis subsp. lactis (Milani et al., 2013) . 
 
 
4.1.2.5. Mutagenesis of L. acidophilus 
The human GIT has been designated as the natural niche of L. acidophilus (O'Sullivan et 
al., 2009).  The gut is known to be potentially mutagenic environment (Hirayama et al., 
2000), with multiple metabolites, particularly those generating from anaerobic 
fermentation, capable of inducing genetic mutations. The stability of L. acidophilus RAPD 
profiles generated by isolates passaged through the human GIT (Mahenthiralingam et al., 
2009) suggested that either the environment is not sufficiently mutagenic to induce 
sequence variation detectable at such a granular level, or that L. acidophilus is capable of 
efficiently repairing DNA damage and maintaining a highly stable genome. Exposure to 
the chemical mutagen Methyl Methanesulphonate (MMS) has been shown to induce 
mutations in wide range of bacteria, including mutations that result in detectable 
phenotypes in Lactobacillus delbrueckii ATCC 9649 (Demirci and Pometto, 1992), a 
member of the L. acidophilus taxonomic sub-group. Given the successful use of MMS in a 
closely related species, it was used to further investigate the susceptibility of L. 
acidophilus to the type of chemical mutation that might occur in the human GIT. 
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4.1.3. SPECIFIC AIMS 
 
The aims of this chapter were as follows: 
 
 Conduct a small-scale genome diversity survey using reference mapping of 
sequencing reads, combined with SNP discovery. 
 
 
 Expand genomic information on L. acidophilus isolates by resequencing the 
genomes of a diverse collection of isolates from commercial applications and 
culture collections. 
 
 
 Conduct a wider-scale genomic diversity study to establish evolutionary 
history of L. acidophilus isolates using a gene-by-gene comparative approach 
applied via rMLST at the genus-species level and genome-wide MLST at the 
species-strain level. 
 
 
 Investigate the diversity of the CRISPR region of the L. acidophilus genome. 
 
 
 Investigate mutability of L. acidophilus using Methyl Methane Sulphonate 
(MMS) to alkylate DNA and induce mutations, using genome resequencing 
and gene-by-gene comparisons to detect any DNA sequence changes that 
occurred. 
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4.2. METHODS 
 
4.2.1. GENOME RESEQUENCING STRATEGIES 
Two different genome resequencing strategies were employed, reflecting the development 
of Illumina sequencing technology. The first was applied on a small scale at higher cost, 
and the second was applied on a larger scale as follows. 
 
4.2.1.1. Small-scale genome resequencing and comparison strategy 
High molecular weight genomic DNA was extracted from the growth of single-colony 
overnight cultures with a Wizard genomic DNA purification kit (Promega, Southampton, 
United Kingdom). Genomic DNA libraries were prepared and single-reads were sequenced 
by GATC Biotech (Konstanz, Germany) using an Illumina HiSeq2000 with 50 bp 
sequence read length. Single reads were aligned to the L. acidophilus NCFM complete 
genome sequence (GenBank: CP00003) using Burrows-Wheeler Alignment Tool (bwa) 
(Li and Durbin, 2009), and a consensus sequence created. Consensus sequences were 
aligned with Mugsy (Angiuoli and Salzberg, 2011). Phylogenies were calculated using 
MEGA 5.1 (Tamura et al., 2011). Whole genome sequence similarity was visualised with 
the Artemis Comparison Tool (Carver et al., 2005). 
 
4.2.1.2. Large-scale genome resequencing and comparison strategy 
As previously, high molecular weight genomic DNA was extracted from the growth of 
single-colony overnight cultures with a Wizard genomic DNA purification kit (Promega, 
Southampton, United Kingdom). Genomic libraries were prepared and DNA sequenced at 
the Wellcome Trust Centre for Human Genetics, Oxford, UK  
(http://www.well.ox.ac.uk/ogc/home). All genomic libraries were pooled in equimolar 
amounts and analysed in a single flow cell lane of the Illumina HiSeq2000, generating 100 
bp paired-end reads. At this stage, the 50 bp single-reads were introduced from the small-
scale genome resequencing study along with 100 bp paired-end reads from two L. 
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acidophilus genomes (SRA refs: ERR203994 and ERR256998), downloaded from the 
Sequence Read Archive (SRA) at the NCBI. 
 
Genome sequences were assembled using Velvet version 1.2.01 shuffle and optimisation 
scripts, creating contigs with optimal parameters, with k-mer lengths between 87 and 95 bp 
for the paired-end sequence reads generated as part of the wide-scale study, 45 and 49 bp 
for 50 bp single reads from the small-scale study, and 99bp for the sequence reads taken 
from the SRA (Zerbino, 2010, Cody et al., 2013) (Table 4.1). Assembled data were 
deposited in the PubMLST database as implemented by the Bacterial Isolate Genome 
Sequence Database (BIGSDB) software platform (Jolley and Maiden, 2010). To 
supplement and contextualise the new sequence information generated by this study, 
further completed and draft genome sequence data from the L. acidophilus group were 
downloaded from the Integrated Microbial Genomes (IMG) database (Markowitz et al., 
2010) and also deposited into the PubMLST database (Table 4.2). 
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Table 4.1: Velvet assembly statistics of Lactobacillus isolate genomes  
Species Isolate Number of 
sequence reads 
Sequence Read 
Length 
Contig 
N50 
Number of 
Contigs >1Kb 
Lactobacillus acidophilus C21 10353702 100 182313 28 
Lactobacillus acidophilus C46 10776998 100 172985 29 
Lactobacillus acidophilus C47 8590468 100 182321 30 
Lactobacillus acidophilus C49 9788514 100 182321 29 
Lactobacillus acidophilus CUL 21 8648162 100 183130 30 
Lactobacillus acidophilus CUL 60 8372568 100 182851 25 
Lactobacillus acidophilus CulT2 6977356 100 183128 29 
Lactobacillus acidophilus HBCA 9716532 100 182325 25 
Lactobacillus acidophilus LAB 283 10694936 100 120702 28 
Lactobacillus acidophilus LAB 66 10941612 100 167481 33 
Lactobacillus acidophilus LAB 69 11762534 100 172941 30 
Lactobacillus acidophilus LAB 76 10244062 100 167485 33 
Lactobacillus acidophilus LMG 11428 11780070 100 81116 55 
Lactobacillus acidophilus LMG 11466 10754308 100 228858 24 
Lactobacillus acidophilus LMG 11467 12324202 100 242199 21 
Lactobacillus acidophilus LMG 11469 13525190 100 143813 31 
Lactobacillus acidophilus LMG 11470 12022574 100 167948 33 
Lactobacillus acidophilus LMG 11472 12067104 100 167526 34 
Lactobacillus acidophilus LMG 13550 11520676 100 173001 28 
Lactobacillus acidophilus LMG 9433 7833202 100 167519 29 
Lactobacillus acidophilus NCFM 8119384 100 174801 28 
Lactobacillus acidophilus NCFM 1-1 7787216 100 183130 26 
Lactobacillus acidophilus NCFM 1-2 10458212 100 167511 36 
Lactobacillus acidophilus NCFM 2-1 9941284 100 173994 30 
Lactobacillus acidophilus NCFM 2-4 8684056 100 182321 32 
Lactobacillus acidophilus NCFM 3-1 6974196 100 182317 31 
Lactobacillus acidophilus NCFM 3-2 9596090 100 182321 33 
Lactobacillus acidophilus Rm 344 9981982 100 184420 21 
Lactobacillus acidophilus Rm 345 13810300 100 183241 23 
Lactobacillus acidophilus CUL 60 S 18965596 51 81591 50 
Lactobacillus acidophilus LMG 11428 S 31352785 51 120621 42 
Lactobacillus acidophilus CUL 21 S 23488108 51 78118 48 
Lactobacillus acidophilus ERR203994 2601602 100 242509 24 
Lactobacillus acidophilus ERR256998 6433322 100 167515 23 
Lactobacillus gasseri LMG 9203 6505684 100 257847 14 
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Table 4.2: Genome sequences of L. acidophilus group isolates deposited in the PubMLST database for this study
Species Isolate Aliases Country Year Isolate source Sequence source Genome status 
L. acidophilus NCFM NCFM R USA 1970 Derived from LMG 9433 NCBI RefSeq finished 
L. acidophilus ATCC 4796 LMG 11470 USA 1980 Human Microbiome Project  NCBI RefSeq draft 
L. acidophilus C21 - UK 2008 Cultech isolate This study draft 
L. acidophilus C46 - UK 2008 Cultech isolate This study draft 
L. acidophilus C47 - UK 2008 Cultech isolate This study draft 
L. acidophilus C49 - UK 2008 Cultech isolate This study draft 
L. acidophilus CUL 21 - UK 2004 ProHEMI isolate This study draft 
L. acidophilus CUL 60 - UK 2004 ProHEMI isolate This study draft 
L. acidophilus CulT2 - UK 2008 Cultech isolate This study draft 
L. acidophilus HBCA - UK 2008 Isolated from product This study draft 
L. acidophilus LAB 283 ATCC 4357; Kulp strain 
PAK 
USA 1963 - This study draft 
L. acidophilus LAB 66 LMG 11428 USA 1922 - This study draft 
L. acidophilus LAB 69 -  - - This study draft 
L. acidophilus LAB 76 LMG 11428 USA 1922 - This study draft 
L. acidophilus LMG 11428 ATCC 832; Rettger 4B USA 1922 Fed lab Rat This study draft 
L. acidophilus LMG 11466 - UK 1960 NIRD This study draft 
L. acidophilus LMG 11467 ATCC 314; L. F. Rettger 43 USA 1920 Human This study draft 
L. acidophilus LMG 11469 ATCC 4355; Kulp R-1-1 USA 1924 Rat or human  (Kulp & Rettger, 
1924) 
This study draft 
L. acidophilus LMG 11470 ATCC 4796  USA 1980 - This study draft 
L. acidophilus LMG 11472 ATCC 9224 USA 1950 - This study draft 
L. acidophilus LMG 13550 LMG 9433; ATCC 4356 USA 1964 Human This study draft 
L. acidophilus LMG 9433 ATCC 4356; LMG 13550 USA 1964 Human This study draft 
L. acidophilus NCFM Derived from LMG 9433 Canada 1975 - This study draft 
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Table 4.2: Genome sequences of L. acidophilus group isolates deposited in the PubMLST database for this study (cont.)
Species Isolate Aliases Country Year Isolate source Sequence source Genome status 
L. acidophilus Rm 344 - China 2012 Cultech isolate This study draft 
L. acidophilus Rm 345 - China 2012 Cultech isolate This study draft 
L. acidophilus CUL 60 S CUL 60 UK 2004  Small-scale L. acidophilus genome study 
(50bp single reads) 
draft 
L. acidophilus LMG 11428 S LMG 11428 USA 1922  Small-scale L. acidophilus genome study 
(50bp single reads) 
draft 
L. acidophilus CUL 21 S CUL 21 UK 2004  Small-scale L. acidophilus genome study 
(50bp single reads) 
draft 
L. acidophilus ERR203994 LMG 9433; LMG 
13550; ATCC 4356 
USA 1964  NCBI Sequence read archive (SRA) draft 
L. acidophilus ERR256998 - - -  NCBI Sequence read archive (SRA) draft 
L. crispatus JV-V01 - - - Human vaginal flora NCBI RefSeq draft 
L. crispatus MV-1A-US - - - Human vagina NCBI RefSeq draft 
L. delbrueckii ATCC 11842 - Bulgaria 1919 Yoghurt NCBI RefSeq finished 
L. delbrueckii ATCC BAA-365 - France 1987 Gastrointestinal NCBI RefSeq finished 
L. gasseri ATCC 33323 - - -  NCBI RefSeq finished 
L. gasseri 202-4 - - -  NCBI RefSeq draft 
L. gasseri JV-V03 - - - Human vaginal flora NCBI RefSeq draft 
L. gasseri LMG 9203 - France 1970  This study draft 
L. helveticus DSM 20075 - - - Emmental cheese NCBI RefSeq draft 
L. helveticus DPC 4571 - - -  NCBI RefSeq finished 
L. iners DSM 13335 - Sweden - Urine NCBI RefSeq draft 
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Table 4.2: Genome sequences of L. acidophilus group isolates deposited in the PubMLST database for this study (cont.) 
 
Rows containing data relating to L. acidophilus records are coloured based on their history; commercial isolates in green and culture collection isolates in blue 
 
 
 
 
Species Isolate Aliases Country Year Isolate source Sequence source Genome status 
L.  jensenii 269-3 - - Human vaginal cavity NCBI RefSeq draft 
L.  jensenii JV-V16 - USA Human vagina NCBI RefSeq draft 
L.  jensenii 27-2-CHN - - Human vagina NCBI RefSeq draft 
L.  jensenii 115-3-CHN - - Human vagina NCBI RefSeq draft 
L.  johnsonii FI9785 - - Human vagina NCBI RefSeq finished 
L.  johnsonii ATCC 33200 - Belgium Human blood NCBI RefSeq draft 
L.  johnsonii NCC 533 - - Faeces NCBI RefSeq finished 
L.  ultunensis DSM16047 - Sweden Human NCBI RefSeq draft 
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4.2.2. IMPLEMENTATION OF GENE-BY-GENE ANALYSIS APPROACHES 
 
4.2.2.1. Generation and storage of data using BIGSDB 
The three main data components of this approach were generated as follows: i) isolate 
genome sequencing and storage of sequence information, ii) a record of isolate provenance 
and other phenotypic characteristics, and iii) reference tables of predefined allele 
sequences for the loci of interest. All of these components were implemented in the 
Bacterial Isolate Genome Sequence Database (BIGSDB) (Jolley and Maiden, 2010) 
(http://pubmlst.org/software/database/bigsdb/). BIGSDB is a scalable, open-source, web-
accessible database which provides tools to store, retrieve and analyse linked phenotypic 
and genotypic information (Figure 4.1). The BIGSDB sequence repository may be 
populated with any amount of sequence data, from single gene sequences to finished 
genome sequences, as well as multiple contigs that make up the genome sequence of single 
re-sequenced isolates. When coupled with extensive information about an isolate, for 
example provenance data such as isolation date and location, or phenotypic characteristics 
such as antimicrobial susceptibility and auxotrophy, the BIGSDB provided a 
comprehensive toolkit for analysing the structure and function of bacteria using a 
population genomics approach (Jolley and Maiden, 2010). 
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Figure 4.1: BIGSDB Structure and analysis pipelines 
The BIGSDB allows users to integrate bacterial isolate provenance, phenotypic data and genotypic data from 
de novo genome sequence assemblies (adapted from Jolley and Maiden, 2010) 
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4.2.3. GENE-BY-GENE POPULATION GENOMICS ANALYSES USING BIGSDB 
 
4.2.3.1. Ribosomal MLST (rMLST) 
Classical MLST schemes typically analyse between six and eight housekeeping loci, 
providing a means of reliably identifying relationships between bacteria  (Gevers et al., 
2005). However, there has been concerns raised that indexing variation at less than eight 
loci may not provide the resolution to differentiate very closely related organisms 
(Achtman, 2008). At the other end of the scale, it is difficult to apply an MLST scheme 
based on eight loci across more distantly related bacteria, and this has meant that several 
different MLST schemes must be devised to cover a bacterial genus, each one unique to a 
particular species or closely related group of organisms. Classical MLST schemes may 
also not provide a practical combined taxonomic and typing approach at all levels of 
bacterial diversity (Jolley et al., 2012).  
 
To address the limitations of classical MLST, BIGSDB may be used to implement 
ribosomal MLST (rMLST), a combined taxonomic and typing approach, and natural 
extension of the original seven locus MLST scheme (Jolley et al., 2012). rMLST provides 
resolution from the sub-species level to the whole bacterial domain, by indexing variation 
of sequences that encode ribosomal proteins (rps genes) (Jolley et al., 2012). Each draft 
genome sequence is searched for each rps locus first using BlastN at a cutoff of 70% 
identity over at least 50% the alignment. If no gene is identified, the stringency of the 
BlastN search is iteratively lowered by 5% identity to 50% identity over 50% alignment. If 
no locus is identified, the search is switched to TBlastX and the same iterative process 
undertaken. This allows diverse rps gene sequences to be identified, and each new 
sequence encountered is assigned a unique number, as in MLST. The final rMLST profile 
for each bacterial isolate comprises of a series of number defining unique sequences at 
genomic loci encoding 53 ribosomal proteins. rMLST has been applied in diverse systems 
including reclassifying Neisseria species (Bennett et al., 2012) and studying the 
epidemiology of pathogenic Campylobacter species (Cody et al., 2013). 
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4.2.3.2.  “Genome-wide” MLST 
When examining closely related isolates, especially those of a single species, BIGSDB   
also allows the user to create a “genome-wide” MLST scheme to index diversity at every 
locus defined within a reference sequence (Jolley and Maiden, 2010). Each locus is 
defined in an annotated reference sequence and iteratively searched for in the draft genome 
sequence of each isolate to be compared in the same way as rMLST searches for the rps 
genes. This allows the user to profile the genomic diversity of isolates genome-wide. 
Genome-wide MLST has been utilised to study the population genomics of 
Campylobacter (Sheppard et al., 2012), Neisseria (Bennett et al., 2012) and Streptococcus 
(Jolley and Maiden, 2010). 
 
4.2.4. IMPLEMENTATION OF BIGSDB-BASED ANALYSES 
Relationships among isolates from the L. acidophilus group were established using 
phylogenetic networks based on rMLST sequences (Section 4.2.3.1). The 53 ribosomal 
subunit loci identified in the automated annotation process were compared among all 
isolates using the BIGSDB Genome Comparator module. The distance matrix generated on 
the basis of shared alleles was visualized with the Neighbor-Net algorithm (Bryant and 
Moulton, 2004), implemented in SplitsTree version 4.8 (Huson and Bryant, 2006) within 
the BIGSDB Web-interface. 
 
Isolates of L. acidophilus species were further analysed with the BIGSDB Genome 
Comparator at all loci defined in L. acidophilus NCFM to generate a distance matrix based 
on shared alleles; the matrix was visualized with Neighbor-net as above. This algorithm 
does not assume a tree-like structure for the data and resolves interrelationships among 
isolates as a phylogenetic network where appropriate. This algorithm accommodates 
departures from tree-like phylogeny, which for example, can result from horizontal gene 
transfer (Cody et al., 2013). Furthermore, the Genome Comparator was used to establish 
both presence/absence and count the number of allelic differences at a particular locus. At 
each locus, a consensus sequence was created from all alleles and the mean distance of all 
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alleles from the consensus sequence was calculated to provide a measure of allelic 
diversity per-locus. The most diverse loci were assumed to have a non-zero mean distance 
value. Isolates were clustered hierarchically using Ward's method based on their allelic 
profiles at loci with non-zero mean distances, using the heatmap2 function in the package 
gplots (Gregory R. Warnes et al., 2013) in R statistical software (R Development Core 
Team, 2012). Heatmaps were coloured using the colour palettes available in the 
RColorBrewer package (Neuwirth, 2011). 
 
In order to examine sequence differences at genomic loci not defined in the L. acidophilus 
NCFM genome sequence, the L. acidophilus NCFM CRISPR sequence was downloaded 
and used to probe other L. acidophilus genome sequence data using BLAST+ tools 
implemented via the BIGSDB Web-interface (Camacho et al., 2009). Complete CRISPR 
sequences with 1 kb of flanking sequence on each side were downloaded and compared 
using the CRISPRtionary: Dictionary Creator tool, at the CRISPRdb (http://crispr.u-
psud.fr/crispr/) (Grissa et al., 2007). Incomplete or partially assembled CRISPR regions 
were excluded from further analysis. 
 
4.2.5. EXPOSURE OF L. ACIDOPHILUS NCFM TO METHYL METHANE SULPHONATE 
(MMS)  
Mutagenesis with MMS was performed in two stages, the first to estimate an MMS 
exposure that would ensure a 99% reduction in viability of a culture of L. acidophilus 
NCFM, and the second to mutagenise L. acidophilus NCFM with three sequential 
exposures to MMS, retaining two isolates for genome resequencing at each culture passage 
stage as follows. Overnight cultures of L. acidophilus NCFM were grown at 37°C in MRS 
broth. Input bacterial suspensions were enumerated using a viable drop count method. 
Serial dilutions were performed in MRS broth; 10 µl drops of bacterial suspension were 
aspirated onto the surface of an MRS agar plate in triplicate and incubated at 37°C for 24 
hours. Individual colonies were counted and the number of viable cells estimated.  
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MMS was added to 1 ml of suspension to a final concentration of 3, 4 or 5% (v/v) for 
exposure times of 10, 15 and 30 minutes. After exposure, suspensions were separated with 
centrifugation and the supernatant containing MMS aspirated. 1 ml of fresh MRS broth 
was added to the pellet to re-suspend, and the drop count enumeration procedure was 
repeated to establish the output from the test. A percentage reduction in culture viability 
was calculated using the ratio of output enumeration to input enumeration.  
 
Subsequently, L. acidophilus NCFM cultures were subjected to three rounds of 
mutagenesis by exposure to MMS at 5 % (v/v) for 15 minutes, an exposure which resulted 
in 99% loss of viability. As previously, 1 ml of bacterial overnight culture was 
enumerated, exposed to MMS, enumerated again to confirm the 99% reduction in viability 
and then frozen at -80°C after the addition of 8% DMSO as a cryoprotectant. This freezer 
stock was revived onto MRS agar and fresh overnight bacterial cultures were inoculated 
from three colonies. High molecular weight DNA was prepared from two overnight 
bacterial cultures as described previously (Section 4.2.1.2) and the third was subjected to 
the same MMS mutagenesis exposure. This was repeated for a third round, ensuring DNA 
was prepared from six MMS-exposed single colony-based isolate cultures. High molecular 
weight DNA from these isolates was subject to the same sequencing and assembly 
procedures described in Section 4.2.1.2, RAPD PCR as described in Chapter 2, and 
assembled data were deposited in the PubMLST database before further analysis. The 
Genome Comparator tool implemented in the BIGSDB was used to identify loci that had 
different alleles to the reference L. acidophilus NCFM genome. These were assumed to be 
mutations induced by exposure to MMS. 
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4.3. RESULTS 
The results are divided into three subsections as follows. The first describes a small scale 
L. acidophilus genomic diversity survey, mapping the genomes of three L. acidophilus 
isolates; CUL21 and CUL60 from the Lab4® capsule and L. acidophilus LMG 11428, a 
culture collection isolate with the earliest-recorded deposition date (1922, Table 4.2). The 
second section describes a large-scale genomic diversity survey of L. acidophilus isolates. 
Overall, 30 L. acidophilus genome sequences were included in this broader study, 
reflecting the progressive shift toward attaining highly-economical (virtually) complete 
prokaryotic genome sequences. Finally, the third results section sought to establish why so 
little genomic variation was observed between L. acidophilus isolates, particularly 
considering their reported ecological niche, the GIT, is a known mutagenic environment. 
 
4.3.1. SMALL SCALE L. ACIDOPHILUS EVOLUTIONARY GENOMICS 
A visual comparison of the genome sequence of L. acidophilus NCFM with L. acidophilus 
CUL21 and CUL60, showed synteny across the entirety of their genome sequences (Figure 
4.2). Single Nucleotide Polymorphism (SNP) detection identified a total of 87 
polymorphisms between L. acidophilus CUL21 and L. acidophilus NCFM, of which 13 
were non-coding, 22 encoded synonymous mutations and 48 encoded non-synonymous 
mutations. Between L. acidophilus NCFM and L. acidophilus CUL60, a total of 85 SNPs 
were observed, 15 non-coding, 21 encoding synonymous mutations and 49 encoding non-
synonymous mutations. Of 364 SNPs between L. acidophilus LMG11428 and L. 
acidophilus NCFM, 48 were non-coding, 57 encoded synonymous mutations and the 
remaining 258 encoded none non-synonymous mutations. When SNP locations were 
compared for all strains, 76 SNPs were found to have identical locations and with same 
alternate base call at each of these positions for CUL21, CUL60 and LMG 11428.  
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Figure 4.2: Whole genome comparison of L. acidophilus NCFM to L. acidophilus CUL21 and L. 
acidophilus CUL60. 
Genome sequences are represented by horizontal lines with L. acidophilus NCFM as the top-most horizontal 
lines. Regions of similar sequence are linked with lines between genomes. Sequence identity is indicated by 
shade intensity. Red indicates similar sequence in the forward direction. The scale bar indicates size in bases 
across the 2 Mb genome comparison. 
 
L. acidophilus NCFM 
L. acidophilus CUL21 
L. acidophilus CUL60 
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To establish the phylogenetic relationships between these isolates, whole-genome 
consensus sequences were created and aligned. A series of whole genome phylogenies can 
be seen in Figure 4.3. Examining phylogenetic relationships at three different taxonomic 
resolutions, the first (Figure 4.3; panel A) shows no phylogenetic distance between L. 
acidophilus isolates when they were compared to reference genomes for 5 species within 
the L. acidophilus group. The second (Figure 4.3; panel B) included just L. amylovorus 
GRL1112, the closest relative of L. acidophilus, based on 16S rRNA gene phylogeny 
(Figure 1.2), and again did not show any phylogenetic distance between the L. acidophilus 
isolates. When just L. acidophilus isolates were examined, phylogenetic distance was 
observed (Figure 4.3; panel C). The distances were objectively small, considering the low 
numbers of SNPs detected (maximum 364 SNPs over 2 Mb genome), but it can clearly be 
seen that L. acidophilus CUL21 and CUL60 are more closely related to one another than L. 
acidophilus NCFM, and that these 3 isolates are more distant to the oldest deposited strain, 
L. acidophilus LMG 11428. 
 
The overall genomic similarity of these isolates presented a considerable challenge when 
examining their genomic diversity, as any variation was hidden within the overwhelming 
identity of their genome sequence. Therefore, for the subsequent large scale L. acidophilus 
genomic diversity survey, the comparative strategy used to establish the evolutionary 
results of polymorphic regions was adapted to consider single genes as the unit of 
comparison, rather than the whole genome sequence. 
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Figure 4.3: Phylogenetic trees of lactobacilli closely related to L. acidophilus  
Phylogenetic analysis of aligned whole genome sequences at three levels of resolution. The L. acidophilus 
group (panel A), L. acidophilus and L. amylovorus (panel B), and just L. acidophilus (panel C). The genetic 
distance scale and bootstrap values (500 replicates) are indicated. 
 
 
 
A) 
B) 
C) 
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4.3.2. EXPANDED L. ACIDOPHILUS GENOMIC DIVERSITY STUDY 
 
4.3.2.1. Assessing genomic diversity of the L. acidophilus group using rMLST  
To contextualise the diversity of L. acidophilus isolates, rMLST was performed on isolates 
from the L. acidophilus group. 53 genes that encode ribosomal proteins were identified in 
all genome sequences (25 L. acidophilus isolates represented by 30 genome sequences, and 
19 other L. acidophilus group genome sequences). The rps genes represent 20,640 
nucleotides in L. acidophilus NCFM and hence account for any observed variation in just 
over 1% of its total genome sequence. 
 
A Neighbour Joining phylogenetic tree of the concatenated sequences of all rMLST loci 
was able to resolve each species within the L. acidophilus group (Figure 4.4), despite some 
species sharing 99% of their 16S rRNA gene sequences (Bull et al., 2012). The phylogeny 
illustrates the strain level diversity of the L. acidophilus group, with L. gasseri, L. 
johnsonii, L. delbruekii and L. helveticus isolates diverging earlier than isolates of L. 
jensenii and L. acidophilus. L. acidophilus isolates fall as a single group, diverging early 
from other L. acidophilus group species, and also diverging recently among themselves. 
Further analysis of isolates of L. acidophilus was conducted using DNA sequence from all 
protein coding regions to improve resolution. 
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Figure 4.4: Neighbour Joining phylogeny of concatenated ribosomal protein genes from L. acidophilus 
group isolates 
The tree was based on the concatenated sequences of 53 rps loci (20, 640 nucleotides). A bootstrap test of 
reliability was performed for 500 replications. 
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4.3.2.2. Genomic diversity of L. acidophilus isolates 
 
4.3.2.2.1. ASSESSING GENOMIC DIVERSITY OF L. ACIDOPHILUS USING A GENOME-WIDE 
GENE-BY-GENE APPROACH  
A Neighbour-Net analysis of the concatenated sequences of all shared loci encoded in the 
L. acidophilus NCFM genome sequence was able to resolve each strain within L. 
acidophilus (Figure 4.5). Isolates that had been deposited in duplicate locations in the same 
culture collection, such as L. acidophilus LMG 9433 and L. acidophilus LMG 13550, 
showed demonstrably similar protein coding gene sequences across their genomes. The 
same isolate sequenced as part of different studies using similar sequencing technologies, 
such as L. acidophilus LMG 9433, represented by sequences LMG 9433 and ERR203994, 
also show co-localising placement in the Neighbour-Net. The same isolate sequenced as a 
part of different studies using different sequencing and assembly technologies with the two 
genome sequences generated from isolates acquired from different culture collections also 
show close placement on the Neighbour-Net; L. acidophilus LMG 11470 (Illumina 
HiSeq2000, Velvet, this study) and ATCC 4796 (454-GS-FLX, Newbler, Human 
Microbiome Project) (Figure 4.5, Table 4.2). The L. acidophilus NCFM reference genome 
sequence was generated in 2005 using Sanger sequencing (Altermann et al., 2005) and its 
sequence was observed to be markedly different to the isolate of L. acidophilus NCFM 
resequenced as part of this study (Figure 4.5).  
 
It was also immediately obvious that genome sequences generated from “commercial” L. 
acidophilus isolates, from Cultech or isolated directly from probiotic products formed a 
tight cluster in the Neighbour-Net (Figure 4.5). In comparison, the genome sequences 
generated from isolates from culture collections were more diffuse in their placement in 
the Neighbour-Net (Figure 4.5). It should also be noted that the genome-wide protein-
coding sequences of all commercial isolates were more similar to one another than 
repeated testing of the same isolate from different studies and sequencing technologies. For 
example all commercial isolates formed a tighter cluster than the cluster created by L. 
acidophilus LMG 9433, LMG 13550 and ERR203994 (Figure 4.5). 
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Figure 4.5: Neighbour-Net of concatenated sequences of all protein coding genes from L. acidophilus 
isolates.  
The analysis was based on the concatenated sequences of 1864 predicted protein coding loci. An overall fit of 
99.49 % indicated that this network accurately represented the original sequence data. Isolates are coloured to 
represent their history with the blue isolates derived from culture collections and the green isolates 
representing commercial isolates from Cultech Ltd. or probiotic products (see Table 4.2 for isolate details). 
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4.3.2.2.2. REGIONS NOT PRESENT IN L. ACIDOPHILUS ISOLATES 
All L. acidophilus isolates shared a markedly high (1828/1862) number of protein coding 
DNA sequences with L. acidophilus NCFM reference to which they were compared 
(Figure 4.6). The remaining loci that were variably present in L. acidophilus isolates are 
shown in Figure 4.7. Interestingly, the majority of these fluctuating loci were attributed to 
the three PAU regions of L. acidophilus NCFM (see Section 1.3.3) or loci closely 
associated with these regions. An additional variant region was composed of three 
consecutive gene loci, LBA0058, LBA0059 and LBA0060, also encoded within phage-
related DNA, but distinct from the PAU DNA. When isolates of L. acidophilus were 
separated based on their history (commercial and culture collection), differences in the 
distribution of the three PAU regions was evident. The PAU1 locus was widely distributed 
across all isolates, culture collection and commercial, with the exception of CUL21 and 
C47. Both of these isolates are from Cultech, with CUL21 used as part of the Lab4® 
probiotic. Other commercial isolates had the other PAU regions, 2 and 3, intact and shared 
more loci found in L. acidophilus NCFM than isolates from culture collections (Figure 
4.7). Culture collection isolates demonstrated more variably present all loci, including 
PAU2 and PAU3, and other coding regions (Figure 4.7). 
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Figure 4.6: L. acidophilus NCFM protein coding loci found in other L. acidophilus isolates. 
The distribution of all protein-coding loci defined in the L. acidophilus NCFM genome sequence, in all other 
L. acidophilus isolates is represented. 1828 loci are found in all isolates, 17 loci are found in between 90% 
and 95% of isolates etc. 
 
CHAPTER FOUR – POPULATION GENOMICS OF L. ACIDOPHILUS 
 
134 
 
Locus Product
A
T
C
C
 
4
7
9
6
L
M
G
 
1
1
4
7
0
L
M
G
 
1
1
4
7
2
L
A
B
 
2
8
3
L
A
B
 
6
6
L
A
B
 
7
6
L
M
G
 
1
1
4
2
8
L
M
G
 
1
1
4
6
6
L
M
G
 
1
1
4
6
7
L
A
B
 
6
9
L
M
G
 
1
1
4
6
9
L
M
G
 
1
3
5
5
0
L
M
G
 
9
4
3
3
E
R
R
2
0
3
9
9
4
N
C
F
M
C
4
9
C
2
1
C
4
6
C
4
7
C
U
L
 
2
1
C
U
L
 
6
0
C
u
l
T
2
H
B
C
A
N
C
F
M
R
m
 
3
4
4
R
m
 
3
4
5
E
R
R
2
5
6
9
9
8
L
M
G
 
1
1
4
2
8
 
S
C
U
L
2
1
 
S
C
U
L
6
0
 
S
LBA0021 cadmium resistance protein (cadB) 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 X X 1 1 1 1 1 1 1 1 X 1
LBA0022 cadmium resistance regulatory protein (cadX) 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 X X 1 1 1 1 1 1 1 1 X 1
LBA0023 hypothetical protein 1 1 3 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 X X 1 1 1 1 1 1 1 1 X 1
LBA0026 hypothetical protein 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 X X 1 1 1 1 1 1 1 1 X 1
LBA0028 hypothetical protein 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 X X 1 1 1 1 1 1 1 1 X 1
LBA0029 putative integrase 1 1 2 1 1 1 1 1 1 1 1 2 2 2 1 1 1 1 X X 1 1 1 1 1 1 1 1 X 1
LBA0058 putative phage DEAD box family helicase X X X T T T T X T X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 T 1 1
LBA0059 penicillin-binding protein (pbpX) X X X X X X X X X X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 X 1 1
LBA0060 polypeptide deformylase X X X X X X X X X X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 X 1 1
LBA0325 integrase 1 1 1 1 1 1 1 1 1 X X X X X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0326 hypothetical protein 1 1 2 1 1 1 1 1 1 X X X X X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0328 hypothetical protein 1 1 1 1 1 1 1 1 1 X X X X X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0331 hypothetical protein 1 1 1 1 1 1 1 1 1 X X X X X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0332 methylase 2 2 2 1 1 1 1 1 1 X X X X X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0333 hypothetical protein 1 1 1 1 1 1 1 1 1 X X X X X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0398 putative DNA binding protein 1 1 1 2 1 1 T 4 X 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1
LBA0475 restriction endonuclease 2 2 1 3 4 4 3 X X 1 X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1
LBA0476 hypothetical protein 2 2 6 3 4 4 3 X X 5 X 7 7 7 1 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1
LBA0477 putative DNA methyltransferase 1 1 2 1 1 1 1 X X 1 X 3 4 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0478 methylase 1 1 1 1 1 1 1 X X 1 X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0479 hypothetical protein 1 1 1 1 1 1 1 X X 1 X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0480 hypothetical protein 1 1 1 1 1 1 1 X X 1 X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0481 putative DNA segregation ATPase (ftsK) 1 1 1 1 1 1 1 X X 1 X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0482 hypothetical protein 1 1 1 1 1 1 1 X X 1 X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0483 putative replication initiator protein (repB) 1 1 1 1 1 1 1 X X 1 X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0484 integrase 1 1 1 1 1 1 1 X X 1 X 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA0620 UDP-N-acetylglucosamine 2-epimerase T X X X X T X 2 2 3 X 2 T 2 1 2 2 2 2 2 2 2 2 2 3 3 T X X X
LBA1020 putative mucus binding protein X X X 4 4 4 4 4 4 X X 5 6 5 1 2 2 2 3 3 2 2 2 2 2 2 2 T T T
LBA1131 ABC transporter ATP binding and permease protein 1 1 1 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 X 1 1 1 1 1 1 2 1 X
LBA1480 putative beta-glucosidase 1 1 1 2 3 3 T X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1
LBA1720 UDP-N-acetyl glucosamine-2-epimerase T X X X X T X 1 1 2 X 1 T 1 1 1 1 1 1 1 1 1 1 1 2 2 T X X X
LBA1893 GMP reductase 1 1 1 1 1 1 1 X 1 2 1 1 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA1894 hypothetical protein 1 1 1 1 1 1 1 X 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
LBA1895 hypothetical protein 1 1 1 1 1 1 1 X 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
PAU3
PAU3 associated
PAU2 associated
PAU1 associated
Genomic Region
Phage-related
Culture collection isolates Commercial isolates Single reads
PAU1
PAU2
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Figure 4.7: Variably present protein coding loci 
Loci are defined in the L. acidophilus NCFM genome sequence (GenBank: CP000033), and representative 
predicted gene products from the same sequence are listed. Completely missing loci are noted with an X, and 
truncated loci, indication that a proportion of the locus present at the end of a sequence contig, are noted with 
a T. The three PAU regions and phage related DNA within of the L. acidophilus NCFM genome are marked 
(add the genomic region header and phage-related DNA label), and isolate names are coloured blue for 
culture collection isolates and green for commercial isolates. Also included in a separate column is the 
analysis of the genome sequences generated from the small scale genome resequencing study (section 4.3.1) 
 
 
4.3.2.2.3. LOCI SHOWING SEQUENCE DIVERSITY 
Sequence diversity was estimated by calculating mean distances for all protein coding loci 
defined in the L. acidophilus NCFM reference genome. A consensus sequence was 
generated from the sequences of all isolates at each locus, and then the distance of each 
individual isolate sequence from this consensus derived for each locus. The mean of these 
distances provided a simple way of assessing diversity at each protein coding locus. A 
mean distance of zero was observed at over 70% of genomic loci (1305/1864). The 
remaining loci that showed non-zero mean distances were filtered to remove: i) truncated 
loci present at the ends of sequence contigs, and ii) paralogous loci that were mostly 
attributed to multicopy transposases. The remaining loci were then compared across all 
isolates, and each time a new sequence was encountered, this was assigned a new “allele” 
number. An “allelic profile” for each isolate was then generated, similar to a traditional 
MLST scheme, but encompassing only the diverse protein coding loci. Ten different alleles 
were encountered at the most diverse locus and this variation in correlation with the 
genome sequences was used to generate a heatmap of locus diversity (Figure 4.8). When 
isolates were clustered based on the similarity of their allelic profiles, culture collection 
isolates again clearly separated from commercial isolates (Figure 4.8). Commercial isolates 
were much more homogenous in their allelic profiles, and more similar in sequence to L. 
acidophilus NCFM. The culture collection isolates were much more diverse, although 
CHAPTER FOUR – POPULATION GENOMICS OF L. ACIDOPHILUS 
136 
 
duplicate isolates from different culture collections such as L. acidophilus ATCC 4796 and 
LMG 11470, and L. acidophilus LMG 9433, LMG 13550 and ERR203994, clustered 
together respectively. 
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Figure 4.8: Variable loci in L. acidophilus genome sequences 
L. acidophilus genome sequences (columns) are represented by their most diverse loci (rows), forming an 
allelic profile for each isolate. Each locus in each genome sequence is coloured from red to green relative to 
its allele number (1 is red, 10 is green). As new allele numbers are assigned only when a new sequence is 
encountered at that particular locus, the most diverse alleles have a larger amount of green cells. The genome 
sequences are clustered according to their allelic profile similarity, and the loci according to their overall 
diversity. Again, genome sequences are coloured based on their history, culture collection isolates in blue and 
commercial isolates in green. Two clusters of diverse loci examined in further detail are highlighted in purple 
(Group 2) and orange (Group 1). 
 
Two groups of diverse loci, group 1 and group 2, were identified in heatmap analysis 
(Figure 1.8) and further details on these coding sequences is provided in Figure 4.9. The 
group 1 loci (Figure 1.9; orange font) were highly diverse in isolates from culture 
collections, yet distinctly homogenous in commercial isolates. Loci encoding outer-
membrane and transport-related functions were most diverse coding sequences in these 
group 1 loci (LBA1300, LBA0166 and LBA1463). LBA1146 displayed a similar level of 
diversity but has no annotated function attributed, although it has close (>80% sequence 
identity) homologues in Lactobacillus kefiranofaciens ZW3 and Lactobacillus crispatus 
ST1. LBA1360 and LBA0079 were less diverse and also associated with cross-membrane 
transport. Although up to ten different alleles were encountered at these loci, overall mean 
distances were below 0.008 and generally in the range of 0.001 to 0.002 (Figure 1.9).  
 
The second group of diverse loci, group 2, (Figure 1.9, purple font), were entirely 
homogenous in sequence in the commercial isolates, and diverse in the culture collection 
isolates, but less so than the group 1 sequences. Two loci had large mean distances 
(LBA0327 and LBA0329, 0.043 and 0.038 respectively), but this may be attributed to 
them being part of PAU2, of which parts were observed to be variably present in L. 
acidophilus isolates (Section 4.3.2.2.2). Of the remaining loci within group 2, three 
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(LBA0293, LBA0408 and LBA1384) were associated with “housekeeping” type products 
such as ribosomal proteins and DNA repair. 
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LBA1300 oligopeptide ABC trasporter substrate binding protein ABC transporter 10 10 10 8 9 2 6 7 7 5 5 4 4 2 2 1 1 1 1 3 3 3 1 1 1 1 1 1 1 1 0.008
LBA1360 ABC transporter ATP-binding protein none 5 5 5 2 2 2 4 2 2 2 2 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA0746 response regulator none 5 5 5 1 1 2 4 1 1 3 3 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.002
LBA0079 putative histidine kinase Heme uptake and utilisation 5 5 5 2 4 2 2 3 2 3 3 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA1676 probable ATP-dependent helicase none 4 4 4 4 4 4 4 3 4 4 4 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA0038 putative cobalamin adenosyltransferase none 1 6 6 3 3 5 4 3 3 3 3 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA0132 putative transcriptional regulator none 7 7 8 1 1 6 4 5 5 3 3 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA0166 K+ uptake protein Potassium homeostasis 9 9 10 2 2 8 6 2 7 5 5 4 4 2 2 1 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0.001
LBA0536 putative membrane protein none 3 3 8 5 3 7 3 6 3 5 5 6 4 2 2 1 3 3 3 3 3 3 1 3 3 3 3 3 3 3 0.002
LBA1463 lactose permease Lactose utilization 9 9 9 7 8 2 4 5 6 3 3 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA1780 hypothetical protein N/A 8 8 8 6 7 2 4 5 5 3 3 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA1146 putative family protein none 10 10 10 7 8 9 1 2 2 6 6 5 5 2 2 1 1 1 4 3 3 3 1 1 1 1 1 1 1 1 0.002
LBA0036 hypothetical protein N/A 3 3 3 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA0141 acetyl esterase none 6 1 1 1 5 1 1 4 4 3 3 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.002
LBA0293 50S ribosomal protein L23 Ribosome 3 3 3 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA0327 replication protein none 3 3 3 1 2 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.043
LBA0329 putative cell division protein none 3 4 3 1 3 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.038
LBA0408 DNA mismatch repair DNA repair, bacterial MutL-MutS system 4 4 4 1 1 3 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA0588 ribose-5-phosphate isomerase D-ribose utilization, pentose phosphate pathway 5 5 5 3 4 2 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.002
LBA0635 transporter protein -putative hemolysin none 3 3 3 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA0912 2-oxoglutarate-malate translocator none 1 7 1 1 5 6 1 4 4 1 1 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.002
LBA0975 putative family protein none 4 4 4 1 1 1 1 3 3 1 1 1 1 2 4 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA1233 transcriptional regulator none 4 4 4 2 2 3 2 2 2 2 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
LBA1384 dihydroorotate dehydrogenase B, catalytic unit de novo  Pyrimidine synthesis 3 3 3 1 1 1 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.001
G
r
o
u
p
 
1
 
d
i
v
e
r
s
e
 
l
o
c
i
G
r
o
u
p
 
2
 
d
i
v
e
r
s
e
 
l
o
c
i
CHAPTER FOUR – POPULATION GENOMICS OF L. ACIDOPHILUS 
141 
 
←Previous page 
Figure 4.9: Selected diverse loci in L. acidophilus  
Two groups of selected diverse loci in L. acidophilus, group 1 and group 2, are expanded from Figure 4.8. 
Loci are coloured as per Figure 4.8 and their SEED functional categories listed. The allelic profile of each 
isolate at each of these loci is coloured in the same way as Figure 4.8. The overall mean distance of each 
locus is noted. (again add sub-header labels to group 1 and 2). 
 
 
4.3.3. L. ACIDOPHILUS CRISPR REGION DIVERSITY 
All complete (on a single sequence contig) CRISPR regions from L. acidophilus isolates 
were extracted and analysed (Figure 4.10). The archetypal L. acidophilus CRISPR 
sequence is defined in the genome sequence of L. acidophilus NCFM, and consists of 33 
units of a repeat region and a spacer region. The L. acidophilus NCFM CRISPR had the 
full gamut of spacer sequences and comprised the longest sequence length of 1980 bp. The 
shortest CRISPR sequences were 1493 bp in length, and missing up to four spacers (Figure 
4.10; L. acidophilus LMG 13550, LMG 9433, ERR203994 and C46). Four regions of 
diversity in L. acidophilus CRISPR sequences were identified. BlastN was used to find 
similar sequences to these polymorphic spacers (Table 4.3).  Unexpectedly, seven out of 
eight of thee polymorphic spacers showed at least partial similarity to L. acidophilus 
ribosomal protein encoding genes (Table 4.3). 
 142 
 
 
 
 
    1                                     2                                         3                                                                                                          4 
CHAPTER FOUR – POPULATION GENOMICS OF L. ACIDOPHILUS 
143 
 
←Previous page 
Figure 4.10: L. acidophilus CRISPR sequences 
The complete CRISPR region from each L. acidophilus isolate is represented by a series of repeats (dark blue 
diamond) and unique spacers (light blue oblong). Each unique spacer sequence is assigned a new number, 
which can be seen above its relevant spacer oblong. Four regions of polymorphism are highlighted with 
coloured boxes, and numbered below. The size of each CRISPR region is given in bp. 
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Table 4.3: Sequences similar to polymorphic CRISPR spacers
Diversity 
region 
Spacer 
No. 
Spacer sequence Similar sequences Sequence 
coverage (%) 
Identity 
(%) 
1 2 TGGAATCTCATCGTAAGAAATAAGTCGCATATA L. acidophilus 16S rRNA 
gene (partial) 
45 100 
3 CCTTTTCCTAGGATCTTCATAAGCTTCTCGCCA L. acidophilus 23S rRNA 
gene (partial) 
39 92 
2 7 CGGCAATTTTTGAAACAAACAACTATGTATATA L. acidophilus 23S rRNA 
gene (partial) 
54 100 
8 AAATAAGGAAGATATTGCCACCCTCGGTACCCA L. acidophilus 23S / 16S 
rRNA genes (partial) 
30 100 
9 ACAAGTTTTGCTCTAACCATGATGTTGTAAACA L. acidophilus 23S rRNA 
gene (partial) 
45 100 
3 7 CGGCAATTTTTGAAACAAACAACTATGTATATA L. acidophilus 23S rRNA 
gene (partial) 
54 100 
4 28 TAATACGTAGGTGGCAAGCGTTGTCCGGATTTA 16S rRNA gene conserved 
region 
100 100 
29 ATAAAAATAAGAGGAAACCACCGTTTTCTCTTA L. acidophilus 23S rRNA 
gene (partial) 
27 100 
30 TTTTGGGCGTTAATCCCGTGGCGAATTAATTCG    
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4.3.4. MUTAGENESIS OF L. ACIDOPHILUS NCFM WITH MMS 
To replicate and exceed the mutagenic capacity of the GIT as the natural niche of L. 
acidophilus, strain NCFM was exposed to MMS, which causes DNA alkylation and 
double-stranded DNA breaks. The range of exposure strategies was chosen based on 
successful previous mutagenesis of L. delbrueckii (Demirci and Pometto, 1992). L 
acidophilus NCFM was exposed to MMS at final media concentrations of ranging from 
3% to 5% (v/v) for durations of 10, 15 and 30 minutes. An exposure of 15 minutes to 
5%(v/v) MMS was selected as the  exposure required to reduce viability of the bacterial 
culture by 99% (Figure 4.11). Three exposures were performed at this MMS exposure 
condition and duplicate isolates collected after each exposure and their genomic DNA re-
sequenced (Table 4.4). No gross differences in genome structure between the MMS 
exposed isolates and the parent L. acidophilus NCFM isolate were observed using RAPD 
profile comparisons (Figure 4.12). 
 
Draft genomes were assembled for each isolate, and their sequences compared at all 
protein coding loci defined in the L. acidophilus NCFM genome sequence, as in Section 
4.3.2. Of 1862 protein coding loci, 1732 were identical in all isolates. The remaining 
polymorphic loci were screened for paralogous and truncated loci, and after their removal 
38 polymorphic loci were available to elucidate the results of MMS exposure (Table 4.5). 
None of these loci differed to the L. acidophilus NCFM reference sequence by more than 
two nucleotides, and polymorphisms in isolates from the first exposure to MMS (1-1 and 
1-2) were rarely preserved in isolates from the third exposure to MMS (3-1 and 3-2). 
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Figure 4.11: The effect of MMS on L. acidophilus NCFM at a range of exposure concentrations and 
times.  
The percentage kill due to different MMS concentrations and exposure times is plotted as a bar chart.
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Table 4.4: Genome sequences generated for mutagenized L. acidophilus NCFM isolates 
 
 
 
 
 
 Species Isolate Year Isolate source Sequence source Genome status 
Parent isolate L. acidophilus NCFM 1970 Derived from LMG 9433  This study draft 
Mutagenised 
isolates 
L. acidophilus NCFM 1-1 2013 Mutagenesis of L. acidophilus 
NCFM – 1st round 
This study draft 
L. acidophilus NCFM 1-2 2013 Mutagenesis of L. acidophilus 
NCFM – 1st round 
This study draft 
L. acidophilus NCFM 2-1 2013 Mutagenesis of L. acidophilus 
NCFM – 2nd round 
This study draft 
L. acidophilus NCFM 2-4 2013 Mutagenesis of L. acidophilus 
NCFM – 2nd round 
This study draft 
L. acidophilus NCFM 3-1 2013 Mutagenesis of L. acidophilus 
NCFM – 3rd round 
This study draft 
L. acidophilus NCFM 3-2 2013 Mutagenesis of L. acidophilus 
NCFM – 3rd round 
This study draft 
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Figure 4.12: RAPD profiles of mutagenized L. acidophilus NCFM isolates 
RAPD-PCR products from L. acidophilus NCFM (lanes 1), and mutagenised L. acidophilus NCFM 1-1 (lane 
2), 1-2 (lane 3), 2-1 (lane 4), 2-4 (lane 5), 3-1 (lane 6) and 3-2 (lane 7) a negative PCR water control (lane 
12) and L. acidophilus NCFM DNA as a positive control (lane 13). Lane M contains molecular size marker 
with sizes of relevant bands given in bp. 
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Table 4.5: Sequence changes in polymorphic loci from L. acidophilus NCFM isolates exposed to 5% 
(v/v) MMS for 10 minutes 
Sequence change in mutagenised isolates (bp) 
Mutagenesis: 1st Round 2nd Round 3rd Round 
Locus Locus size NCFM 1-1 NCFM 1-2 NCFM 2-1 NCFM 2-4 NCFM 3-1 NCFM 3-2 
LBA0058 2835 
- - - - - 1 
LBA0121 747 
- - - - - 1 
LBA0130 453 1 1 1 1 1 - 
LBA0236 843 
- - - - - 1 
LBA0238 630 
- - - - - 1 
LBA0250 705 
- - - - - 1 
LBA0326 189 
- - - - 1 - 
LBA0414 1239 
- - - - 1 - 
LBA0636 1572 
- - - - - 1 
LBA0697 1032 
- - - - - 1 
LBA0725 1992 
- - - - - 1 
LBA1019 7953 
- - - - - 1 
LBA1048 603 
- - - - - 1 
LBA1106 564 
- - - - - 1 
LBA1191 798 
- - - - - 1 
LBA1234 2274 
- - - - - 2 
LBA1261 4314 
- - - - - 2 
LBA1285 429 
- - - - 1 - 
LBA1350 900 
- - - - - 1 
LBA1166 3483 
- - - - - 1 
LBA1442 1257 - - - - - 1 
LBA1460 1020 - - - - - 1 
LBA1578 2085 - - - - - 1 
LBA1642 1296 - - - - - 1 
LBA1788 210 - - - - - 1 
LBA1789 540 - - - - 1 - 
LBA1799 1323 - - - - - 1 
LBA1817 750 - - - - - 1 
LBA1939 2340 - - - - - 1 
LBA1165 3624 - - - - - 1 
LBA1166 3483 1 1 1 1 1 - 
LBA0238 630 - - 1 - 1 - 
LBA1926 1515 - - - - - 1 
LBA0278 2157 - - - - - 1 
LBA0582 657 1 1 1 1 1 - 
LBA0516 702 - - - - - 1 
LBA1382 957 - - - - - 1 
LBA0626 1158 1 1 1 1 1 - 
Total 4 4 5 4 9 31 
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4.4. DISCUSSION 
Genome resequencing analysis was successful in uncovering variation within L. 
acidophilus isolates which was not observed by RAPD as a low resolution pattern 
matching typing technique. It also illustrated how both the ability to generate genome 
sequences and analyse them has progressed in a relatively short space of time within this 
PhD study. Although genome resequencing corroborated the findings of RAPD that 
indicated L. acidophilus was a highly clonal species, it was able to reveal that commercial 
isolates in current use show even less diversity than other more “historical” isolates from 
recognised culture collections. Variation in the PAU regions selected as species-specific 
markers was also observed as well as intriguing differences in the CRISPR regions. The 
significance of these findings is discussed below. 
 
4.4.1. SMALL SCALE L. ACIDOPHILUS GENOMIC DIVERSITY SURVEY 
The genomes of two commercial isolates, L. acidophilus CUL21 and CUL60 were 
resequenced and reads were mapped to the L. acidophilus NCFM reference sequence. The 
whole genome was the unit of comparison in this instance, and polymorphism was 
measured at the single nucleotide level. The level of genomic identity conserved between 
these commercial isolates and L. acidophilus NCFM was exceptionally high. A recent 
study (Stahl and Barrangou, 2013) yielded similar levels of identity when recently applied 
to L. acidophilus La-14, a commercial isolate used in probiotic products produced by 
Danisco (Copenhagen, Denmark). Overall, 95 SNPs were discovered between L. 
acidophilus La-14 and L. acidophilus NCFM, similar to the 87 and 85 SNPs observed in 
this study between L. acidophilus NCFM and L. acidophilus CUL21 and CUL60 
respectively (Stahl and Barrangou, 2013). The inclusion of the genome sequence of L. 
acidophilus LMG 11428, a culture collection isolate, showed more overall polymorphisms, 
but whole genome phylogenies were only able to resolve L. acidophilus isolates when only 
L. acidophilus genome sequences were compared (Figure 4.3).  
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When examining diversity at the scale of the whole genome sequence, highly related 
sequences such as those generated by L. acidophilus isolates present a particular problem. 
The polymorphic regions, which are the important areas from the point of view of a 
genomic diversity study, are lost against the backdrop of overwhelming sequence identity. 
Purely phylogenetic information can be extracted from these SNPs, and phylogenetic 
analyses built on sequences composed of solely polymorphic positions, as in pathogenic 
Salmonella, where SNP information was used to inform epidemiology (Okoro et al., 2012). 
The subsequent large scale L. acidophilus study, as an alternative to SNP mapping, took a 
more functional approach to examining genomic diversity by examining each protein 
coding locus defined in a reference genome sequence (L. acidophilus NCFM).  
 
4.4.2. LARGE SCALE L. ACIDOPHILUS GENOMIC DIVERSITY SURVEY 
 
4.4.2.1. Gene-by-gene analysis approach 
4.4.2.1.1. RMLST OF L. ACIDOPHILUS GROUP ISOLATES 
Indexing the variation of 53 rps loci, which are shared and functionally conserved amongst 
all members of the domain (Roberts et al., 2008) allows a natural combination and 
extension of both 16S rRNA gene sequence comparison and traditional MLST to provide 
resolution from the strain to the domain level (Jolley et al., 2012). Despite the overall 
genomic diversity within the L. acidophilus group, the 16S rRNA gene sequences between 
some of its members are highly conserved (Bull et al., 2012). This makes the L. 
acidophilus group an ideal candidate for testing the resolution of the rMLST approach, as 
the 16S rRNA gene phylogenetic trees traditionally used to study evolutionary history are 
unstable because of their level of sequence conservation (Figure 1.2). A simple Neighbour 
Joining (NJ) phylogenetic tree based on the sequences of the rps genes was able to group 
isolates of all species together and illustrated the strain-level variation in rps genes seen in 
other Lactobacillus species (Figure 4.4). The phylogeny was also better supported than the 
16S rRNA gene-based NJ phylogeny drawn from similar isolates (Figure 1.2), suggesting 
rMLST could provide a greater insight into the evolutionary history of the genus 
Lactobacillus than simple 16S rRNA phylogenies. 
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4.4.2.1.2. GENOME-WIDE ANALYSES 
Numerous studies have used comparative genomics to identify genomic similarities and 
differences within the LAB (Makarova et al., 2006, Coenye and Vandamme, 2003, 
O'Sullivan et al., 2009) and at the species level within the L. acidophilus group (Berger et 
al., 2007). No single study however, has conducted a comparative genomics analysis 
encompassing such a large number of LAB isolates below the species level. This should be 
considered a fundamental gap in knowledge concerning probiotic bacteria, as probiotic 
characteristics in many species are unique to a single strain (see Section 2.1). Elucidating 
the underlying genomic foundations for probiotic phenotypes should be a key target for 
investigating the mode-of-action of bacterial probiotics. As far as we are aware, this study 
is the first within the genus Lactobacillus to use next-generation DNA sequencing 
technology combined with a functional, gene-by-gene diversity analysis approach to assess 
the relatedness and intraspecies diversity of a single probiotic species. 
 
4.4.2.2. Variably present loci 
Maintenance of prophage regions within a genome has been shown to affect growth rate 
and other physiological characteristics such as virulence in pathogenic bacteria (Clark et 
al., 2012). A small number of protein coding loci were variably present in all isolates, with 
many of these loci found within regions that show homology to phage-genes (Altermann et 
al., 2005). Examination of protein sequences show PAU1 and PAU2 are the most closely 
related, with PAU3 significantly different (Altermann et al., 2005). Two conflicting 
hypotheses for the origin of the PAU regions are proposed, the first that PAU3 evolved in a 
different organism and was the latest acquisition and the second that PAU3 was the most 
ancient integration event and subsequently underwent a duplication event to form PAU1 
(Altermann et al., 2005). The presence of PAU1 in L. acidophilus LMG 11466, LMG 
11467 and LMG 11469, which show no evidence of the presence of PAU3, suggests that 
PAU3 did indeed evolve in a different organism and was the most recent integration event. 
There is evidence that PAU region functional homologs exist in other LAB (Altermann 
and Klaenhammer, 2011). L. acidophilus LMG 11466 and LMG 11469 were both shown 
to lack the region targeted by the L. acidophilus specific marker PCR developed in Chapter 
2, confirming the negative result shown in Table 2.4. 
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Generally, loci annotated in the L. acidophilus NCFM genome sequence were found in all 
commercial isolates, with the exception of L. acidophilus CUL21 and C47, which lacked 
PAU1 associated loci. The same situation was not reflected in the culture collection 
isolates, which were much more diverse in the loci that were absent in their genomes 
(Figure 4.8 and Figure 4.9). The commercial isolates were more similar to themselves and 
L. acidophilus NCFM than they were to the culture collection isolates which were largely 
more diverse. The predicted exoproteomes, i.e. the entire set of bacterial proteins predicted 
to be found in the extracellular milieu (Desvaux et al., 2009) in all isolates of L. 
acidophilus are highly comparable. That is to say, without considering the impact of 
individual gene sequence on the physiology and characteristics of a strain, the proteins and 
hence functions that encoded by each gene in the genome of each strain are largely 
identical. 
 
4.4.2.3. Diverse protein-coding genomic loci 
The commercial and culture collection isolates of L. acidophilus share almost all protein 
coding loci defined in the L. acidophilus NCFM genome sequence. Two populations 
emerge when the sequences of these loci are examined and grouped based on allelic profile 
similarity. These two groups directly reflect the history of the isolates contained within 
them; culture collection or commercial. The variable loci of commercial isolates of L. 
acidophilus were more similar in sequence to L. acidophilus NCFM and formed a 
homogenous cluster. Similarly to the distribution of absent loci, culture collection isolates 
formed a more heterogeneous group, distinct from the commercial isolates. No functional 
category of loci appeared to be more diverse in the genome sequences of culture collection 
isolates.  
 
One possible explanation for this is the global propagation, storage and repeated re-use of 
commercial probiotic isolates of L. acidophilus, directly related to L. acidophilus NCFM. 
In a similar case in a different probiotic species, two commercial isolates of L. casei, 
isolated directly from probiotic products produced by different companies were found to 
share a virtually identical genome sequence, encoding a comparable exoproteome and 
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displaying just 29 SNPs (Douillard et al., 2013). These data and the results of our study 
indicated that human practice in terms of the use of probiotic LAB or diary starter cultures 
may be restricting the “natural” evolution of these bacteria, leading the widespread 
distribution of highly clonal strains. 
 
4.4.2.4. CRISPR regions 
The CRISPR regions of L. acidophilus isolates were examined as a non-protein-coding 
region that is typically diverse at the sub-species level in LAB, for example, when diversity 
in CRISPR loci was indexed in 124 strains of Streptococcus thermophilus, 109 different 
CRISPR arrangements were observed (Horvath et al., 2008). CRISPR regions are usually 
referred to as CRISPR-Cas (where Cas stands for CRISPR-associated proteins). The Cas 
genes are normally located within 1kb of the CRISPR locus. They are predicted to be 
involved in integration of new spacer DNA (Koonin and Makarova, 2009). No Cas genes 
are present in the L. acidophilus genome sequence, which might explain why diversity in 
the CRISPR region of L. acidophilus appears to be driven more by loss of spacer regions 
rather than acquisition of new spacer regions (Figure 4.10).  
 
L. acidophilus NCFM has a single spacer region that shows 100% sequence identity to its 
own 16S rRNA gene (Spacer 28, Table 4.3) (Stern et al., 2010). This type self-targeting 
CRISPR spacer is uncommon, with 0.4% of CRISPR spacers surveyed by Stern et al 
(2010) having incorporated self-genes. The acquisition of self-targeting spacers is also 
hypothesised to be an accident caused by CRISPR insertion mechanism (Cas genes) and 
may potentially lead to deleterious effects on the cell (Stern et al., 2010). The fitness cost 
of self-targeting spacer regions has been demonstrated in E. coli, where isolates containing 
them were seen to have highly degenerated Cas systems (Díez-Villaseñor et al., 2010). 
Here, a parallel is drawn in L. acidophilus where, to alleviate the deleterious effect of a 
self-targeting CRISPR spacer, L. acidophilus has lost all associated Cas genes, and 
therefore the diversity of these CRISPR regions is not driven by spacer acquisition, 
specifically those of a self-targeting nature, in this group of isolates.  
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4.4.3. EXPOSURE OF L. ACIDOPHILUS TO MMS 
Exposure to 5%(v/v) MMS for 15 minutes was required to kill 99% of L. acidophilus 
NCFM, directly comparable to the Ethyl Methanesulphonate (EMS) exposure conditions 
required to kill 99% of L. delbrueckii subsp. delbrueckii ATCC 9649 (4.5%(v/v) for 15 
minutes) (Demirci and Pometto, 1992). In L. delbrueckii subsp. delbrueckii ATCC 9649, 
no attempt was made to establish the genetic impact of the mutagenesis procedure. Demirci 
(1992) selected for a mutants that were more tolerant to (d-)-lactic acid by coupling the 
exposure to EMS with exposure to levels of (d-)-lactic acid above the minimum inhibitory 
concentration seen in the wild type isolate. This stabilised the random mutagenesis 
procedure and resulted in an induced, measurable phenotype in their mutants (Demirci and 
Pometto, 1992).  
 
L. acidophilus NCFM mutants generated in this study were random with no stabilising 
pressure to enhance a particular phenotype. No observable differences were detected 
between the RAPD profiles generated by the MMS exposed isolates and the parent L. 
acidophilus NCFM isolate, although this was not unexpected as RAPD is a particularly 
granular method for examining genomic diversity. This was reinforced when the genome 
sequences of the MMS exposed isolates showed just 38 polymorphic loci across all 
exposed isolates, with polymorphic sequence less than two nucleotides in every case. It 
should be noted however, that this analysis only analysed coding regions of the L. 
acidophilus genome, and mutagenesis is under greater selective pressure in these regions 
than the intergenic sequence (Lobry and Sueoka, 2002). However, this variation after a few 
culture passages in the presence of mutagen does demonstrate that L. acidophilus may 
evolve rapidly as a result of mutation. It re-enforces the hypothesis that the stability seen in 
commercial isolates is a result of derivation from a single clone which has been kept stable 
as a result of industry practice. 
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4.4.4. SUMMARY AND PERSPECTIVE 
 
The coding capacity displayed by the L. acidophilus isolates examined in this study is 
highly clonal, with 98% of the protein coding loci found in L. acidophilus NCFM present 
in all other isolates tested. This group of organisms provides a unique opportunity to 
examine whether diverse probiotic characteristics are a function of genes that are present 
or absent or, if a level playing field of genes are present, very small changes in the 
sequence of those genes have a marked effect on the overall probiotic capacity of an 
isolate. Our study presents an interesting challenge for the bacterial species concept (Fraser 
et al., 2009), and whether or not bacterial “strains” meaningfully exist as discreet units of 
sequence diversity in the wider continuum of bacterial species. Although as taxonomic 
units they may display an array of different sequence types, bacterial strains and species 
should be defined by measurable and stable phenotypic characteristics. If minor variations 
in sequence truly influence probiotic effect, low resolution measures of strain type, such as 
RAPD profile or PFGE profile, are not sufficient to identify a strain. This means that future 
identification of a probiotic strain of L. acidophilus should be based at least on the 
sequence of a polymorphic genomic locus, or more likely on a whole genome sequence. 
 
In addition, commercially marketing a particular strain of L. acidophilus should be 
dependent on a unique phenotypic characteristic. At this stage however, the homogeneity 
of the genome sequences of commercial isolates of L. acidophilus, also provides 
companies with the opportunity to assume that evidence of probiotic effect demonstrated in 
studies undertaken on one particular isolate of L. acidophilus would support their own 
strains equally as well. The demonstration of unique or enhanced probiotic ability in a 
single isolate will set it apart from the others, and this cannot be achieved in any 
meaningful way until detailed phenotypic studies encompassing the diversity of isolates 
seen in this study are conducted. 
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4.5. CONCLUSIONS 
 
The conclusions from this chapter are as follows: 
1. rMLST (rps) gene-based phylogenies are a more effective and stable method for 
establishing phylogenetic relationships within the L. acidophilus group than 
traditional 16S rRNA gene phylogenies. 
 
2. Variably present genomic loci were dominated by genes associated with phage-
related regions (PAU). PAU1 was the most widely distributed phage related region, 
PAU2 and PAU3 were present in all commercial isolates but only some culture 
collection isolates. 
 
3. Overall, the sequences of 70% of the protein coding loci defined in L. acidophilus 
NCFM were highly conserved in all other L. acidophilus, from both commercial 
applications and culture collections.  
 
4. When genomic diversity was indexed at all protein-coding loci defined in the L. 
acidophilus NCFM genome, two clear divisions of isolates were observed, clearly 
reflecting whether the isolate had come from a commercial or culture collection 
background. Commercial L. acidophilus isolates formed a more homogenous group 
than the more diverse culture collection isolates. The homogeneity of the group of 
L. acidophilus isolates of commercial origin suggests that they are a single clone 
propagated for used in probiotic products globally. 
 
5. When exposed to levels of a chemical mutagen seen to cause mutations detectable 
as phenotypes in L. delbrueckii, analysis of the genome sequences of MMS 
exposed L. acidophilus NCFM showed 38 polymorphic loci that were shared 
between six isolates. This demonstrated that L. acidophilus was capable of genomic 
change as a result of mutation, and suggests that the homogeneity seen in 
commercial isolates is a result of their industrial heritage and propagation practice.
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5. PHENOTYPIC DIVERSITY OF LACTOBACILLUS ISOLATES 
 
5.1. INTRODUCTION 
A range of biochemical, physiological, chemotaxonomic, and more recently, nucleic-acid-
based methods such as 16S rRNA gene sequence analysis and multilocus sequence typing 
(MLST) comprise the set of tools useful for obtaining a polyphasic identification and 
characterisation of both novel and known bacterial isolates (Sintchenko et al., 2007). 
Historically, the phenotypic methods for characterisation have informed today’s bacterial 
taxonomy. The advent of modern rapid, cost effective and highly accurate methods for 
analysing nucleic acids has caused phenotypic methods for characterising bacteria to take 
somewhat of a back seat in typing, identification and taxonomy. The application of 
techniques for accurately and rapidly identifying and characterising bacteria however, is 
essential to numerous fields in microbiology (De Bruyne et al., 2011). From a commercial 
probiotic perspective it is important to select bacterial isolates that have desirable 
phenotypic characteristics, particularly the ability to grow to high densities in as little time 
as possible.  
 
The characterisation of bacterial isolates by profiling their ability to ferment carbohydrate 
substrates has long been a staple method of distinguishing between LAB, and indeed forms 
the basis of the primary divisor of LAB into those that are obligately homofermentative, 
those that are obligately heterofermentative and those that are facultatively 
heterofermentative (Hammes and Vogel, 1995). The API 50 CH test evaluates the ability 
of isolates to ferment 50 carbohydrate substrates, allowing discrimination up to the species 
level when compared with a database of known biochemical profiles (Boyd et al., 2005). 
 
Matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-
TOF MS) is a novel rapid and high-throughput method, that has been recently introduced 
as a tool for bacterial taxonomy and characterisation, and has been applied to a number of 
taxa (Zhu et al., 2013) (Kern et al., 2013), including lactobacilli (Angelakis et al., 2011) 
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(Dušková et al., 2012). MALDI-TOF MS has the ability to analyse complex peptide 
mixtures, such as intact bacterial cells or total protein extracts from bacterial cultures.  
 
Previous chapters have indexed the diversity of Lactobacillus, particularly L. acidophilus 
at the nucleic acid level, finding little variation between L. acidophilus isolates. In this 
chapter the phenotypic diversity of L. acidophilus was examined at multiple taxonomic 
levels. At the species level, carbohydrate fermentation characteristics were evaluated, and 
at the isolate level growth parameters and gross proteomes were compared between 
isolates. 
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5.1.1. SPECIFIC AIMS 
 
The aims of this chapter were as follows: 
 
 Examine species-level differences in Lactobacillus in the metabolism of 
carbohydrates using API 50CHL and evaluate it as a method for identifying 
L. acidophilus. 
 
 
 Measure parameters of growth (length of lag phase, maximum growth rate 
and maximum culture density) of L. acidophilus to determine if isolate to 
isolate differences exist. 
 
 
 Evaluate the use of Matrix Assisted Laser Desorption/Ionisation – Time Of 
Flight (MALDI-TOF) mass spectrometry as a tool to examine the gross 
proteome of Lactobacillus isolates. 
 
 
 Assess the use of MALDI-TOF MS as an identification tool for Lactobacillus 
isolates on both the species and strain levels. 
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5.2. METHODS 
5.2.1. EVALUATION OF LACTOBACILLUS CARBOHYDRATE FERMENTATION PROFILES 
USING THE API 50CHL SYSTEM 
Lactobacillus isolates were grown on MRS agar at 37°C for 24 h, as described previously. 
As per the manufacturer’s instructions, single colonies from each culture were suspended 
in API 50 CHL medium (BioMérieux, France). The suspension was transferred into API 
50 CH strips (BioMérieux, France). All wells were overlaid with sterile mineral oil ensure 
anaerobic metabolism. API strips were incubated at 37°C as recommended by the 
manufacturer. Changes in the colour of wells were recorded after 24 and 48 h. API test kit 
results were interpreted using the Analytical Profile Index (API) database of the apiweb™ 
software (version 4.0; BioMérieux, Marcy l'Etoile, France).  
 
5.2.2. MEASURING LACTOBACILLUS GROWTH RATES 
 
5.2.2.1. Bioscreen C 
The growth dynamics of L. acidophilus isolates LMG 11470, LMG 11428, LMG 9433, 
NCFM, CUL 21, CUL60, Rm 344; L. casei LMG 6904 and six MMS exposed L. 
acidophilus (see Section 4.2.5) were examined using a Bioscreen Microbiolgical Growth 
analyser C (Labsystems, Finland). Lactobacillus isolates were cultured as previously 
described (Section 2.2.2). 3 ml overnight (18 h) cultures were diluted to an optical density 
of 1±0.2 (600nm), then diluted 10-fold and transferred to triplicate wells of a Bioscreen 
microplate (200 µl). Growth analysis was performed for 48 hours at 37°C; turbidity 
measurements were taken at 15 minute intervals using a wide-band filter (450-580 nm), 
after shaking the microplates for 10 seconds at an intermediate intensity. Experiments were 
repeated with different starting cultures to obtain two biological replicates with a combined 
total of six technical replicates.  
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5.2.2.2. Estimation of growth parameters  
Before analysis, to prepare the data, the mean optical density of triplicate blank wells (with 
no inoculum) was subtracted from each test well and growth curves were trimmed to 20 h 
to ensure that curves were fitted correctly. Growth parameters were then estimated using 
the gcFit function within the grofit package (Kahm et al., 2010) in R statistical software (R 
Development Core Team, 2012). Briefly, a model-free spline was fitted to logarithmically 
transformed optical density data (solid red line, Figure 5.1) and visually checked for 
accuracy. Any wells that generated poorly fitted splines were discarded from further 
analysis. Accurately placed splines were then used to estimate three growth parameters for 
each well; length of lag phase, maximum growth rate and maximum culture density 
reached (Figure 5.1). All of the above parameters were calculated for each well and 
exported from the software. 
 
5.2.2.3. Comparing growth parameters  
Growth parameters generated by Lactobacillus isolates were grouped, as in Chapter 4, into 
six groups; L. acidophilus culture collection isolates (LMG 11470, LMG 11428 and LMG 
9433), L. acidophilus commercial isolates (NCFM, CUL 21, CUL60 and Rm 344), non- L. 
acidophilus isolates (L. casei LMG 6904) and three groups of MMS exposed L. 
acidophilus NCFM isolates, one from each round of exposure to MMS (see Section 4.2.5). 
Boxplots were generated using the boxplot function in R statistical software (R 
Development Core Team, 2012).  
 
Data were tested for normality using the Shapiro-Wilk test in R statistical software (R 
Development Core Team, 2012). Significant differences between groups were investigated 
using the Kruskall-Wallis H-test followed by pairwise, post-hoc Mann-Whitney U tests 
with the familywise error rate controlled using Bonferroni correction in IBM Statistics 20 
(IBM Corporation, New York, US). 
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Figure 5.1: Three growth parameters calculated using grofit 
The three measured parameters are indicated with blue lines and describe the length of the lag phase, the 
maximum growth rate and the maximum culture density reached in each culture. 
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5.2.3. GROSS PROTEOME ANALYSIS USING MATRIX-ASSISTED LASER 
DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY (MALDI-TOF 
MS) 
 
5.2.3.1. Bacterial strains 
Proteomes of L. acidophilus isolates and isolates of other LAB were examined with 
MALDI-TOF MS (Table 5.1). Strains were resuscitated from charcoal transport swabs 
(Fisher Scientific, UK) onto MRS agar at 37 °C for 24h. After resuscitation, strains were 
grown anerobically on MRS agar at 37 °C for 24 h and checked for purity. Prior to 
MALDI-TOF MS analysis, the strains were subcultured at least twice. 
 
5.2.3.2. Sample preparation – “Cell extract” 
The crude protein sample preparation protocol is described in detail by De Bruyne et al 
(2011). Briefly, α-cyano-4-hydroxycinnamic acid (CHCA) (5 mg/ml):acetonitrile 
(ACN):water:trifluoroacetic acid (TFA) are combined in the ratio 50:48:2 to form a matrix-
organic solvent mixture as described by Williams et al (2003). Chemicals were of high 
performance liquid chromatography (HPLC) grade quality. 1 µL of bacterial cells 
(manipulated by Looplast® inoculation loops) was washed in HPLC grade water and 
ethanol. 70% formic acid and pure ACN were added in a 1:1 (v/v) ratio to the bacterial 
pellet, and the suspension mixed by vortex for 30 s. The supernatant, obtained after 
microcentrifugation, was then transferred into a new tube, forming the “cell extract”. Cell 
extracts (1.5 µL) were then transferred to the spot sites on a 384-well stainless steel target 
plate and air-dried for about 10 min. The matrix–organic solvent mixture (1 µL) was added 
to the spots and allowed to dry. Each sample was spotted at least in quadruplicate, to verify 
reproducibility. The samples were allowed to air-dry at room temperature, inserted into the 
mass spectrometer and subjected to MALDI-TOF MS analysis. 
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Table 5.1: Lactobacillus and Enterococcus isolates used in MALDI-TOF proteome analysis 
 
Species Isolates 
L. acidophilus                LMG 11428     
LMG 11430 
LMG 11470 
LMG 13550 
LMG 9433 
CUL21           
CUL60           
NCFM  
RM 344          
RM 345           
L. brevis                     LMG 6906 
L. casei                      LMG 6904 
L. gasseri                    LMG 9203 
L. johnsonii                  LMG 9436 
L. paracasei subsp. paracasei LMG 7955 
L. plantarum                  LMG 6907 
Enterococcus  faecium                   LMG 14205   
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5.2.3.3. MALDI-TOF MS sample analysis 
Prior to analysis, the mass spectrometer was externally calibrated with a peptide mix of 
adrenocorticotropic hormone (ACTH) (18-39), insulin (bovine), ubiquitine, cytochrome 
c and myoglobin. The matrix solution and external calibration peptide mix were mixed 
in a 1:1 (v/v) ratio and spotted (1 µl) on the designated calibration spots on the 384-well 
target plate. The 4800 Plus MALDI TOF/TOF™ Analyzer (Applied Biosystems, 
Framingham, MA, USA) was used in the linear mode. The mass spectrometer uses a 
200-Hz frequency tripled Nd:YAG laser, operating at a wavelength of 355 nm. Ions 
generated by the MALDI process were accelerated at 20 kV through a grid at 19.3 kV 
into a linear, field-free drift region and subsequently into the detector. The detector, an 
electron multiplier, detected and counted the generated ions. For each spot, 40 sub-
spectra for each of 50 randomized positions within the spot (2000 spectra/spot) were 
collected and presented as one main spectrum. MALDI-TOF mass spectra were 
generated in the mass range 2–20 kDa. Laser intensity was set between 3600 and 3800 
V, obtaining signal intensities between 5 × 102 and 1 × 104. Data were collected in an 
automated fashion using random sampling over the sample spot. 
 
5.2.3.4. Data pre-processing 
Raw data were extracted as .t2d files from the 4800 Plus MALDI TOF/TOF™ 
Analyzer. The t2d files were imported in the Data Explorer 4.0 software (Applied 
Biosystems, CA, USA) and transformed to text files. These text files consisted of an 
array containing the signal intensity for each 0.5 mass-to-charge ratio (m/z) value. A 
Data Explorer script (De Bruyne et al., 2011) was used to export the peak list of each of 
the samples from one spot set to separate text files, which were used as input files for 
the BioNumerics 6.0 software package (Applied-Maths, Sint-Martens-Latem, Belgium). 
In BioNumerics 6.0 a densitometric curve was reconstructed, plotting signal intensity 
against (m/z). This workflow was integrated into a script to facilitate the import of the 
normalized peak lists as densitometric curves. Since all measurements were performed 
after calibration of the 4800 Plus MALDI TOF/TOF™ Analyzer, data could be 
considered normalized, and additional normalization of the experiment type was not 
performed. Data were reduced and de-noised using the methods described by De 
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Bruyne et al (2011). The quality of each spectrum was evaluated using the following 
criteria; minimum signal intensity of 1000 units, less than 30% leading slope into 
spectrum and more than five peaks. Any spectra not meeting these criteria were 
removed from further analysis. 
 
5.2.3.5. Data analysis 
Similarities between densiometric curves generated by each spot were calculated using 
curve-based (Pearson Product Moment Correlation Coefficient, PMCC) measures and 
clustering was initially performed using the unweighted paired-group method with 
arithmetic mean (UPGMA) method. Multi-dimensional scaling (MDS) was used for the 
visualization of the likeliness of data, for example, for exploring similarities or 
dissimilarities. The MDS approach started with a matrix of data similarities generated in 
BioNumerics 6.0. This was then imported into IBM Statistics 20 and similarities were 
plotted in 2-dimensional space using a non-linear least squares fit, to minimise the 
distances between the data points, known as Multidimensional Scaling. The resulting 
data positions were visualised in a 2-dimensional scatter plot using Microsoft Excel. 
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5.3. RESULTS 
For clarity, the results were divided into three parts, the first (Section 5.3.1) concerns 
the elucidation of carbohydrate fermentation profiles of L. acidophilus isolates. These 
included two L. acidophilus isolates from the Cultech Lab4® probiotic supplement 
(CUL21 and CUL60), L. acidophilus isolates from culture collections, and L. casei (L. 
acidophilus) TBCC, which was re-classified from L. acidophilus to L. casei in Chapter 
2 based on its RAPD profile. The second part (Section 5.3.2) describes the comparison 
of growth characteristics of L. acidophilus isolates from culture collections, commercial 
applications and those that were exposed to the mutagen MMS (Section 4.2.5). The 
third (Section 5.3.3) compares gross proteomes of Lactobacillus isolates using MALDI-
TOF MS.  
 
5.3.1. CARBOHYDRATE FERMENTATION BY LACTOBACILLUS ISOLATES  
The API 50CHL test was used to evaluate the carbohydrate fermentation characteristics 
of L. acidophilus isolates. Figure 5.2 catalogues the ability of eight L. acidophilus 
isolates and L. casei TBCC to ferment 20 carbohydrate substrates. The fermentation 
characteristics of L. casei TBCC were markedly different to the L. acidophilus isolates 
tested. L. casei TBCC did not ferment D-maltose or sucrose, both of which were 
fermented by 100% of L. acidophilus isolates. L. casei TBCC was also able to ferment 
D-mannitol, arbutin, D-melezitose, D-tagatose and potassium gluconate, none of which 
were fermented by any L. acidophilus isolates (Figure 5.2). The apiweb™ fermentation 
profile analysis software classified this profile as L. paracasei subsp. paracasei, 
although it was still assumed to be a doubtful designation. Among L. acidophilus 
isolates, API 50 CHL profiles showed a large degree of heterogeneity. This was 
reflected in the apiweb™ classifications for each of the profiles, which classified five 
isolates as L. acidophilus with a good or acceptable profile, two isolates as L. 
acidophilus with doubtful or not valid profiles and a single isolate as Lactobacillus to 
the genus level (Figure 5.2).  
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Four carbohydrates; D-glucose, Esculin, D-maltose and D-saccharose were fermented 
by 100% of L. acidophilus isolates, with the fermentation of D-maltose and D-
saccharose clearly differentiating between L. casei TBCC and L. acidophilus isolates. 
D-galactose, D-fructose, D-mannose, salicin and D-trehalose were fermented by 87.5% 
of L. acidophilus isolates, although the lack of ability to ferment all of these substrates 
was not restricted to a single L. acidophilus isolate. L. acidophilus CUL 60 was able to 
ferment the largest array of carbohydrate substrates (15). L. acidophilus NCFM and 
LMG 11470 fermented 14 carbohydrates, LMG 11472 and LMG 11467 fermented 12, 
LMG 9433 fermented 11, and LMG 11428 and LMG 11466 fermented 10. There was 
no clear distinction in the fermentation profiles of isolates from culture collections (L. 
acidophilus LMG 11470, LMG 11472, LMG 11467, LMG 9433, LMG 11428 and 
LMG 11466) and those from commercial applications (L. acidophilus NCFM and 
CUL60). 
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Figure 5.2: Carbohydrate fermentation profiles of Lactobacillus isolates 
Carbohydrate fermentation profiles from API 50 CHL. Only tests that were positive in one or more 
isolates are included. Positive tests are coloured red. Indicated provisional identification was generated 
using apiweb™ software (bioMérieux UK, Basingstoke, UK). 
Test Active carbohydrate
GLU D-glucose 1 1 1 1 1 1 1 1 1 100
ESC Esculin 1 1 1 1 1 1 1 1 1 100
MAL D-maltose 0 1 1 1 1 1 1 1 1 100
SAC D-saccharose (sucrose) 0 1 1 1 1 1 1 1 1 100
GAL D-galactose 1 1 1 1 1 1 0 1 1 87.5
FRU D-fructose 1 1 1 1 1 1 0 1 1 87.5
MNE D-mannose 1 1 1 1 1 1 1 0 1 87.5
SAL Salicin 1 1 1 1 1 0 1 1 1 87.5
TRE D-trehalose 1 1 1 1 1 1 1 0 1 87.5
NAG N-acetylglucosamine 1 1 1 0 0 1 1 1 1 75
LAC D-lactose (bovine origin) 1 1 1 0 1 1 0 1 1 75
CEL D-cellobiose 1 1 1 1 1 0 0 0 1 62.5
GEN Gentiobiose 0 1 1 0 1 0 1 1 0 62.5
AMY Amygdalin 1 0 1 0 0 0 1 1 1 50
RAF D-raffinose 0 1 1 0 0 0 0 0 0 25
MAN D-mannitol 1 0 0 0 0 0 0 0 0 0
ARB Arbutin 1 0 0 0 0 0 0 0 0 0
MLZ D-melezitose 1 0 0 0 0 0 0 0 0 0
TAG D-tagatose 1 0 0 0 0 0 0 0 0 0
GNT Potassium gluconate 1 0 0 0 0 0 0 0 0 0
apiwebTM Provisional ID
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5.3.2. LACTOBACILLUS GROWTH CHARACTERISTICS 
L. acidophilus isolates were divided into five groups, the first representing culture 
collection isolates, the second commercial isolates and three groups representing the 
three rounds of exposure to MMS (see Chapter 4). L. casei LMG 6904 was included for 
comparison, as a non-L. acidophilus isolate. The growth kinetics of these groups are 
represented by three parameters defined in Figure 5.1, which include length of lag 
phase, maximum growth rate and maximum culture density. The spread of these data is 
shown in Figure 5.3. None of the data generated for any of the three parameters was 
normally distributed when tested with the Shapiro-Wilk test, so differences between 
groups were tested for significance using the non-parametric Kruskall-Wallis H-test, 
which was corrected for tied ranks, followed by post-hoc pairwise Mann-Whitney U 
tests with Dunn-Bonferroni correction.  
 
All growth parameters showed significant differences across groups. The Kruskal-
Wallis test revealed a significant effect of group on maximum culture density 
(χ2=83.51, d.f.=5, p < 0.01), maximum growth rate (χ2=49.39, d.f.=5, p < 0.01) and lag 
time (χ2=37.37, d.f.=5, p < 0.01).  Pairwise comparisons of groups for each growth 
parameter are given in Table 5.2. The non-L. acidophilus group grew to significantly 
higher maximum culture density than all other groups except MMS 3. No significant 
differences were observed between the culture collection and commercial groups, or 
between either of the latter groups and the MMS exposed groups. The culture collection 
group had a significantly lower maximum growth rate than all groups except the 
commercial group, between which there was no significant difference. Commercial 
isolates also had a lower maximum growth rate than the non- L. acidophilus group and 
the MMS 1 group. The MMS exposed groups (MMS 1, MMS 2 and MMS 3) had 
significantly longer lag phases than the culture collection group and the commercial 
group. No significant difference was observed in the lag phases of the commercial and 
culture collection groups, or between these groups and the non- L. acidophilus group. 
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Figure 5.3: Growth parameters of Lactobacillus isolates 
Growth parameters maximum culture density, maximum growth rate and length of lag phase are defined in Figure 5.1. Lactobacillus isolates are divided into groups representing 
isolates from culture collections (LMG 11470, LMG 11428 and LMG 9433), commercial applications (NCFM, CUL 21, CUL60 and Rm 344), non- L. acidophilus (L. casei 
LMG 6904) and isolates from three rounds of mutagenesis with MMS, as described in (Chapter 4). Boxes represent median and inter-quartile range; whiskers extend to 1.5 times 
the inter-quartile range, or the most extreme datum, whichever is closer to the median. Outliers are shown as circles outside whiskers. 
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Table 5.2: Significant differences in growth parameters between groups of Lactobacillus isolates 
Statistics are reported as effect size, followed by significance if greater than 0.05. Comparisons with no 
significant differences are reported with NSD. 
Maximum culture density
Culture collection
Commercial NSD
Non-L. acidophilus 5. 61, <0.01 3. 91, <0.01
MMS 1 NSD NSD 4. 08, <0.01
MMS 2 NSD NSD 4. 56, <0.01 NSD
MMS 3 3. 61, <0.01 NSD NSD NSD NSD
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Max growth rate
Culture collection
Commercial NSD
Non-L. acidophilus 4. 84, <0.01 3.19, <0.05
MMS 1 5. 56, <0.01 3.27, <0.05 NSD
MMS 2 4. 08, <0.01 NSD NSD NSD
MMS 3 4. 91, <0.01 NSD NSD NSD NSD
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Lag phase
Culture collection
Commercial NSD
Non-L. acidophilus NSD NSD
MMS 1 8. 15, <0.01 6.45, <0.01 3.42, <0.01
MMS 2 5. 18, <0.01 3.25, <0.05 NSD 2.97, <0.05
MMS 3 5. 34, <0.01 3.53, <0.01 NSD NSD NSD
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5.3.3. COMPARISON OF THE GROSS PROTEOME OF LACTOBACILLUS ISOLATES 
MALDI-TOF MS was used to examine the gross proteome of Lactobacillus isolates with 
particular emphasis on L. acidophilus isolates. A scaling workflow of data analysis was 
undertaken, represented by the progression of data quantity displayed in three MALDI-
TOF profiles in Figure 5.4, to tens of profiles analysed and displayed in Figure 5.5, to 
finally hundreds of profile similarities easily visualised in Figure 5.6. 
When visualised at the single profile level with no similarity analysis undertaken (Figure 
5.4), L. acidophilus profiles are visually similar, and the included L. brevis profile is 
markedly different. When examined based on MALDI-TOF profile similarity (Figure 5.5), 
all L. acidophilus isolates cluster together at greater than 81% MALDI-TOF profile 
similarity. Repeat testing of the same isolates of L. gasseri LMG 9203, L. johnsonii LMG 
9436 and E. faecium LMG 14205 show profile stabilities of 95.7%, 94.7% and 94.5% 
respectively (Figure 5.5). The MALDI-TOF profiles generated by L. gasseri LMG 9203 
and L. johnsonii LMG 9436 show 64.6% similarity to each other (Figure 5.5). 
 
Non-metric multidimensional scaling (nMDS) allows the visualisation of hundreds of 
MALDI-TOF profiles in low-dimensional (in this case two-dimensional) space. More 
similar MALDI-TOF profiles are plotted as points with low Euclidian distances between, 
and more dissimilar MALDI-TOF profiles are plotted more disparately on a set of arbitrary 
axes. When applied to Lactobacillus isolates, this approach visualised the high level of 
MALDI-TOF profile conservation of repeat tests of the same strain i.e. profiles generated 
by the same isolate occupy similar space within the nMDS plot (Figure 5.6). L. gasseri 
LMG 9203 and L. johnsonii LMG 9436 occupy a similar area on the nMDS plot (Figure 
5.6), although their profiles share 64.5 % similarity (Figure 5.5). All other Lactobacillus 
species formed distinct clusters (Figure 5.6). All L. acidophilus isolates shared the same 
area on the nMDS plot, although diversity in profiles can be observed (81.0% profile 
similarity in Figure 5.5 and distance between points in (Figure 5.6). To reflect the two 
groups of L. acidophilus genotypes observed in Chapter 4 and Section 5.3.2, the MALDI-
TOF nMDS plot was coloured to represent culture collection and commercial L. 
acidophilus. No clear distinction was seen in the graph area occupied by these two groups. 
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This indicates that the diversity of L. acidophilus MALDI-TOF profiles generated by L. 
acidophilus isolates cannot be explained by differences between these two groups. 
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Figure 5.4: MALDI-TOF spectra of three Lactobacillus isolates and their relation to MALDI-TOF 
fingerprints 
Signal intensity (y-axis) is plotted against m/z (x-axis). MALDI-TOF profiles are given for three 
Lactobacillus isolates; L. acidophilus CUL 60 (blue), L. acidophilus Rm 345 (green) and L. brevis LMG 
6906 (orange). Their corresponding MALDI-TOF fingerprints are given above the spectra, with peaks of 
greater intensity represented as darker bands. 
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Figure 5.5: Clustered MALDI-TOF profiles generated by Lactobacillus isolates 
L. johnsonii (orange), L. gasseri (blue), L. acidophilus (red) and E. faecium (green) MALDI-TOF profiles 
were clustered using BioNumerics 6.0 (Applied Maths, Belgium). Pearson correlation similarity coefficient 
with a UPGMA dendrogram type was used, and position tolerance optimisation was set to 2%. Pertinent 
profile similarity values are indicated in red text adjacent to the corresponding node. 
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Figure 5.6: Diversity of Lactobacillus MALDI-TOF profiles 
MALDI-TOF profile distance scores are plotted in two dimensions, axes are arbitrary. Distances between profiles are represented by Euclidian distance, i.e. more similar profiles 
are plotted as points closer together. Distances were calculated using the Pearson correlation similarity coefficient and position tolerance optimisation was set to 2%. Coordinates 
were calculated using multidimensional scaling. .
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Figure 5.7: Diversity of L. acidophilus MALDI-TOF profiles 
MALDI-TOF profile distance scores are plotted in two dimensions, axes are arbitrary, as previous (Figure 5.6). L. acidophilus isolates were grouped into commercial and culture 
collection isolates as described previously (see Chapter 4). Distances were calculated using the Pearson correlation similarity coefficient and position tolerance optimisation was 
set to 2%. Coordinates were calculated using multidimensional scaling. 
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5.4. DISCUSSION 
 
5.4.1. CARBOHYDRATE FERMENTATION PROFILES OF L. ACIDOPHILUS ISOLATES 
A diverse range of carbohydrate fermentation characteristics were observed within L. 
acidophilus, and identifications with the associated database (apiweb™) varied in veracity 
and taxonomic-level discrimination. A previous, comprehensive study of the diversity 
within the L. acidophilus group using a polyphasic approach used API as a part of that 
approach. Two distinct fermentation profiles for two L. acidophilus  isolates (NCFM and 
ATCC 11975) that had been thoroughly characterised using comparative nucleic acid 
sequences at all levels from single functional genes to whole genomes were found (Berger 
et al., 2007). The degree of variability in API fermentation profiles displayed by L. 
acidophilus isolates in this study and previously (Berger et al., 2007), means that it is 
difficult to identify isolates based on carbohydrate fermentation profile alone and indeed 
the European Union-funded “Biosafety Assessment of Probiotics used for Human 
Consumption” (PROSAFE) project recommend that biochemical systems (such as API 50 
CHL) should not be used as a stand-alone approach for identification of probiotic cultures. 
These systems may be useful to obtain a first tentative classification at the genus level in 
conjunction with primary phenotypic tests, but the identification result should in any case 
be confirmed by other (molecular) methods, forming the basis of the polyphasic taxonomy 
required for accurate identification and typing of LAB (Vankerckhoven et al., 2008). The 
value of polyphasic typing methods is exemplified in the case of L. casei (L. acidophilus) 
TBCC, whose partial 16S rRNA gene sequence was not sufficient to identify the isolate 
correctly. Comparative analysis of carbohydrate fermentation ability in this chapter (Figure 
5.2) and RAPD profile (see Chapter 2) have shown that this isolate does not belong to L. 
acidophilus. It was doubtfully classified as L. paracasei subsp. paracasei by apiweb™, did 
not produce a RAPD profile that was similar to L. paracasei subsp. paracasei, and showed 
greater than 75% RAPD profile similarity to L. casei LMG 6904 (see Chapter 2). 
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5.4.2. GROWTH KINETICS 
Diversity in L. acidophilus growth characteristics was observed, and differences were 
measureable at a statistically significant level. The most marked differences between 
groups were seen between L. acidophilus isolates and the non- L. acidophilus out-group. 
This was particularly exemplified by the greater culture density reached by the non- L. 
acidophilus group, which was significantly higher than all other groups except the MMS3 
group containing isolates exposed to MMS three times. The ability of an isolate to grow to 
high densities is presumably a useful trait from a commercial probiotic perspective, 
particularly in the case of large-scale cultures that are freeze-dried and added into dairy 
products, but in capsules. Within the L. acidophilus groups, no significant differences in 
any growth characteristics were observed between the culture collection and commercial 
groups, which were assigned to isolates based on the diversity of their genome sequences 
(see Chapter 4). This indicates that the small differences observed in gene sequence and 
content between these groups isolates do not have a significant impact on their growth 
characteristics. It should be noted however, that translating these effects from the 
microculture discussed in this chapter to the large-scale cultures required for industrial 
production of probiotic products should be done with caution, as just a small increase in 
the size of the culture vessel may have profound effects on the growth characteristics of a 
particular strain (Arnold et al., 1999). 
 
The groups containing isolates that were exposed to MMS once, twice or three times 
(MMS1, MMS2 and MMS3 respectively) were originally derived from L. acidophilus 
NCFM, a member of the commercial L. acidophilus group. Drawing comparisons between 
the MMS exposed isolates and the commercial L. acidophilus group showed no significant 
difference in overall culture density reached. The MMS1 group had a weakly (p<0.05) 
significantly increased growth compared to the commercial L. acidophilus group, but no 
other growth-rate effects were observed. The effect of MMS exposure is most obviously 
observed when comparing the lag-times of exposed isolates to their parent culture 
collection isolates; all are significantly longer. The phenomenon of sub-lethal stress 
resulting in increased culture lag-times is well documented in Lactobacillus (Smelt et al., 
2002) and other genera (Guillier et al., 2005), and it appears that exposure to MMS has 
induced the same response in L. acidophilus NCFM. 
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5.4.3. MALDI-TOF MS PROFILING OF LACTOBACILLUS ISOLATES 
Several recommendations were made by the EU-PROSAFE project as areas for further 
research in the area of identification of LAB (Vankerckhoven et al., 2008). MALDI-TOF 
MS profile analysis was implicated as a highly desirable, rapid and cost-effective 
phenotypic method to augment and validate sequence-based taxonomy and identification 
schemes for commercial probiotic LAB cultures (Vankerckhoven et al., 2008). Automated 
systems using MALDI-TOF MS to identify unknown isolates are already commercially 
available (Bruker Daltonik GmbH, 2010), but identification by these systems is achieved 
by matching new MALDI-TOF profile entries with a database of known profiles and 
calculating similarity scores (Bruker Daltonik GmbH, 2010). The approach used in this 
chapter used only data generated by this study in a purely comparative way. As the 
characterisation of the isolates tested has been undertaken on multiple levels, from DNA 
fingerprinting (see Chapter 2) to whole genome sequence (see Chapter 4), this chapter 
describes a purely comparative study that illustrates the power of MALDI-TOF MS profile 
analysis to both accurately place similar Lactobacillus  isolates close together, and 
disparate isolates further apart (Section 5.3.3; Figure 5.6). The developed workflow 
allowed visualisation and validation of data on multiple scales, from comparisons of single 
MALDI-TOF MS spectra, to comparisons of more than 100 Lactobacillus profiles. 
MALDI-TOF MS profile analysis has been shown to accurately resolve closely related 
LAB species in the genera Leuconostoc and Pediococcus (De Bruyne et al., 2011), and the 
data presented in this chapter suggest that it is a similar case for Lactobacillus. MALDI-
TOF MS profile analysis also has the potential to resolve isolates at the sub-species level 
(Vargha et al., 2006), with a strain-level resolution comparative to that of MLST in certain 
studies (De Bruyne et al., 2011). The advantages of MALDI-TOF include that it does not 
require genomic DNA, removing the cultivation step before DNA extraction required for 
MLST; that it requires no previous knowledge of DNA sequence in order to design 
efficient PCR primers targeting housekeeping genes which is essential for MLST and that 
bacterial colonies may be analysed directly, enabling extremely fast typing of isolates. 
 
When applied to Lactobacillus isolates from food products using the Bruker BioTyper 
system (Bruker Daltonik GmbH, 2010), MALDI-TOF MS and PCR-based identification 
concurred in 95.6% of isolates (Dušková et al., 2012). The approach taken in this chapter 
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was able to classify all Lactobacillus species tested into different profile types, with the 
exception of L. gasseri LMG 9203 and L. johsonii LMG 9436, both closely related 
members of the L. acidophilus phylogenetic subgroup. This again illustrates the value of a 
polyphasic approach to typing, as the additional information gathered from RAPD profile 
similarity analysis (see Chapter 2) allows the classification of these two isolates as two 
distinct taxa. 
 
When considered as a single taxonomic entity, L. acidophilus isolates generated diverse 
MALDI-TOF profiles, although all isolates were more similar to other L. acidophilus 
isolates than any other Lactobacillus species, and no obvious divergent groups of L. 
acidophilus were observed (Figure 5.6). When divided into the groups devised by genomic 
analysis (see Chapter 4), the diversity of MALDI-TOF profiles both within and between 
culture collection and commercial isolates was approximately equal (Figure 5.7), i.e. the 
variation in MALDI-TOF profiles generated by L. acidophilus isolates was not associated 
with their genome sequence. Additionally, the most genomically homogenous group of L. 
acidophilus isolates, those from commercial probiotic products, generated a range of 
MALDI-TOF profiles similar in diversity to the more genomically diverse culture 
collection isolates (Figure 5.7). In a species that shows greater genomic conservation than 
L. acidophilus; Bifidobacterium animalis subsp. lactis, MALDI-TOF profiles were seen to 
vary by up to 4% (Ruiz-Moyano et al., 2012). This shows that there is at least some 
MALDI-TOF profile variation that cannot be explained by genetic diversity been isolates, 
and is more likely attributable to sample preparation and growth conditions (Liu et al., 
2007). 
 
5.4.4. SUMMARY AND PERSPECTIVE 
The variation in phenotypic characteristics of L. acidophilus isolates observed in this 
chapter is typical of phenotypic approaches to characterising bacteria in general. The 
phenotype of a particular isolate may be influenced by a vast array of external factors, 
including but not limited to culture conditions (e.g. temperature and oxygen availability) 
stress and growth phase. This makes generating consistent results particularly difficult, and 
because of this, phenotypic approaches have been complemented and to a large extent 
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superseded by genotypic approaches (Stackebrandt et al., 2002). As identified by the EU-
PROSAFE project (Vankerckhoven et al., 2008), the accurate identification of probiotic 
cultures is imperative, particularly if they are sold commercially. This chapter emphasises 
the requirement for a polyphasic approach to probiotic characterisation, and using both 
genotypic and phenotypic elements as part of that approach ensures a comprehensive 
description of a probiotic culture. 
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5.5. CONCLUSIONS 
 
The main conclusions from this chapter are as follows: 
 
5) Carbohydrate fermentation profiles of L. acidophilus isolates vary considerably. 
The API 50 CHL test was unable to classify well classified isolates based on 
carbohydrate fermentation ability alone.  
 
 
6) The carbohydrate fermentation profile of L. casei (L. acidophilus) TBCC was 
markedly different to L. acidophilus profiles. The reclassification of this isolate 
based on RAPD profile analysis is supported by the API 50 CHL test. 
 
 
7) There were no significant differences in maximum culture density, maximum 
growth rate or lag time between culture collection and commercial L. acidophilus 
isolates.  
 
 
8) MMS exposed L. acidophilus isolates did not grow to different culture densities or 
with different maximum growth rates to their parent, commercial L. acidophilus 
group. The lag phase of all MMS exposed isolates was significantly longer than the 
commercial L. acidophilus group. 
 
 
9) MALDI-TOF profile analysis was able to differentiate all tested Lactobacillus 
species, with the exception of L. gasseri and L. johsonii. L. acidophilus isolates 
showed diversity in their generated MALDI-TOF profiles which was not related to 
their genotypes.   
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6. COMPARATIVE GENOMICS OF COMMERCIAL BIFIDOBACTERIUM 
STRAINS 
 
6.1. INTRODUCTION 
The human GIT is host to a large, diverse and dynamic microbial community, of which 
Bifidobacterium is a dominant genus (Gill et al., 2006). The overall number and 
composition of bifidobacterial species in the human intestine is dynamic over time 
(Barrangou et al., 2009). From birth, particularly following vaginal delivery, the GIT of 
healthy neonates is colonised by bifidobacteria, especially in breast-fed infants during early 
life (Jost et al., 2012). Variation in the composition of the gut microbiota between 
individuals however, is remarkable in infants (Jost et al., 2012), and this is reflected in the 
variation of dominant genera seen in different metagenomic studies of the human gut 
microbiota (Gill et al., 2006, Palmer et al., 2007, Ley et al., 2008). The microbiome of the 
infant GIT becomes more diverse as the diet encompasses greater complexity, although 
Bifidobacterium is typically the dominant genus until weaning (Jost et al., 2012).  
 
Bifidobacteria are also intensively used in functional foods, as they may exert a health 
benefit on their human host (see Chapter 1). The causal molecular mechanisms for these 
health-promoting activities however, are still relatively uncharacterised. Recently, the 
sequencing and analysis of genome sequences of probiotic bacteria, specifically aimed at 
the discovery of genetic determinants responsible for the adaptation to the gastrointestinal 
tract of their host, has been referred to as “probiogenomics” (Ventura et al., 2012). 
Combined with in vivo and in vitro characterisation of bacterial-host interactions, 
probiogenomics offers a powerful means to elucidate the molecular mechanisms behind 
beneficial probiotic effects. 
 
Bifidobacterium animalis subsp. lactis is a Gram-positive lactic acid bacterium commonly 
found in the GIT of healthy humans (Turroni et al., 2009). From a probiotic perspective, 
the benefits associated with strains of B. animalis subsp. lactis have resulted in their 
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inclusion in the human diet via a large array of dietary supplements and foods, including 
dairy products such as yoghurts (Barrangou et al., 2009). As a result, B. animalis subsp. 
lactis has become the most common bifidobacterium species utilised as a probiotic in 
commercial dairy products in North America and Europe (Gueimonde et al., 2004).  
Despite this extensive commercial and probiotic importance, the strain-level differentiation 
of B. animalis subsp. lactis using classical genotyping techniques such as PFGE (Section 
1.5.1.1) has been hindered by the high genetic similarity of these organisms. Fortunately, 
the availability of genome sequences for nine B. animalis subsp. lactis isolates (Table 1.6) 
allows an unprecedented ability to identify the genetic and pan-genome variation within 
this species and in comparison to other members of the genus. From examination of these 
genomes, the extent of genetic variability occurring among members of B. animalis subsp. 
lactis has been shown to be remarkably low (Milani et al., 2013).  
 
Studies of the ecology of Bifidobacterium bifidum show a similar niche to B. animalis 
subsp. lactis, as another dominant species within the infant GIT microbiota (Turroni et al., 
2009). In contrast to B. animalis subsp. lactis, gross genomic statistics relating to draft and 
complete genome sequences of B. bifidum strains show that genome size, GC (%) content 
and number of ORFs are variable between strains. B. bifidum strains have also seen use in 
multiple probiotic and food supplements (Shah et al., 1995, Masco et al., 2005), including 
the Lab4® formulation used by Cultech Ltd. As a final component of this PhD study, 
phylogenomic analysis of B. bifidum and B. animalis subsp. lactis isolates was conducted 
to examine the genomic similarity and phylogenetic placement of two commercial 
Bifidobacterium isolates, B. bifidum CUL 20 and B. animalis subsp. lactis CUL 34, used as 
part of the Lab4® probiotic produced by Cultech Ltd.  
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6.1.1. SPECIFIC AIMS 
 
The aims of this chapter were as follows: 
 
 Obtain draft genome sequences for two commercial Bifidobacterium isolates, 
Bifidobacterium bifidum CUL 20 and Bifidobacterium animalis subsp. lactis 
CUL 34 
 
 
 Use comparative genomics to establish the evolutionary history and 
phylogenetic placement of commercial isolates 
 
 
 Develop molecular markers for detecting Bifidobacterium bifidum at the 
species level 
 
 
 Test molecular markers in culture independent approach to establish their 
efficacy and investigate distribution of bifidobacteria within the GIT. 
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6.2. METHODS 
 
6.2.1. COMMERCIAL BIFIDOBACTERIUM GENOME RESEQUENCING 
As previously (see Section 4.2.1.2), high molecular weight genomic DNA was extracted 
from the growth of single-colony overnight cultures (see Section 2.2.2) with a Wizard 
genomic DNA purification kit (Promega, Southampton, United Kingdom), following the 
manufacturer’s instructions. Genomic DNA libraries were prepared and single-reads were 
sequenced by GATC Biotech (Konstanz, Germany) using an Illumina HiSeq2000 with 50 
bp sequence read length. Genome sequences were assembled using Velvet version 1.2.01 
shuffle and optimisation scripts, creating contigs with optimal parameters, with k-mer 
lengths between 21 and 51 bp (Table 6.1) (Zerbino, 2010, Cody et al., 2013). Assembled 
data were deposited in the PubMLST database as implemented by the Bacterial Isolate 
Genome Sequence Database (BIGSDB) software platform (Jolley and Maiden, 2010). To 
supplement and contextualise the new sequence information generated by this study, 
further completed and draft genome sequence data from strains of B. bifidum, B. animalis 
subsp. lactis  and other bifidobacteria were downloaded from the Integrated Microbial 
Genomes (IMG) database (Markowitz et al., 2010) and also deposited into the PubMLST 
database (Table 6.2). 
 
6.2.2. GENOMIC DIVERSITY ANALYSIS OF BIFIDOBACTERIA USING RMLST 
Relationships between Bifidobacterium genomes, from genus- to strain-level, were 
identified using phylogenetic networks based on rMLST sequences. The 53 ribosomal 
subunit loci identified in the automated annotation process (described in Section 4.2.2) 
were compared among all isolates using the BIGSDB Genome Comparator module. The 
distance matrix generated on the basis of shared alleles was visualized with the Neighbor-
Net algorithm (Bryant and Moulton, 2004), implemented in SplitsTree version 4.8 (Huson 
and Bryant, 2006) within the BIGSDB Web-interface (Jolley and Maiden, 2010). 
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6.2.3. GENOMIC DIVERSITY ANALYSIS OF B. BIFIDUM AND B. ANIMALIS SUBSP. LACTIS 
STRAINS USING “GENOME-WIDE” MLST 
Genome sequences of B. bifidum and B. animalis subsp. lactis isolates were analysed at the 
strain level using BIGSDB Genome Comparator. The genome sequences of B. animalis 
subsp. lactis strains were compared at all loci defined in the genome sequence of the type 
strain DSM 10140 (GenBank accession: CP001606). For the B. bifidum genomes loci 
comparison was made against those defined in B. bifidum BGN4 (GenBank accession: 
CP001361) because it was the genome sequence with the largest number of defined loci 
currently available. Presence/absence of each locus in all genomes was established and 
sequence variation indexed at each locus, using the approach described in Chapter 4. 
 
6.2.4. DEVELOPMENT OF SPECIFIC MARKERS FOR B. BIFIDUM 
Regions of the B. bifidum genome that were unique to this species were found using 
INSIGNIA (Phillippy et al., 2009). Their distribution in all B. bifidum genomes including 
B. bifidum CUL 20 was confirmed using the BlastN function implemented by the BIGSDB 
(Jolley and Maiden, 2010).  PCR primers targeting a selected unique region (ORF 
BBB_0726; see results) were designed using Primer3 (Table 6.3) (Rozen and Skaletsky, 
2000). A second set of nested PCR primers was designed in the same way to improve on 
the sensitivity of the PCR (see Section 2.2.6).  The specific marker PCR was tested on total 
faecal DNA extracted from the faeces of 10 healthy human adult males taking part in a 
Lab4® probiotic feeding trial (see Section 2.3.3.2). DNA samples tested corresponded to 
pre-feeding time points when the individuals were not taking probiotic containing B. 
bifidum CUL20 and 3 additional probiotic bacteria (see Chapter 1). 
 
A nested PCR test for the presence of the region specific to B. bifidum was carried out as 
follows. A 25 µl PCR mixture was set up as follows: 1x PCR buffer, 1x Q-solution, 100 
µM final concentration of dNTPs, 0.4 µM final concentration of each primer, 2 µl of 
template DNA (extracted from total faecal DNA (Sections 2.2.10 and 2.2.11) or from the 
first round of PCR), and 1 U of Taq DNA polymerase. The nested PCR was carried out in 
two stages using a BioRad C1000 thermal cycler (BioRad, Hemel Hempstead, United 
Kingdom) the first using the program; 94°C for 180 sec, then 30 cycles of 30 sec at 94ºC, 2 
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min at 59ºC, 60 sec at 72ºC, then a final step at 72ºC for 10 min. The product from this 
PCR was then used as the template DNA for the second round of PCR using the same 
program. The resulting PCR products were visualised by agarose gel electrophoresis on a 
1.5% (w/v) gel. 
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Table 6.1: Commercial Bifidobacterium isolates resequenced as part of this study 
Species Strain 
Number of 
sequence reads 
Read 
Length 
Contig 
N50 
Number of 
contigs >1kb 
Bifidobacterium animalis subsp. lactis CUL 34 16792017 51 50662 60 
Bifidobacterium bifidum CUL 20 23278433 51 56725 85 
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Table 6.2: Bifidobacterium genome sequences used in this study 
 
Species Strain Source Genome status 
rMLST 
type 
Bifidobacterium animalis subsp. lactis Bl-04 human fecal finished 1 
Bifidobacterium animalis subsp. lactis DSM 10140 yogurt finished 2 
Bifidobacterium animalis subsp. lactis HN019 draft 1 
Bifidobacterium animalis subsp. lactis BB-12 finished 1 
Bifidobacterium animalis subsp. lactis V9 human faeces finished 1 
Bifidobacterium animalis subsp. lactis B420 finished 1 
Bifidobacterium animalis subsp. lactis Bi-07 finished 1 
Bifidobacterium animalis subsp. lactis CUL 34 Cultech Draft; this study 1 
  
Bifidobacterium bifidum NCIMB 41171 human Draft 3 
Bifidobacterium bifidum IPLA 20015 Draft 4 
Bifidobacterium bifidum LMG 13195 Draft 5 
Bifidobacterium bifidum S17 Finished 6 
Bifidobacterium bifidum PRL2010 Finished 7 
Bifidobacterium bifidum BGN4 human feces Finished 8 
Bifidobacterium bifidum CUL 20 Cultech Draft; this study 9 
  
Bifidobacterium breve DSM 20213 human Draft 10 
Bifidobacterium catenulatum DSM 16992 human Draft 11 
Bifidobacterium dentium ATCC 27678 human Draft 12 
Bifidobacterium gallicum DSM 20093 human Draft 13 
Bifidobacterium longum DJO10A human Finished 14 
Bifidobacterium longum NCC2705 infant faecal Finished 15 
Bifidobacterium pseudocatenulatum DSM 20438 human Draft 16 
Genome sequences generated in this study are indicated in bold text 
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 Table 6.3: PCR primers for B. bifidum ORF BBB_0726 specific marker region 
PCR Primer  Melting temp PCR Primer Sequence PCR product size (bp) 
Bbif_F 60.14 GTGACGATTGCGATACGTTG 413 
Bbif_F 59.83 CAGCGGTAATAGCTCGATCC 
Bbif_NEST_F 60.16 CGATGAAACCGGATATGACC 106 
Bbif_NEST_R 59.99 TCGAGCACCTGACTGATGAC 
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6.3. RESULTS 
This results section is divided into three sections as follows. The first applied comparative 
genomic methods, to examine genus and strain level diversity of Bifidobacterium using 
rMLST. The second applied intraspecies, genome-wide comparisons of B. bifidum and B. 
animalis subsp. lactis genomes, respectively, to examine the diversity of each species at all 
protein coding loci as defined by a reference genome sequence. The third evaluated a PCR 
test for the presence of B. bifidum using a specific marker sequence identified via a 
comparative genomics approach (Phillippy et al., 2007, Phillippy et al., 2009). 
 
6.3.1. APPLICATION OF RMLST TO BIFIDOBACTERIUM GENOMES 
rMLST was applied to the genome sequences of eight bifidobacterial species, including 
two isolates resequenced as part of this study; B. animalis subsp. lactis CUL34 and B. 
bifidum CUL 20. A Neighbour-net generated from the concatenated sequences of 52 rps 
protein coding loci placed B. bifidum CUL 20 within a diverse group of other B. bifidum 
isolates (Figure 6.1). In contrast, the B. animalis subsp. lactis CUL 34 strains was located 
within a group of highly related B. animalis subsp. lactis genomes, which were not clearly 
resolved by Neighbour-net analysis (Figure 6.1). Correlating to this observation, each B. 
bifidum genome tested had a unique rMLST profile (rMLST type 3 – 9; Table 6.2), while 
all rMLST profiles generated for B. animalis subsp. lactis isolates were identical (sequence 
type 1; Table 6.2), with the exception of B. animalis subsp. lactis DSM 10140, which 
differed by a single nucleotide at a single locus resulting in a different overall rMLST type 
(rMLST type 2; Table 6.2). 
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Figure 6.1: Bifidobacterium genus rMLST Neighbour-net 
The analysis was based on the concatenated sequences of 53 ribosomal protein coding loci. An overall fit of 99.99 % indicated that this network accurately represented the 
original sequence data. Nodes are coloured by species and Cultech isolates are labelled in bold text. 
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6.3.2. GENOME-WIDE MLST  
As rMLST was unable to differentiate B. animalis subsp. lactis isolates, genome-wide 
MLST (Section 4.2.3.1) was used to compare genome sequences of eight isolates. When 
searched for protein coding loci defined in genome sequence of the B. animalis subsp. 
lactis type strain, DSM 10140, of 1560 defined loci 1554 (99.6%) were found in all B. 
animalis subsp. lactis genomes tested (Figure 6.2). Of the remaining six protein coding 
loci, five were absent only from B. animalis subsp. lactis HN019 and a single protein 
coding locus absent from B. animalis subsp. lactis CUL 34 (Table 6.4). When examined at 
the sequence level in all B. animalis subsp. lactis isolates, just 58 loci were found to have 
coding sequences with internal nucleotide diversity. 1470 (94%) loci had identical 
sequences in all isolates, while 26 loci were found to have identical sequences in all 
isolates apart from B. animalis subsp. lactis DSM 10140. 
 
In contrast, B. bifidum was considerably more diverse when all protein coding loci 
corresponding to those defined in the genome sequence of B. bifidum BGN4 were 
examined. The mean B. bifidum genome size was larger (2.2 Mb ± SEM = 0.014) than that 
of B. animalis subsp. lactis genome (1.94 ± SEM = 0.002), and had 17% more protein 
coding loci defined within its genome sequence. Of the 1835 protein coding loci defined in 
the B. bifidum BGN4 genome sequence, 1565 (85%) were present in all other B. bifidum 
genome sequences analysed (Figure 6.2). 18 (<1%) protein coding loci defined in the 
genome sequence of B. bifidum  BGN4 were identical in all other B. bifidum strains at the 
sequence level (Table 6.5). When the sequences of the shared loci of B. bifidum were 
analysed, there was no evidence of groups of genome sequences, each sequence was 
equally as distant from those within the other genome sequences.  
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Table 6.4: Loci absent from B. animalis subsp. lactis HN019 and CUL 34 
 
 
 
 
 
X indicates missing locus 
T indicates truncated locus 
 
Locus Product 
Sequence 
length 
Genome 
position HN019 CUL 34 
Balat 0510 50S ribosomal protein L31 210 604073 X T 
Balat 0523 50S ribosomal protein L31 213 622554 X T 
Balat 1572 
ABC transporter solute-
binding protein 1335 1854711 T X 
Balat 1582 NAD synthetase 537 1868120 X - 
Balat 1583 NAD+ synthetase 1335 1868691 X - 
Balat 1584 hypothetical protein 270 1870189 X - 
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Figure 6.2: Percentage of protein coding loci found in B. animalis subsp. lactis strains and B. bifidum 
strains 
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Table 6.5: Protein coding loci with identical DNA sequence in all B. bifidum genomes  
 
 
 
 
 
 
 
 
 
 
Locus Product Sequence length Genome position 
BBB 0216 hypothetical protein 126 263969 
BBB 0298 ribosomal protein L28 195 358485 
BBB 0337 hypothetical protein 252 403695 
BBB 0386 hypothetical protein 273 464161 
BBB 0565 hypothetical protein 69 698955 
BBB 0619 DNA-binding protein 282 759720 
BBB 0786 modification methylase 246 954966 
BBB 0995 hypothetical protein 147 1195074 
BBB 1290 hypothetical protein 219 1537073 
BBB 1379 ribosomal protein L31 213 1648437 
BBB 1431 conserved hypothetical transmembrane protein 132 1705113 
BBB 1498 ribose 5-phosphate isomerase A 699 1793503 
BBB 1499 hypothetical protein 90 1794369 
BBB 1522 ribosomal protein L30 183 1822970 
BBB 1527 30S ribosomal protein S14 type Z 186 1825301 
BBB 1565 hypothetical protein 117 1859690 
BBB 1674 aspartyl/glutamyl-tRNA (Asn/Gln) amido transferase subunit C 330 1996481 
BBB 1842 ribosomal protein L34 135 2223178 
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6.3.3. DEVELOPMENT AND TESTING OF A PCR TEST FOR THE PRESENCE OF B. BIFIDUM  
Using INSIGNIA, the single copy ORF defined as BBB_0726 which encoded a 
predicted phosphomannomutase within the genome sequence of B. bifidum BGN4 was 
selected as a likely unique marker for B. bifidum. The ORF had the following features: 
(i) 1176 bp in length; (ii) encoded a protein of 275 amino acids, with a predicted 
molecular mass of 29,937 Da; and (iv) encoded a phosphomannomutase Pfam domain 
predicted to be involved in the synthesis of GDP-mannose and dolichol-phosphate-
mannose. 
 
To establish the wider prevalence and conservation of ORF BBB_0726, its nucleotide 
sequence was used to probe all Bifidobacterium genome sequences available at the 
BIGSDB using BlastN (Table 6.6).  Only B. bifidum genomes showed the presence of the 
complete sequence, producing, 1176 bp alignment lengths that were representative of 
conservation of across the entire gene sequence.  The alignments were used to design 
specific PCR markers for B. bifidum specifically avoiding any mismatches; similarly, 
nested PCR primers were designed to internal conserved regions of BBB_0726 to allow 
potential detection of low levels of B. bifidum DNA. 
 
The B. bifidum specific markers were tested on total faecal DNA prepared from XX 
healthy male adults enrolled on a probiotic (Lab4®) feeding trial in a semi-quantitative 
manner, as no detection limits were defined for this test. After a first round of PCR, two 
participants tested positive for  B. bifidum (Figure 6.3, panel a, lanes 1 and 6). After the 
second, nested round of PCR, all participants tested positive for the B. bifidum specific 
marker (Figure 6.3, panel b). PCR products were subsequently sequenced and 
confirmed to be identical in sequence to BBB_0726. 
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Table 6.6: Specific marker region in Bifidobacterium genomes 
 
 
 
 
Species Strain 
% 
identity 
Alignment length 
(bp) Mismatches Gaps 
B. bifidum NCIMB 41171 99.23 1076 9 0 
B. bifidum IPLA 20015 99.23 1076 9 0 
B. bifidum LMG 13195 99.40 1076 7 0 
B. bifidum S17 99.83 1076 2 0 
B. bifidum PRL2010 99.74 1076 3 0 
B. bifidum BGN4 98.89 1076 13 0 
B. bifidum CUL 20 100.00 1076 0 0 
B. longum DJO10A 75.79 318 65 11 
B. longum NCC2705 75.79 318 65 11 
B. longum ATCC 55813 75.79 318 65 11 
B. longum CCUG 52486 75.79 318 65 11 
B. longum ATCC 15697 75.47 318 66 11 
B. breve DSM 20213 75.82 273 60 5 
B. dentium Bd1 77.16 232 51 2 
B. dentium ATCC 27678 77.16 232 51 2 
B. catenulatum DSM 16992 76.45 242 50 7 
B. animalis subsp. lactis HN019 76.02 246 52 7 
B. animalis subsp. lactis CUL 34 76.02 246 52 7 
B. animalis subsp. lactis Bl-04 76.02 246 52 7 
B. animalis subsp. lactis DSM 10140 76.02 246 52 7 
B. animalis subsp. lactis AD011 76.02 246 52 7 
B. animalis subsp. lactis BB-12 76.02 246 52 7 
B. animalis subsp. lactis V9 76.02 246 52 7 
B. animalis subsp. lactis B420 76.02 246 52 7 
B. animalis subsp. lactis Bi-07 76.02 246 52 7 
B. angulatum DSM 20098 74.00 200 52 0 
B. adolescentis ATCC 15703 73.31 236 51 8 
B. pseudocatenulatum DSM 20438 73.37 199 53 0 
B. gallicum DSM 20093 92.16 51 4 0 
B. adolescentis L2-32 72.77 235 54 9 
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Figure 6.3: Examining adult total faecal DNA from healthy human males enrolled on a probiotic 
(Lab4®) feeding trial (pre-feeding), for the presence of B. bifidum 
Panel (A) shows PCR products from 10 total faecal DNAs (lanes 1-10), a negative PCR water control (lane 
12) and B. bifidum CUL 20 DNA as a positive control (lane 11). Panel (B) shows the same, with DNA testing 
positive for B. bifidum DNA in panel (A) removed. An additional B. bifidum CUL 20 DNA positive control 
for the second round of PCR (lane 10) and an additional water PCR control for the second round of PCR lane 
12). The 413 bp (panel A) and 106 bp (panel B) predicted PCR product sizes (Table 6.3) are indicated. Lane 
M contains molecular size marker with sizes of relevant bands given in bp. 
A) 
B) 
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6.4. DISCUSSION 
Overall, the genus Bifidobacterium encompasses a large amount of genomic diversity and 
a wide pan-genome, with few functions shared across all species. In fact, the gene pool 
pertaining to the whole genus is more than twice the size of a single bifidobacterial 
genome, and the pan-genome of the genus is described as open (Bottacini et al., 2010). 
Within bifidobacterial species however, the story is very different. Genomic diversity 
exists, but individual species are more likely to form discreet pan-genomic units within 
themselves (Bottacini et al., 2010). Here we indexed the genomic diversity in two different 
bifidobacterial species, B. animalis subsp. lactis and B. bifidum, and found the possessed 
differing levels of intraspecies genomic identity. This was most clearly reflected when the 
number of genomic loci that share identical sequences across all isolates of a species was 
examined; 96% of loci examined were identical in sequence among the in B. animalis 
subsp. lactis genomes, contrasting with less than 1% of loci sharing the same sequence in 
the B. bifidum genomes examined.  
 
 
6.4.1. APPLICATION OF RMLST TO BIFIDOBACTERIAL STRAINS 
The diversity of B. animalis subsp. lactis and B. bifidum genomes was well reflected by the 
rMLST analysis (Figure 6.1). The Neighbour-net showed the high level of rps gene 
sequence conservation in all B. animalis subsp. lactis genomes, which was also echoed 
when observed at the genome-wide level. In contrast B. bifidum, exhibited much greater 
diversity in rps gene sequence, mirrored by its more diverse genome-wide MLST profile, 
with conserved sequences detected across all genomes for just 18 loci. rMLST is a useful 
tool therefore, for reflecting genomic diversity of bifidobacteria using a limited set of 
phylogenetic markers that describes genome evolution across a diverse range of 
Bifidobacterium isolates, without the need to investigate phylogeny based on an entire 
core-genome as in Bottacini et al (2010).  
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6.4.2. GENOMIC DIVERSITY OF B. ANIMALIS SUBSP. LACTIS STRAINS 
It is clear that B. animalis subsp. lactis isolates have highly conserved genome sequences, 
with all isolates for which genomes are available being highly congruent in sequence. 
Previous research has shown that for 10 B. animalis subsp. lactis isolates that were 
examined, shared more than 99.82% sequence identity across their entire genome 
sequences and possessed 1,518 identical ORFs (Milani et al., 2013). Milani et al (2013) 
used a manual annotation approach to assign protein coding regions to each genome 
individually, and subsequently compared predicted proteomes of strains to find that only 3 
ORFs were variable in presence among the isolates examined although their existence was 
not experimentally validated. This highlights the variability inherent in annotating genome 
sequences, particularly when multiple annotation platforms are used.  
 
The genome-wide MLST approach does not suffer this pitfall, as it only requires a single 
reference annotation set to which other genome sequences are compared, either as contigs 
or as a complete genome sequence. Here we found no evidence of the 3 variable ORFS 
encoded in any B. animalis subsp. lactis genomes in comparison to the Milani et al. (2013) 
study. When examined for the presence of all protein coding loci defined in the type strain 
B. animalis subsp. lactis DSM10140, just six loci were found to be variably present, and 
with the entire set missing from B. animalis subsp. lactis HN019 and a single ORF, Balat 
1572 missing from CUL34, the only draft genome sequences included in this analysis 
(Table 6.4). The truncation of two loci; Balat_0510 and Balat_0523, in B. animalis subsp. 
lactis suggests that they are present, but at the border of a contig. Both ORFs are identical 
in sequence in B. animalis subsp. lactis suggesting that the truncation occurred as a result 
of an assembly fault. The draft genome of B. animalis subsp. lactis HN019 is smaller 
(1916 kb) than the complete genomes of all other B. animalis subsp. lactis isolates (1938 
kb), so it was inevitable that sequence data would be seen as absent in the comparative 
analysis. To confirm the true absence of these ORFs, experimental validation via 
amplification and sequencing of this genomic region would be required.  
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The addition of the draft genome sequence data generated from B. animalis subsp. lactis 
CUL34 did not alter hypothesis that B. animalis subsp. lactis is a highly clonal taxon with 
its genomic content encoding markedly similar exoproteomes. The reason for the highly 
isogenic nature of this species may be a recent divergence from B. animalis subsp. 
animalis by reductive adaptation to growth in yoghurt (Lee and O'Sullivan, 2010). B. 
animalis subsp. lactis genomes are unique within bifidobacteria because they have no 
genes, or an incomplete number, predicted to be involved in the utilisation of complex 
carbohydrate and polyols such as arabinofuran, arabinogalactan, arabinan, cyclodextrin, 
xylan and sugar alcohols (Lee and O'Sullivan, 2010). The ability to utilise complex 
carbohydrates is a common feature of GIT adapted bacteria, and the prolonged exposure of 
bifidobacteria to environmental niches with less complex nutrient availability has been 
shown to cause deletion of superfluous genomic loci (Lee et al., 2008). The genome 
reduction evolutionary step from B. animalis subsp. animalis to B. animalis subsp. lactis 
may also have implications for its probiotic ability, as bifidobacteria with reduced genomes 
have been shown to be less competitive than their progenitor strains with larger genomes 
(Lee et al., 2008). 
 
6.4.3. GENOMIC DIVERSITY OF B. BIFIDUM STRAINS 
In direct contrast to B. animalis subsp. lactis, B. bifidum genomes are considerably more 
diverse in both presence and absence of protein coding loci, as well as the nucleotide 
sequences of loci that are present. B. bifidum genomes shared fewer loci between one 
another than B. animalis subsp. lactis genomes, as evidenced by a lower percentage of loci 
present in 100% of genomes, and increased numbers of loci present in just one or more 
genomes (Figure 6.2). The loci that are conserved in sequence in all B. bifidum strains 
commonly encode proteins that are related to the ribosome (Table 6.5), whose sequence is 
would be expected to be highly conserved within species (Yutin et al., 2012). Another 
frequently encountered feature of B. bifidum genomics reflected in this analysis (Table 6.4) 
was the large numbers of ORFs of unknown function. It has been hypothesised that the 
proteins encoded by these hypothetical loci may play important roles in the interaction of 
bifidobacteria with the human host (Gueimonde et al., 2012). Further research will be 
needed to define these exact functions however. Previous comparative genomic analysis of 
eight B. bifidum strains indicated that there were large regions of the genome that vary both 
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in presence and sequence among the strains analysed (Turroni et al., 2010), corroborating 
the findings of our own study. 
 
6.4.4. DEVELOPMENT AND TESTING OF A B. BIFIDUM SPECIFIC MARKER 
A simple species-specific PCR test for B. bifidum based on conservation of the species-
unique BBB_0726 ORF was developed (Table 6.3). In this study, access to a limited 
number bifidobacterial isolates or defined strains meant that the specificity of the region 
was tested in silico using tools at the BIGSDB (Section 6.4.4), and when the NCBI non-
redundant database is search using BlastN, only sequences matching B. bifidum genomes 
are returned. BBB_0726 is predicted to encode a phosphomannomutase, an isomerase that 
catalyses the structural rearrangement between alpha-D-mannose 1-phosphate and D-
mannose 6-phosphate. It is a carbohydrate-modifying enzyme that is part of the 
glycosylation pathway, which is well developed in Bifidobacterium species (Barrangou et 
al., 2009, Kim et al., 2009, Schell et al., 2002). The sequence of BBB_0726 was greater 
than 98% conserved in B. bifidum and was much more divergent in sequence in other 
bifidobacteria (Table 6.6), making it an excellent candidate for further development and 
evaluation as a species-specific marker gene. 
 
The B. bifidum BBB_0276 marker showed in a semi-quantitative manner that 20% of 
healthy individuals tested were carrying B. bifidum at the higher detection limit, and the 
remaining 80% carried B. bifidum at levels higher than the lower detection limit, which in 
a similar test in L. acidophilus correlate to approximately 50 cfu and 5,000 cfu 
respectively.  Bifidobacteria are found in relatively high numbers (up to 37% of total 16S 
rRNA gene sequences) in the human gut (Hill et al., 2010a), particularly in infants (up to 
80% of total 16S rRNA gene sequences) (Turroni et al., 2009). Culture-independent 
studies using the 16S rRNA gene as a broad phylogenetic marker do not accurately 
distinguish these bacteria to the species level, and as such there is little reliable quantitative 
information available on the exact distribution of B. bifidum in the human gut.  
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This limited understanding of bacterial species distribution is especially evidenced in 
culture-independent studies markers other than the 16S rRNA gene, for example the groEL 
gene, is used to establish diversity profiles of the faecal microbiota (Hill et al., 2010a). Hill 
et al (2010a) hypothesise that the use of 16S rRNA to speciate bacteria in metagenomic 
studies underrepresents bifidobacterial species by up to 35%. Specific markers for B. 
bifidum based on the 16S rRNA gene have been previously described (Matsuki et al., 1998, 
Matsuki et al., 2003). A PCR test based on the 16S rRNA gene is useful for identification 
of pure cultures and presence/absence of the target organism in a qualitative approach. The 
multi-copy nature of the 16S rRNA operon in B. bifidum (approximately two copies per 
chromosome (Candela et al., 2004)) however, means that its utility for enumeration of cells 
is surpassed by a probe targeting a single-copy gene, such as BBB_0726. Further study to 
evaluate the detection limit of this test and additional development of a fully quantitative 
qRT-PCR test for B. bifidum based on BBB_0726 could be an excellent way to accurately 
quantify levels of B. bifidum in faecal material, especially when applied in a probiotic 
feeding trial.  
 
6.4.5. SUMMARY AND IMPLICATIONS FOR COMMERCIAL BIFIDOBACTERIUM ISOLATES 
The comparative genomic approach taken in this study corroborates existing information 
concerning the diversity of B. animalis subsp. lactis, namely that it is a clonal 
monophyletic taxon. Credible hypotheses for the highly clonal genome of this species have 
been presented and the addition of the genome sequence of B. animalis subsp. lactis CUL 
34 follows the same pattern. B. bifidum is a more genomically diverse species, with the 
inclusion of the genome sequence of B. bifidum CUL 20 into analyses showing previously 
unseen sequences at some loci. 
 
The highly clonal and reduced genomes of B. animalis subsp. lactis isolates means that 
data collected for a particular isolate can be extrapolated across the whole species with 
reasonable confidence. From a commercial perspective, this suggests that any claims made 
on probiotic products containing B. animalis subsp. lactis will be challenging to justify as 
specific to that particular product. The case for individual strains and distinct probiotic 
effects of B. bifidum is much more clear-cut, as although 85% of loci were shared between 
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all strains, their sequences were divergent and suggests they would encode unique 
probiotic activities at the strain level. 
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6.5. CONCLUSIONS 
 
The conclusions from this chapter are as follows: 
 
6. rMLST (rps) gene-based phylogenies are an effective and method for establishing 
both phylogenetic relationships and indexing genomic diversity within the genus 
Bifidobacterium.  
 
 
7. Previous studies showing the clonality of B. animalis subsp. lactis isolates were 
corroborated with the genome-wide MLST approach. B. animalis subsp. lactis 
CUL 34 is a clonal member of this monophyletic taxon. 
 
 
8. B. bifidum genome sequences were considerably more diverse, reflected in both 
rMLST and genome-wide MLST analyses.  B. bifidum CUL 20 represents a novel 
strain with a genome sequence diverse from other isolates of B. bifidum. 
 
 
9. The development of a B. bifidum specific PCR test, based on a single copy gene, is 
useful for detecting the presence of B. bifidum in total faecal DNA. Its specificity 
will require further testing, however if validated it could be further developed into a 
fully quantitative species-specific probe. 
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7. GENERAL CONCLUSIONS, DISCUSSION AND PERSPECTIVE  
 
7.1.1. CONCLUSIONS 
A comprehensive study describing the diversity of probiotic bacteria at the strain level was 
undertaken. Particularly in the case of L. acidophilus, a diversity analysis encompassing the 
number of isolates investigated in this study has never been undertaken.  The techniques and 
methods applied reflected changing times in molecular strain-typing. Isolates of three major 
probiotic species were characterised and typed using classical phenotypic techniques, 
genotyped using conventional DNA fingerprinting techniques, which was then extended to 
the most novel, state-of-the-art whole-genome resequencing strategies. By using this range of 
methods we were able to index the variation between them at multiple levels, right down to 
the resolution of single nucleotide polymorphisms. The use of newly-developed next 
generation sequencing techniques also allowed the detailed examination of a hitherto 
unachievable number of genome sequences.  
 
Below are the main conclusions from this study: 
 
1. L. acidophilus isolates show limited genetic diversity when assessed with RAPD. 
When their whole genome sequences are compared however, they separate into two 
broad groups representing commercial isolates and culture collection isolates, 
although the differences between the groups are small and the L. acidophilus  core 
genome is stable across all isolates tested (Chapters 2 and 4). 
 
RAPD profile similarity analysis is an effective and highly reproducible method of examining 
their sub-species level genetic diversity. The L. acidophilus isolates we examined were from 
disparate isolation locations, deposition dates and host species. A single RAPD profile type, 
based on 75% profile similarity, was generated by all L. acidophilus isolates tested. This 
indicated that L. acidophilus isolates were all of a single strain type at the level of resolution 
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offered by RAPD analysis. Absolute genetic identity of these isolates could not be 
conclusively verified using RAPD profile similarity analysis alone, so further investigation at 
a discriminatory power beyond that of RAPD, was undertaken examine the underlying genetic 
structure of L. acidophilus and whether, as a species, it truly is clonally monophyletic. 
 
Further to an initial survey with RAPD profile similarity analysis, a whole genome 
resequencing and comparison strategy was undertaken on a large collection of L. acidophilus 
isolates. This provided insight into the level of genomic variation required to translate to a 
significantly different RAPD profile type. L. acidophilus isolates broadly divided into two 
groups, representing isolates from culture collections and commercial isolates sold as 
probiotic supplements or cultivated from products. Limited RAPD profile variation had been 
observed within L. acidophilus isolates, but this did not correlate to the commercial or culture 
collection heritage of the isolates tested. 
 
Commercial use or marketing a particular strain of L. acidophilus should be dependent on a 
unique phenotypic characteristic in relation to is probiotic or food-additive properties. Given 
the extensive homogeneity of the genome sequences of commercial isolates of L. acidophilus, 
our results potentially provides companies with the opportunity to assume that evidence of 
probiotic effect demonstrated in studies undertaken on one particular isolate of L. acidophilus 
would support their own strains equally as well. The demonstration of unique or enhanced 
probiotic ability in a single isolate may however set it apart from the others, but the validity of 
such a property may be questionable until detailed phenotypic studies encompassing the 
diversity of isolates seen in this study are conducted.  
 
With very minor phenotypic differences among the L. acidophilus isolates observed in growth 
rate and protein-profile, it is hard to imagine given the level of clonal identity and limited 
number of non-synonymous mutations that any phenotypes of the isolates will differ greatly. 
This leads to hypothesis that more than any other factor, the commercial success of L. 
acidophilus lies in its stability and possession of phenotypes that have remained unaffected by 
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evolution due to mutation or horizontal gene transfer events.  Perhaps like many other 
organisms it has been “domesticated” to be man’s best friend when it comes to the microbial 
enhancement it brings to dairy products and digestive supplements used by humans over the 
ages. 
 
2. L. acidophilus is a minor constituent of the GIT microbiota that is variably present 
in humans and was not detected in wild rodents (Chapter 2). 
 
To attempt to ensure that the true genetic diversity of L. acidophilus was reflected by the 
isolates examined and to reduce the bias of our collection toward commercial and culture 
collection isolates, wild rodent faeces was examined as potential source of natural L. 
acidophilus isolates. To effectively search for L. acidophilus in wild rodent faeces, a species-
specific molecular marker for L. acidophilus was developed and proved highly effective for 
detecting this species. No L. acidophilus was cultivated from wild rodent faeces or detected 
via the cultivation-independent approach, indicating that was either absent or present in 
numbers too low to detect within rodent faeces. Overall, our survey of wild rodents suggests 
that they do not naturally carry L. acidophilus within their GIT tract. Wider surveys of animal 
species using these tools may now be carried out to identify potential sources organisms 
beyond man and domesticated animals. 
 
Also in the course of this study, the distribution of L. acidophilus human GIT carriage was 
estimated on a small-scale in healthy adults, using the species specific PAU-region PCR test. 
As with the wild rodent study, these probes were applied to total DNA extracted from faeces 
as an indicator of GIT carriage. When estimated in this way, it was shown that L. acidophilus 
carriage was highly variable, with between 32% and 75% of individuals carrying L. 
acidophilus at a low level. Corresponding culture independent studies indicate that lactobacilli 
may compose just 0.2-1% of the total microbiota in the human colon and faeces and also 
show that their prevalence is highly variable between individuals (Kleerebezem and Vaughan, 
2009, Walter, 2008). Metagenomic studies commonly use molecular markers to elucidate 
bacterial community structure, particularly the sequence of the bacterial 16S rRNA gene. As 
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was shown in Chapter 3, the 16S rRNA gene sequences of certain Lactobacillus isolates are 
more than 98% similar when assessed across their whole length (>1200 bp) and potentially 
more similar if just a partial 16S rRNA gene sequence is used. To fully capture the diversity 
of Lactobacillus an alternative, more diverse molecular marker should be employed in culture 
independent diversity studies.  
 
The gene that encodes the universal 60-kDa chaperonin protein Hsp60 has been used to study 
the diversity of Bifidobacterium in the GIT (Hill et al., 2010b) and may be a good alternative 
to the 16S rRNA gene for profiling very diverse communities of bacteria that contain clusters 
of very closely related species, such as the lactobacilli (Blaiotta et al., 2008). As a corollary, 
the diversity of the gut microbiome may not be particularly well estimated by studies that use 
faecal samples as an endpoint for community profiling, although it is a non-invasive method. 
Overall, gut carriage of L. acidophilus appears highly variable and while the species is clearly 
capable surviving passage through the gastrointestinal tract of humans (Mahenthiralingam et 
al., 2009), it is questionable as to whether the gut is the optimal or ancestral niche of this 
species. 
 
3. Comparative genomics and genome (re)sequencing of probiotic bacteria will become 
a “gold standard” method for characterisation and typing of isolates, and it is 
imperative that the metadata attached to publically available genome sequence 
information should be scrutinised stringently to ensure accuracy before subsequent 
analysis (Chapters 3, 4 and 6). 
 
We showed that the genome sequence of L. acidophilus 30SC was wrongly attributed to L. 
acidophilus, when it was more similar to L. amylovorus (Bull et al., 2012). The reliance of 
future analyses on the data provided with genome sequence depositions means that it is 
imperative that this metadata is correct. Fundamental components of this data are the correct 
taxonomic placement and species name that is attached to the genome record. The 
proliferation of genome resequencing means that a technology once restricted to the cutting-
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edge of genomics is now available to a wider audience, including non-specialists and 
commercial parties. They may be unaware of such misidentification, and assume that a 
genome sequence deposited in a curated database and announced in a well-respected journal 
is to be trusted without performing their own analysis. Secondarily, organisms of considerable 
ecological, clinical and commercial interest, like L. acidophilus and L. amylovorus, may have 
probiotic effects that are strain-specific, and therefore ensuring that genome sequences of 
these bacteria are assigned the correct taxonomic nomenclature is vitally important. With a 
complete genome, researchers have all the information required to obtain the correct 
taxonomic nomenclature or evolutionary placement of a bacteria isolate. 
 
To provide all interested parties, but particularly those that are not specialist genome (re)-
sequencing laboratories, with a simple and effective method for establishing the provenance 
of their genome sequence, a bioinformatics workflow was developed. 16S rRNA, gyrB and 
pheS genes were designated as DNA biomarker genes and when applied to the L. acidophilus 
30SC genome sequence the bioinformatics workflow showed that its genome was more 
similar to L. amylovorus LMG 9496. Secondarily, whole genome comparisons of available L. 
acidophilus and L. amylovorus genome sequences also showed that the genome of L. 
acidophilus 30SC showed greater synteny with L. amylovorus UCC1118 than L. acidophilus 
NCFM. This simple bioinformatic workflow and the need for correct genome taxonomy 
placement were recently validated by Mende et al. (2013), who developed a fully automated 
bioinformatic pipeline for bacteria species assignment using genome sequence data. Once it is 
certain that the data accompanying genome sequences are correct, the ability to integrate 
genome sequence data with a comparison platform, such as the BIGSDB, means that future 
phylogenetic analyses will be carried out using all of the information available within a 
genome sequence, attaching to it any pertinent phenotypic or physiological information that 
may be required for comparison. This type of analysis lends itself to investigating the 
evolution of particular physiological characteristics of bacterial strains and species. 
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4. Methods for phenotypically characterising and typing LAB have generally been 
superseded in accuracy by DNA sequence based methods. Commercial and culture 
collection L. acidophilus isolates do not significantly differ phenotypically (Chapter 
5). 
Conventional biochemical methods for identifying L. acidophilus such as carbohydrate 
fermentation profiling show that isolates of vary considerably in their phenotype. However, 
by their very nature, phenotyping tests like the API 50 CHL are less sensitive than typing tests 
based on nucleic acids, i.e. a single isolate may display a wide range of phenotypic test results 
and still be classified as the same species. The number of variable traits assessed by API 50 
CHL is limited and cannot compare to either variation inherent in DNA sequence or 
potentially, the stability offered when the background genotype is stable and invariant as seen 
with L. acidophilus. This means that without any a priori knowledge of an isolate, API tests 
are demonstrably less accurate and reliable than DNA sequence based methods. They should 
no longer be used as a tool for commercial L. acidophilus quality control or typing unknown 
isolates, particularly when there are more accurate, faster and cheaper molecular methods to 
achieve the same result. 
 
There were no detected significant differences in growth kinetics between culture collection 
and commercial L. acidophilus isolates. MMS exposed L. acidophilus isolates did not grow to 
different culture densities or with different maximum growth rates in comparison to their 
parental commercial L. acidophilus strain NCFM however, as a group, they did have a longer 
lag phase. L. acidophilus isolates showed limited diversity in MALDI-TOF profiles which 
was not related to their genotypes. Given that commercial L. acidophilus isolates were 
genomically homogenous, they did display a degree of phenotypic diversity when analysed 
with MALDI-TOF MS and API 50CHL carbohydrate profiling. As this diversity does not 
have an obvious foundation in the genome, it may be possible that exogenous circumstances 
such as culture conditions, stress, or the inherent differences in handling cells within these 
procedures  leads to the minor phenotypic diversity seen in L. acidophilus. Potentially, if the 
proprietary status of commercial L. acidophilus isolates is lost because they are not 
demonstrably genomically different from company to company, the ability to manipulate and 
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obtain a stable and defining phenotype of probiotic L. acidophilus isolates could form new 
criteria from which to derive patents. 
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7.1.2. DELIVERABLE TOOLS AND STRATEGIES FOR TRANSLATION TO INDUSTRY (CULTECH) 
 
7.1.2.1. Specific markers for L. acidophilus and B. bifidum 
Species specific markers based on the PAU3 region in L. acidophilus, and a unique 
phosphomannomutase gene in B. bifidum, were developed as part of this study (Chapter 2 and 
Chapter 6). These molecular tools may be used to track these species as part of a culture-
based feeding study, expanding on previous work which used RAPD profiles to type isolates 
(Mahenthiralingam et al., 2009), increasing throughput and ensuring a positive/negative test 
rather than one that relies on matching DNA fingerprints. When used in a culture independent 
context, the specific marker tests were designed as a two stage, nested PCR and hence 
provided a level of semi-quantitative information about the numbers of their respective target 
organisms. The single copy nature of the gene targets for these probes make them excellent 
candidates for development into a fully quantitative qRT-PCR test. This would allow future 
probiotic feeding studies to accurately enumerate numbers of L. acidophilus and B. bifidum, 
both before and after feeding, to examine the dynamics of the impact made on the gut 
microbiota in terms of probiotic numbers. 
 
7.1.2.2. Development of a simple method for describing genome sequences before 
deposition 
As previously discussed, the ever decreasing costs of high-throughput next-generation 
sequencing technologies means that genome (re)sequencing is becoming available to 
commercial enterprises and non-experts, instead of being restricted to a few, expert groups. 
Many commercial laboratories still use phenotypic techniques such as carbohydrate 
fermentation profiling to identify unknown isolates, and this data should not be relied upon 
alone to inform the metadata attached to a genome sequence. The developed bioinformatic 
workflow (Chapter 3) allows non-expert groups to confidently identify a genome sequence, 
and make a good estimate of its taxonomic placement. The genome sequence also provides an 
all-encompassing measure of quality control and stability of commercial strains and in future 
should be used as the gold standard measure for probiotic regulation and patent/commercial 
claims. 
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7.1.2.3. Draft genome sequences for all isolates within the Lab4® probiotic 
supplement 
In 2008 (Vankerckhoven et al.) it was identified that conventional biochemical methods for 
characterising probiotic bacteria were insufficient and should be supplemented with molecular 
methods performed by an expert laboratory, such as those that maintain culture collections. 
With probiotic sales in the ascendancy, an important part of the marketing of probiotic 
products is the ability to label these foods with a health claim. Any petition to a regulatory 
agency for a health claim will have to name or describe the active ingredients in the product to 
be approved and provide evidence of efficacy (Farnworth, 2008). Polyphasic characterization 
combining phenotypic, biochemical, genotypic, and whole genome-sequencing results is 
considered to be the only way to reliably identify bacteria to the strain level (Mainville et al., 
2006), which is important as even closely related bacterial species can have different probiotic 
properties. To obtain a health claim for a probiotic product, food manufacturers will have to 
precisely define their microorganism (Farnworth, 2008, Vankerckhoven et al., 2008). The 
availability of a set of almost-complete, draft genome sequences for the four probiotic strains 
marketed by Cultech, given in the context of other commercially available strains, provides 
invaluable information concerning their identity at a more complete level than can be 
achieved with all other existing methods such as RAPD, PFGE, carbohydrate utilisation 
profiling and MALDI-TOF MS.  
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7.1.3. GENERAL DISCUSSION 
 
The implications and questions-raised during this study in the wider context of commercial 
probiotic usage and their history are discussed below. Focussed discussion of the results 
generated in each chapter is available at the end of each chapter and summarised here (see 
Section 7.1.1). 
 
7.1.3.1. Why is L. acidophilus used as a probiotic? 
The historical background for the use of L. acidophilus as a probiotic is well documented, but 
what was known as L. acidophilus in 1920 is vastly different to what is known as L. 
acidophilus sensu stricto in the present day (Figure 1.1). The elucidation of the probiotic 
functionality and physiology of L. acidophilus was undertaken after its status as a probiotic 
organism had been decided and “grandfathered-in” from the broader, historical definition of 
L. acidophilus. With the knowledge of the minor role of lactobacilli (L. acidophilus in 
particular) in the human GIT, at least in terms of it proportional representation, the question of 
why L. acidophilus is used as a probiotic is raised. 
 
Historically, soured milk drinks were originally developed as preservation methods for milk 
products, and there are references to sour milk or fermented cultures as far back as the Bible 
(Anukam and Reid, 2007). Probiotic theory is attributed to Elie Metchnikoff who noted that 
the regular consumption of lactic acid bacteria in fermented dairy products, such as yoghurt, 
was associated with enhanced health and longevity in Bulgarian peasant populations. He 
linked this to the ‘Bulgarian bacillus’, a constituent of fermented milk products, which was 
discovered by a 27-year old Bulgarian physician Stamen Grigorov. Grigorov later had noted 
that bacteria in yogurt and other fermented milk products aided digestion and improved the 
immune system laying the foundations of potential probiotic health benefits (Grigoroff, 1905). 
Metchnikoff formalised this notion and posed the idea that aging was related to toxic bacteria 
in the gut. He proposed that if milk (kefir) soured with Bulgarian bacillus (now known as L. 
bulgaricus subsp. bulgaricus) was drunk regularly it mitigated the effects of aging and 
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“autointoxication” (Metchnikoff, 1907). A substantial number of studies were undertaken by 
contemporaries of Metchnikoff, investigating the effect of the application of L. bulgaricus 
subsp. bulgaricus to rabbits, guinea pigs and monkeys (Bested et al., 2013); preparations 
containing the bacterium were also made commercially available. Experimentation in 1920 
showed that all attempts to colonise the GIT of humans with L. bulgaricus subsp. bulgaricus 
failed, whereas what was known as L. acidophilus at the time (Figure 1.1) was able to 
colonise successfully (Cheplin and Rettger, 1920). This led to the broad commercial adoption 
of L. acidophilus as a probiotic. 
 
As a result of the commercial adoption of L. acidophilus, a great deal of its probiotic 
physiology has been documented ex vivo, under laboratory culture conditions and in isolation 
from the other microbiota that make up the highly complex and diverse gut. It therefore 
remains to be shown whether the same ex vivo probiotic physiologies are observed in the 
diverse and competitive GIT environment. Seemingly, the study of L. acidophilus in a 
probiotic context has been undertaken rather top down manner, deriving from the isolation of 
isolates capable of passage and apparent colonisation of the gut. What we now know to be a 
diverse group of lactose producing bacteria, originally used to preserve food whose 
consumption was postulated to prolong the life of early 20th century Bulgarians, were 
assumed to be probiotic. One could sceptically propose that the study of probiotic physiology 
markers for species “assumed to be probiotic” are often  undertaken largely to support the 
conclusion that the particular species is probiotic. The high genomic and proteomic stability 
of L. acidophilus sensu stricto isolates observed in this study may go some way to explain the 
continued widespread commercial use and probiotic success it has. Such stability provides a 
guarantee that it can be grown and packaged reproducibly, remain unaffected by 
mutation/gene transfer/gene loss, and hence provide the same probiotic health effects over and 
over again. These are fundamental characteristics needed for commercial success of any 
product, and hence L. acidophilus can be likened to a stable currency for the probiotic market. 
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7.1.3.2. Commercial implications of clonal probiotics 
It is highly likely that the global use of probiotic bacteria by man has influenced their 
genomic diversity, and ultimately even altered their population structure. This study shows 
that commercial probiotic isolates of L. acidophilus are genotypically more similar to 
themselves than isolates that have not been marketed as probiotic supplements. The 
homogeneity of genome sequences of commercial L. acidophilus isolates raises the question; 
what is the value of typing strains using molecular techniques such as RAPD, PFGE and 
MLST if appreciable sequence variation is not seen until the species level? The inability to 
distinguish one company’s proprietary L. acidophilus isolate from another using methods 
such as PFGE, RAPD and MLST means that products will not satisfy the product label claim 
criteria set out by Farnworth (2008), unless L. acidophilus is treated as a clonally 
monophyletic species with no single proprietary isolates. Given the rapid ascent of next 
generation sequencing technologies, defining the genome of probiotic strains should now 
supersede the criteria set out by Farnworth et al. (2008)as a much more meaningful genotypic 
measure.  
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7.1.4. DIRECTIONS FOR FUTURE RESEARCH 
 
1. Establish the link between phenotype and genotype of L. acidophilus isolates. Even 
though the overall coding capacity of L. acidophilus genomes is very similar, does 
the difference in sequence within genes appreciably alter probiotic physiology?  
The effect of gene sequence on single probiotic physiological characteristics could be tested 
ex vivo using previously described assays that measure features such as tolerance to bile 
(Pfeiler et al., 2007) and low pH (Azcarate-Peril et al., 2004), ability to adhere to epithelial 
cells (Buck et al., 2005) and production of antimicrobial compounds (Tabasco et al., 2009). 
This would provide a demonstrable measure of how the probiotic effect differs in each 
particular isolate, and presumably would be useful for companies marketing L. acidophilus 
probiotics to differentiate their proprietary isolate from a competitor’s. Moreover, given that 
we know the genetic basis for gene differences between the genome sequenced isolates, we 
are in a position to try to model exactly which pathways these minor differences would alter. 
 
 
2. Extend the semi-quantitative species specific molecular probes for L. acidophilus 
and B. bifidum into a fully quantitative test using quantitative PCR (qPCR). 
Highly specific, fully quantitative probes for probiotic species are useful in feeding trials. The 
function of a probiotic largely occurs in the large intestine, so therefore it must be established 
whether the probiotic reaches the large intestine, and in what numbers. Follow up validation 
of the PAU3 and B. bifidum PCRs using quantitative real time PCR approaches will be 
required to test their efficacy for strain quantitation and tracking. 
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7.1.5. COLLABORATIVE RESEARCH EXTENDING THE METHODS AND SKILLS DEVELOPED 
WITHIN THIS PROJECT 
During this study, a feeding trial using the Cultech Lab4® probiotic supplement was ongoing 
in healthy human male adults. To rapidly and cost-effectively profile the bacterial diversity of 
faecal samples taken from this study, Ribosomal Intergenic Spacer Analysis (RISA) was 
trialled as a method for examining the variable intergenic spacer region of the bacterial 
ribosomal operon. The profiles generated were compared in a similar approach to the RAPD 
profile generated in Chapter 2. The exceptionally high bacterial diversity of human faeces, 
coupled with groups of very closely related species meant that this technique was not 
effective for profiling bacterial diversity of the GIT. 
 
During the course of this PhD, an opportunity to use RISA in a much less diverse bacterial 
system arose. RISA was used to great effect to profile the bacterial diversity of cystic fibrosis 
(CF) sputum. CF sputum diversity is variable between individuals, and many of the bacteria 
present are undetectable by commonly used culture-based methods. Anaerobic bacteria also 
grow to high densities in CF sputum and these are not captured by routine aerobic culture 
used in standard diagnosis of CF infection. Very low diversity or monoculture sputum is 
associated with rapid decline in host prognosis. It is therefore vital to quickly and accurately 
profile the diversity of CF sputum to correctly treat the condition. The initial analysis 
validating the RISA could be used to qualitatively measure changes in bacteria diversity 
within CF sputum was published as part of: 
 
Baxter, C. G., Rautemaa, R., Jones, A. M., Webb, A. K., Bull, M., Mahenthiralingam, E. 
& Denning, D. W. (2013) Intravenous antibiotics reduce the presence of Aspergillus in adult 
cystic fibrosis sputum. Thorax, 68 (7) 652-657. 
 
A copy of this publication is included as Appendix 2 and further studies using the RISA 
method to examine CF infection are in preparation. 
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